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Abstract
Satellite cells are defined by their position beneath the basal lamina of myofibres, and 
are a source of new myonuclei in adult skeletal muscles. However, other phenotypes 
also contribute to muscle regeneration, and the relative importance of satellite cells is 
not known. This work aimed to analyse the stem cell potential of,satellite cells by 
formally investigating their contribution to muscle regeneration.
Myofibres isolated from extensor digitorum longus, soleus, and tibialis anterior 
muscles were found to have respective means of 7, 22 and 10 associated satellite cells. 
When a single myofibre was grafted into an irradiated dystrophic mouse muscle, the 
associated satellite cells underwent extensive, stem cell-like proliferation, generating 
progeny which sometimes gave rise to a cluster of more than 100 new myofibres. 
Cluster size varied according to the muscle group from which the graft was derived, 
but was not proportional to satellite cell number. Primary myoblasts derived from 
equivalent muscle groups did not undergo such extensive proliferation, or show inter­
muscle variability, suggesting that stem cell activity is critically dependent on a 
component of the satellite cell niche. Single myofibres isolated from irradiated 
muscles were non-myogenic after grafting.
Satellite cells associated with single myofibres were found to generate new satellite 
cells in engrafted muscles, demonstrating that satellite cell compartment is maintained 
by self-renewal.
When single myofibre-engrafted muscles were damaged with myotoxin, graft-derived 
cells underwent rapid clonal expansion to regenerate compact clusters of donor- 
derived myofibres. The percentage of engrafted muscles containing identifiable 
donor-derived nuclei was increased after damage, showing that previously inactive 
cells had been recruited into an active myogenic program. Without experimentally- 
induced damage, frequency of muscle formation and cluster size were spontaneously 
augmented over time.
These findings demonstrate that satellite cells have several stem cell-like qualities, 
and thus constitute a self-sufficient and sustainable source of regeneration in adult 
muscles.
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Chapter 1 
Introduction
1.1 General introduction
Adult skeletal muscle has a remarkable ability to regenerate functional tissue 
following damage (Studitsky 1964, Carlson 1968, 1970, Heslop et al. 2000, Luz et al.
2002). The progressive clinical decline of patients suffering from myopathies such as 
Duchenne’s muscular dystrophy (DMD) is in part attributable to failure of the 
regenerative process (Dubowitz 1985, Dubowitz 1992, Rafael et al. 1997, Decary et 
al. 2000).
Satellite cells are anatomically defined by their position beneath the basal lamina of 
myofibres (Mauro 1961), and are thought to be the main source of new myonuclei in 
regenerating skeletal muscles (Moss & Leblond 1971, Snow 1978, Lipton & Schultz 
1979, Rosenblatt et al. 1995, reviewed, Partridge 2002a). In addition, differentiated 
muscle can be derived from sources outside the satellite cell compartment, both from 
separate precursor populations thought to be resident within the tissue (Asakura et al. 
2002, Polesskaya et al. 2003), and from circulatory phenotypes (Ferrari et al. 1998, 
Camargo et al. 2003). Circulating one marrow-derived precursors have also been 
shown to generate anatomically-defined satellite cells (LaBarge & Blau 2002, Dreyfus 
et al. 2004). Although the satellite cell pool is maintained throughout adult life, the 
mechanism by which functional satellite cells are renewed is not fully understood 
(reviewed, Zammit & Beauchamp 2002). The findings of in vitro studies have shown 
that cultured muscle precursor cells (MPC) are capable of maintaining a reserve 
population during differentiation, predicting that satellite cells are capable of self­
renewal (Baroffio et al. 1996, Yoshida et al. 1998, Zammit et al. 2004a). Similarly, 
transplants of MPC into mouse muscles both contribute to differentiated myofibres, 
and generate a reserve population of undifferentiated reserve cells (Yao and Kurachi 
1993, Blaveri et al. 1999, Gross and Morgan 1999, Heslop et al. 2001), at least a 
proportion of which reside within the satellite cell compartment (Blaveri et al. 1999,
21
Heslop et al. 2001). However, the contribution of such cells to subsequent myotoxin- 
induced regeneration is modest in proportion to the original number of grafted cells 
(Gross & Morgan 1999). The poor ability of bone marrow grafts to contribute to 
myotoxin-induced regeneration (Camargo et al. 2003, Corbel et al. 2003) similarly 
suggests that bone marrow-derived satellite cells have insignificant functional 
potential. Consequently, although the regenerative ability of adult skeletal muscle 
(Studitsky 1964, Carlson 1968, 1970, Heslop et al. 2000, Luz et al. 2002) is strongly 
resonant of stem cell function, robust myogenic stem cell activity has not yet been 
localised to any defined phenotype.
Dissecting the relative contributions of the various putative myogenic precursors is 
key to understanding the mechanism of adult skeletal muscle repair. The role of the 
satellite cell compartment remains incompletely defined. Satellite cells could be 
committed, intermediate progenitor cells whose differentiation is temporarily blocked, 
and which have a limited proliferative capacity but are renewed by a separate stem 
cell population. Alternatively, satellite cells might be self-renewing adult stem cells 
which are themselves the basal origin of new myonuclei in regenerating muscles (Fig. 
1.2). This thesis has aimed to analyse the stem cell potential of satellite cells by 
formally investigating their contribution to skeletal muscle regeneration.
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1.2 Structure and origin of skeletal muscle
1.21 The anatomy of adult skeletal muscle
Skeletal or striated muscle is a highly specialised contractile tissue that is responsible 
for movement of the skeleton. It consists predominantly of elongated bundles of 
myofibres ( ‘fasciculi’) that contract to generate directional force (Zammit & 
Beauchamp 2001). Individual fibres are separated by delicate supporting tissue called 
endomysium. The several fasciculi that comprise each muscle are surrounded by the 
perimysium, a loose collagenous sheath, and the whole muscle body is encased in a 
denser collagenous sheath called the epimysium. These connective tissues are 
continuous with those of the tendons and muscle attachments and supply muscle with 
nerves and blood vessels (Getty 1975, Burkitt et al. 1993). (Fig. 1.1)
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Fig. 1.1. The anatomy of adult skeletal muscle. Reproduced from Getty (1975).
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1.22 Myofibres as syncytia
Individual myofibres are highly differentiated cells that each consists of a contractile 
protein apparatus regulated by several hundred peripheral nuclei (Zammit & 
Beauchamp 2001). Counts of total nuclei in myofibres isolated from murine muscles 
have shown that on average, soleus myofibres have 458 nuclei (Zammit et al. 2002, 
unpublished data, J.D. Rosenblatt & T.A. Partridge), extensor digitorum longus 
(EDL) myofibres have 273 myonuclei (Zammit et al. 2002, unpublished data, J.D. 
Rosenblatt & T.A. Partridge), and tibialis anterior (TA) myofibres have around 600 
nuclei (unpublished data, J.D. Rosenblatt & T.A. Partridge). In the rat, counts on 
serial histological sections have determined a mean of 105 nuclei per mm in soleus 
myofibres and 47 nuclei per mm in EDL myofibres (Schmalbruch & Lewis 2000). 
The much larger size of human muscles implies that their myofibres have even greater 
numbers of nuclei, although in contrast to rodents, many human myofibres are 
segmental and therefore each consist of several discrete cells (Bonavaud et al. 2002).
The post-mitotic nature of myonuclei was first demonstrated by Stockdale and 
Holtzer, who showed that 3H-thymidine added to cultures of embryonic chick muscle 
cells was incorporated rapidly into the nuclei of mononucleate myoblasts, but only 
found in the nuclei of multinucleate myotubes after they had been generated by fusion 
of already-labelled mononucleate cells. Syncytial myofibres were not, therefore, 
formed by myonuclear replication in the absence of cytokinesis (Stockdale & Holtzer 
1961). The original observation that muscle could be formed by differentiation of 
mononucleate cells probably comes from the early tissue culture experiments of 
Harrison, who reported that cross-striated fibres were generated from myoblasts 
emanating from tadpole myotome explants (Harrison 1910, cited in Lewis & Lewis 
1917). These workers did not, however, observe these fibres to have been generated 
by fusion of several cells. Later, the in vitro formation of myotubes by fusion of 
mononucleate precursors was observed directly, in clonal cultures (Konigsburg 1961, 
1963) by using time-lapse photography (Cooper & Konigsburg 1961), and by co- 
culturing of 3H-thymidine labelled and unlabelled rat myoblasts (Yaffe & Feldman 
1965). Evidence that these in vitro data recapitulated developmental myogenesis was 
derived from the generation of chimaeric mouse embryos from homozygotic parental 
strains expressing different isoforms of particular metabolic enzymes. The formation
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of heteromeric isoforms of the enzymes in the chimaeras demonstrated that nuclei 
derived from both parental strains shared the common cytoplasm of mosaic myofibres 
(Mintz & Baker 1967, Gearhart & Mintz 1972). In adult tissue, treatment of rat 
muscle with 3H-thymidine similarly showed that mononucleate precursors, but not 
myonuclei, incorporated radioactive label. However, when labelled cells were grafted 
into a new muscle, they became incorporated into host myofibres (Snow et al. 1978). 
Likewise, it was found that heteromeric enzymes were generated in engrafted adult 
mouse muscles when the donor and host strains expressed different homomeric 
enzyme isoforms (Partridge et al. 1978, reviewed, Partridge 1982). Together, these 
studies showed that throughout developmental myogenesis and adult regeneration, 
myofibres are derived from the fusion of mononucleate precursors and are themselves 
of a consistently postmitotic nature.
1.23 The developmental origin of skeletal muscle
(a) Developmental origin of skeletal muscles
The paraxial mesoderm of the vertebrate embryo gives rise to the somites, epithelial 
balls of cells that are located on either side of the neural tube and notochord, and are 
the origin of skeletal myogenesis (Chevallier et al. 1977). The ventro-medial region 
of each somite forms into the mesenchymal cells of the sclerotome, which later 
generates the axial skeleton and ribs. The dorso-lateral region of the somite gives rise 
to the dermomyotome from which skin and muscular tissues are derived. The epaxial 
(body wall) muscles are generated from the dorso-medial lip of the dermomyotome, 
whilst the hypaxial (limb, tongue and ventral wall) muscles derive from the dorso­
lateral lip. Some craniofacial muscles originate from the unsegmented anterior 
paraxial mesoderm (reviewed, Christ & Ordahl 1995, Francis-West et al. 2003, 
Buckingham et al. 2003).
The dorso-lateral lip of the dermomyotome delaminates and gives rise to the limb 
muscle progenitors, in a process controlled by the paired box transcription factor Pax3 
(Williams & Ordahl 1994, Daston et al. 1996). Pax3 is expressed throughout the 
somite during its formation, but becomes restricted to the dermomyotome as 
development progresses (Schubert et al. 2001). In PaxS'1' Splotch mice (Auerbach 
1954), cells do not delaminate from the hypaxial dermomyotome and the limb
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muscles fail to develop (reviewed, Birchmeier & Brohmann 2000). Pax3 is required 
for expression of the hepatocyte growth factor (HGF) receptor, c-met (Epstein et al. 
1996). Mice lacking either HGF or c-met similarly do not develop skeletal muscles 
(Schmidt etal. 1995, Bladt etal. 1995).
Muscle progenitors migrating into the limb bud express myogenic regulatory factors 
(MRFs), basic helix-loop-helix family transcription factors that define committed 
myogenic precursors (reviewed, Pownall et al. 2002). Of the four vertebrate MRFs 
(Myf5, MyoD, Mrf4 and myogenin), the Myf5 gene is expressed earliest (Braun et al.
1992), followed by MyoD (reviewed, Pownall et al. 2002, Francis-West et al. 2003). 
Myf5 is expressed in response to signalling from the neural tube, whilst MyoD 
expression is controlled by signals from the dorsal ectoderm (Cossu et al. 1996). 
Although relatively normal muscle development occurs in the absence of either Myf5 
(Tajbakhsh & Buckingham 1994) or MyoD (Rudnicki et al. 1993), in M yf^'/MyoD'1’ 
double mutants the primitive progenitor population fails to form and skeletal muscles 
are absent (Rudnicki et al. 1993). Whilst either Myf5 or MyoD are sufficient as 
determinants, they define different myogenic precursor cell subsets (Kablar et al.
2003) that adopt alternative non-muscle fates in mutants (Tajbakhsh et al. 1996b, 
Kablar et al. 2003). The MRF myogenin acts downstream of Myf5 and MyoD, and is 
required to support muscle differentiation (Hasty et al. 1993, Rawls et al. 1995, 
reviewed, Francis-West et al. 2003). Mrf4 protein is also thought to be involved in 
differentiation (Naidu et al. 1995).
Migrating muscle precursors express the homeobox genes Lbxl and Msxl. Lbxl 
expression is initiated prior to delamination, maintained by migratory cells, and 
downregulated on differentiation. In Lbxl mutants, the migration of muscle precursors 
is inhibited and development of limb muscles severely restricted (Gross et al. 2000, 
reviewed, Birchmeier & Brohmann 2000). Msxl protein prevents premature 
differentiation and maintains proliferation (Houzelstein et al. 1999). Fibroblast 
growth factor receptor 4 (FGFR-4) is thought to be involved in the arrest of 
proliferation prior to differentiation (Maries et al. 2002).
Primary muscle fibres are formed in the first wave of embryonic myogenesis, in a 
nerve-independent process. After a second wave of proliferation, secondary foetal
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muscle fibres are formed concomitantly with the initiation of innervation (Ontell & 
Kozeka 1984, Ross et al. 1987, Harris et al. 1989). Postnatal muscle is composed of 
myofibres of several distinct types, distinguishable by their expression of different 
isoforms of the contractile protein, myosin heavy chain (MyHC). Type I MyHC is 
expressed by slow-twitch oxidative myofibres, which in the mouse, are formed mainly 
in the primary wave of myogenesis. Type II MyHC isoforms are expressed by fast- 
twitch glycolytic myofibres, formed during the second wave (Condon et al. 1990, 
Narusawa et al. 1987, Harris et al. 1989). In birds, fast and slow MyHC genes are 
expressed by different lineages of committed embryonic myoblasts (DiMario et al.
1993). In mice, clonal analysis of muscle progenitor cells has shown that the 
embryonic origin of individual muscle groups is oligoclonal (Eloy-Trinquet & Nicolas 
2002, reviewed, Buckingham et al. 2003).
(b) The developmental origin of satellite cells
A subset of undifferentiated muscle progenitors persists in adult muscle. First 
identified in the frog (Mauro 1961, Katz 1961), these cells are defined by their 
anatomical position between the basal lamina and sarcolemma of myofibres, and are 
termed satellite cells (Mauro 1961). In mouse embryos, satellite cells first appear
17.5 days post-coitum. Their developmental origin remains enigmatic (reviewed, 
Buckingham 2003). Clonal analysis of cells derived from chick embryos at various 
stages of development has suggested that in birds, satellite cells comprise a 
functionally-distinct lineage by the mid-foetal stage of development (Feldman & 
Stockdale 1992). Experimental grafting of quail somitic mesoderm tissue into the 
somitic mesoderm of chick embryos suggested that like differentiated muscle fibres, 
satellite cells are of somitic origin (Armand et al. 1983). However, more recent work 
has suggested that satellite cells may alternatively be derived from foetal 
mesoangioblasts originating in the dorsal aorta (De Angelis et al. 1999, Minasi et al. 
2002, Sampaloesi et al. 2003). When quail or mouse embryonic aortas were 
transplanted into chick embryos, associated cells were found to contribute to a variety 
of mesodermal tissues including smooth, cardiac and skeletal muscle. Clonal progeny 
of transplanted cells were capable of undergoing extensive in vitro expansion without 
subsequent loss of multipotency on grafting into a second host (Minasi et al. 2002). 
The hypothesis that satellite cells may be derived from such vascular stem cells is 
supported by the finding that like foetal mesoangioblasts (De Angelis et al. 1999),
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adult satellite cells express certain endothelial markers such as the haematopoietic 
differentiation antigen, CD34 (Beauchamp et al. 2000).
Pax3 expression is retained in some satellite cells, notably those of the gracilis muscle 
(reviewed, Buckingham et al. 2003). In addition, the majority of satellite cells 
express another closely related paired-box transcription factor, Pax7 (Seale et al.
2000), which is also expressed by part of the dermomyotome during embryonic 
development (Mansouri et al. 1996). In PaxT/' mice there is no overt embryonic 
muscle defect (Mansouri et al. 1996) but the adult satellite cell compartment is 
substantially reduced (Seale et al. 2000). This was originally interpreted as evidence 
that Pax7 is required for satellite cell specification (Seale et al. 2000). However, a 
recent study has shown that juvenile PaxT/~ mice have relatively normal numbers of 
satellite cells, which do, however, decline as animals reach maturity. This implies 
that Pax7 is not an absolute requirement for satellite cell specification, but is required 
for postnatal satellite cell renewal (Oustanina et al. 2004). Transfection of Pax7 into 
previously uncommitted muscle-derived cells has been shown to be sufficient to 
induce myogenic commitment (Seale et al. 2004).
1.24 Expression of MyHC isoforms in developing and adult muscles
Fast and slow fibre types are distinct both in terms of their contractile speed and the 
pH stability of myofibrillar adenosine triphosphatase (mATPase) activity (Barany 
1967, reviewed, Pette & Staron 2000, 2001). mATPase resides in the heavy chain 
portion of myosin molecules, and histochemically-detectable differences in mATPase 
activity directly correlate with specific MyHC isoform profiles. Myosin light chains 
and other proteins also exhibit fibre type specific expression profiles (reviewed, Pette 
& Staron 2000, 2001).
MyHC proteins are a major component of the cytoskeletal apparatus of myofibres. 
Eight MyHC protein isoforms have been identified in mammals, each of which is 
encoded by a different gene, which are regulated by different pathways (Allen et al.
2001). Embryonic myosin and neonatal (perinatal) myosin are predominantly 
expressed during development. Adult tissues express two isoforms of Type I (slow) 
MyHC, a and p. Type la  MyHC is expressed almost exclusively in cardiac muscle,
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whilst Type Ip MyHC is found in both cardiac muscle cells and slow-twitch oxidative 
muscle fibres such as those of the murine soleus. There are three adult isoforms of 
Type II (fast) MyHC, Ha, Hb and IIx (Hd). An additional isoform is specific to 
extraocular and pharyngeal muscles. The three adult Type II isoforms contribute the 
vast majority expression in murine skeletal muscles, with the lib isoform alone 
forming >70% of total MyHC. Expression of Ila and IIx isoforms is also, however, 
high in certain muscles such as the soleus and diaphragm (reviewed, Pette & Staron
2000, 2001, Agbulut et al. 2003).
The earliest myofibres formed in the somitic myotome initially express embryonic 
myosin mRNA, shortly followed by expression of slow myosin mRNA, but not 
neonatal myosin mRNA (Sacks et al. 2003). During later embryonic and early 
postnatal development, expression of embryonic and neonatal MyHC isoforms 
predominates, and only trace levels of adult MyHC mRNAs are detectable (Lu et al. 
1999). Although there is evidence that during development, myoblasts have an 
intrinsic commitment to particular patterns of myosin expression (Miller & Stockdale 
1986), transplantation of clones of foetal myoblasts of known MyHC profile into 
chick limbs has demonstrated that the host environment can override this commitment 
and induce expression of a myosin profile characteristic of the new environment 
(Robson & Hughes 1999). In newborn muscle, the adult slow Type ip isoform makes 
a significant contribution to total MyHC protein, but adult fast MyHC isoforms are 
not co-expressed at high levels until about seven days after birth. By 21 days after 
birth, embryonic myosin is not expressed, but expression of neonatal myosin persists 
in some muscles such as the soleus and diaphragm, whilst it is absent in the EDL, 
gastrocnemius and plantaris. Neonatal myosin is virtually absent from adult muscles 
but persists in certain craniofacial muscles such as the masseter (Allen & Leinwand
2001, Agbulut et al. 2003).
Adult muscles contain both pure fibre types, which express a single MyHC isoform, 
and hybrid fibre types, which express two MyHC isoforms (reviewed, Pette & Staron 
2000, Stephenson 2001). In hybrid fibres one isoform usually predominates. Hybrid 
fibre types include Type I/HA (MyHClp>MyHcIIa), Type HA/I 
(MyHCIIa>MyHCip), Type IIAD (MyHCna>MyHCIId), Type IIDB 
(MyHCIId>MyHCIIb) and Type HBD (MyHCIIb>MyHCIId) (reviewed, Pette &
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Staron 2000). Type Ip slow myosin and is rarely co-expressed with the fastest myosin 
isoform, Type lib. However, co-expression of these isoforms has been observed in 
regenerated soleus muscle after transplantation into the EDL muscle bed (Snoj- 
Cvetko et al. 1996). Regulation of fibre type expression is primarily determined by 
the electrical activity of the associated nerve (Buller et al. 1960, reviewed, Hughes & 
Salinas 1999), though adult muscle fibres and myoblasts exhibit certain characteristics 
which are retained independently of their type of innervation (reviewed, Hughes & 
Salinas 1999).
1.3 Adult stem cells
1.31 Definition of a stem cell
A stem cell is functionally-defined as a cell which has the sustained ability to both 
self-renew and generate at least one differentiated cell type, and accordingly the 
potential to robustly reconstitute a given tissue in vivo (Lajtha 1979, Moore 1979, 
Morrison et al. 1997, Anderson et al. 2001). In comparison, a progenitor cell also has 
the ability to generate one or more differentiated cell types, but does not have the 
ability to self-renew, although it may undergo extensive proliferation prior to 
differentiation (Elwood 2004). Characteristic attributes of stem cells include rarity, 
the potential to generate several distinct differentiated phenotypes (multipotency), the 
ability to exist in a state of reversible mitotic quiescence, and the ability to undergo 
asymmetric division, thereby both replacing themselves and generating a 
differentiation-committed lineage (Hall & Watt 1989, Potten & Loeffer 1990, 
Morrison et al. 1997, Weissman et al. 2000 Marshman et al. 2002). The best- 
characterized adult stem cells are those of the continuously-renewing tissues of the 
haematopoietic system, skin and gut epithelium.
1.32 Stem cells of adult tissues
(a) Haematopoietic system
The cells of the mammalian lymphohaematopoietic system are defined by their pan­
expression of leukocyte common antigen, a protein tyrosine phosphatase commonly 
known as CD45 (Sunderland et al. 1979, Dalchau & Fabre 1981, reviewed,
Trowbridge & Thomas 1994). Differentiated haematopoietic cells have a finite
11 10lifespan, and in man, are renewed at an estimated rate of 10 to 10 cells per day
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(reviewed, Elwood 2004). Haematopoietic stem cells (HSC) are defined by their 
clonogenic ability to generate all the lineages of the lymphohaematopoietic system, 
including B and T lymphocytes, erythrocytes, megakaryocytes, basophils, eosinophils, 
neutrophils and macrophages (Till & McCulloch 1961, reviewed, Lajtha 1979, 
Weissman 2000, Smith 2003, Szilvassy 2003). They constitute the canonical example 
of an adult stem cell. The self-renewal capacity of HSC is such that a single grafted 
cell can home to the spleen, proliferate, and repopulate and maintain the entire 
haematopoietic system of a lethally-irradiated mouse (Smith et al. 1991, Osawa et al. 
1996, Matsuzaki et al. 2004). Staining of whole bone marrow with the vital dye 
Hoechst 33342 identifies a small subset of cells, termed side population (SP), which 
has very strong dye efflux activity and contains the vast majority of HSC (Goodell et 
al. 1996). The molecular determinant of the SP phenotype is thought to be expression 
of the ABC transporter Bcrpl (Zhou et al. 2001, 2002). The majority of SP is 
quiescent (phase Go of the cell cycle), but at any given timepoint about 3% of cells are 
cycling (phase S-G2M); all, however, have been shown to have repopulation potential 
in lethally-irradiated mice (Goodell et al. 1996). HSC can also be isolated according 
to their antigen expression profiles. About half of all SP are negative for expression 
of the glycoprotein differentiation antigen CD34, but positive for expression for stem 
cell antigen-1 (Sca-1) and the stem cell factor (SCF) transmembrane receptor c-kit. 
This is considered to be a primitive phenotype (Pearce et al. 2004). Murine HSC are 
characteristically negative for expression of a panel of lineage antigens (Lin) present 
on the differentiated cells of the haematopoietic system (reviewed, Szilvassy 2003). 
A recent study by Matsuzaki et al. (2004) described a population of murine bone 
marrow cells defined by their CD34- c-Kit+ Sca-1+ Lin- expression profile and very 
strong Hoechst dye efflux activity. Single cells derived from such populations were 
found to be capable of multilineage haematopoietic reconstitution in 96% of lethally- 
irradiated mice, suggesting that the most primitive HSC have near absolute 
repopulating efficiency. These data additionally imply that HSC have an 
extraordinarily good ability to home to the spleen, the environment required for their 
survival and proliferation (Matsuzaki et al. 2004).
Primitive HSC exist in a state of reversible mitotic quiescence, but are not truly 
dormant (Bradford et al. 1997, Cheshier et al. 1999). Whilst at least 75% of HSC are 
in Go at any one timepoint (Cheshier et al. 1999), they are recruited back into the cell
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cycle at regular intervals. The majority of HSC cycle at least once during a thirty day 
period, as shown by both bromodeoxyuridine (BrdU) labelling of DNA precursors 
(Cheshier et al. 1999) and measurement of relative levels of rhodamine and Hoechst 
dye fluorescence (Bradford et al. 1997). The sustained self-renewal ability of HSC is 
linked to their production of the enzyme telomerase, which conserves the length of 
telomeres, the non-encoding regions of DNA capping the ends of chromosomes. 
During replication, telomeres position chromosomes within the nucleus and prevent 
DNA from degrading, fusing or rearranging. Telomeres are therefore essential to the 
maintenance of chromosomal stability and their shortening accordingly results in cell 
crisis and senescence. Whilst telomere length and telomerase expression are increased 
in both HSC and transformed cancerous cells, progenitor and differentiated cells have 
only minimal levels of telomerase activity (reviewed, Elwood 2004). It has been 
demonstrated that telomere length can be directly correlated with the known 
proliferative potential of different subpopulations of haematopoietic cells (Van Ziffle 
et al. 2003). HSC telomere length declines with age suggesting that replicative 
potential, though sustained, is finite (reviewed, Elwood 2004).
(b) Intestinal epithelium
The intestinal lumen is lined with simple columnar epithelium formed into finger-like 
villi that harbour the differentiated cells involved in nutrient absorption: enterocytes, 
mucus secreting goblet cells and enteroendocrine cells. Each villus is surrounded by 
invaginated crypts containing multpotential stem cells that continuously renew the 
differentiated phenotypes. Stem cells in the lower portion of each crypt generate 
progeny that form a coherent functional and anatomical hierarchy in which they 
migrate upwards out of the crypt, differentiate into the tissue of the villus and are 
eventually sloughed away through an apical extrusion zone. Some progeny migrate 
downwards into the base of the pit and become anti-microbial Paneth cells (reviewed, 
Marshman et al. 2002, Sancho et al. 2003, Potten 2004). Stem cells can be identified 
by their anatomical position in the crypt hierarchy (reviewed, Marshman et al. 2002), 
their retention of radioactive label (Potten et al. 1978, Potten et al. 2002), and their 
expression of the RNA binding protein musashi-1, which also marks primitive 
progenitor cells (Potten et al. 2004).
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Intestinal epithelial stem cells divide approximately once a day, producing one 
daughter cell and one new stem cell. The daughter cell proliferates through about 
three population doublings forming a ‘transit population’ of progenitors that 
subsequently commits to differentiation and undergoes limited further proliferation 
(reviewed, Marshman et al. 2002, Sancho et al. 2003). If the stem cell population is 
ablated, the undifferentiated transit cells can reassume their full stem cell potential 
and clonogenically repopulate the whole crypt. Removal of even one stem cell 
triggers immediate cell-cycle perturbations that are likely to result in rapid restoration 
of stem cell number (reviewed, Marshman et al. 2002, Potten 2004). In contrast, 
ablation of the Paneth cell population has no effect on the proliferative status of stem 
cells (Stappenbeck et al. 2003). Studies using chimaeric mice have shown that 
although intestinal crypts are oligoclonal during the neonatal period, they become 
monoclonal within two weeks postpartum (Schmidt et al. 1988). Examination of 
DNA methylation tagging patterns has suggested that human colonic crypts contain 
multiple stem cells which periodically go though ‘bottlenecks’ whereby most stem 
cells become depleted, and the niche is subsequently reconstituted by the repeated 
self-renewal of a small number of survivors (Yatabe et al. 2001).
Mouse intestinal epithelial stem cells ultimately undergo approximately 1,000 
population doublings, but show no loss of proliferative potential and rarely develop 
neoplastic mutations (reviewed, Marshman et al. 2002). Intestinal epithelial stem cells 
(Potten et al. 2002) and other asymmetrically-dividing stem cell-like lines (Merok et 
al. 2002) protect themselves from acquiring replication-induced errors by selective 
sorting of template and newly-synthesised DNA strands to ensure consistent retention 
of the original template strand by the renewed stem cell (Potten et al. 2002, Merok et 
al. 2002). Despite their sustained proliferative ability in vivo, isolated intestinal 
epithelial stem cells cannot be cultured for prolonged periods in vitro. They can, 
however, be successfully cultured within intact crypts, suggesting that the crypt 
microenvironment is essential to the maintenance of a functioned stem cell phenotype 
(reviewed, Kaeffer 2002).
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(c) Skin epidermis
The main cellular constituents of the adult skin epidermis are specialised epithelial 
cells called keratinocytes, which form a cohesive barrier and continuously renew the 
epidermal layer (reviewed, Gambardella & Barrendon 2002). Skin epithelial stem 
cells are located in the bulge area of hair follicles (Michel et al. 1996, Morris & 
Potten 1999, Blanpain et al. 2004) and in the interfollicular basal layer of the 
epidermis (Birkenbach 1981), where they can be identified by their long-term ability 
to retain labels such as 3H-thymidine and BrdU (Bickenbach 1981, Morris & Potten
1999) and their expression of keratin 19 (Michel et al. 1996). Similarly to intestinal 
epithelial stem cells, skin epithelial stem cells both self-renew and give rise to 
daughter ‘transient amplifying’ progenitor cells that have a finite proliferative life 
before they exit the basal compartment and differentiate into mature keratinocytes 
(reviewed, Gambardella & Barrendon 2003). Skin epithelial stem cells have the 
ability to clonally regenerate all the epithelial cell types present in the hair follicle, as 
demonstrated both by gene targeting of putative stem cells with an inducible Cre 
recombinase construct (Morris et al. 2004) and transplantation of clonal cell 
populations (Blanpain et al. 2004). In addition, in utero transplantation experiments 
have shown that grafted epidermal stem cells (but not transient amplifying cells) can 
contribute to several different lineages during embryonic development (Liang & 
Bickenbach 2002).
Two distinct populations of multipotent skin stem cells have been identified within 
the bulge region of hair follicles: a basal population which is attached to the basal 
lamina of the extracellular matrix, and a suprabasal population which is detached and 
possibly derived from the attached population (Blanpain et al. 2004). The basal 
lamina appears to have a reversible proliferation-inhibitory effect such that basal cells 
undergo less divisions than suprabasal cells. This suggests that the basal lamina has a 
role in maintaining the niche in a quiescent state (Blanpain et al. 2004).
Epidermal cells contain an SP subset that excludes Hoechst dye (Terunuma et al. 
2003, Triel et al. 2004). However, unlike blood SP, these cells do not exhibit stem cell 
characteristics (Triel et al. 2004) and also do not correspond to the label-retaining 
population (Terunuma et al. 2003, Triel et al. 2004).
34
(d) The nervous system
Neural stem cells are defined by their ability to both self-renew and give rise to the 
three main differentiated phenotypes found in the central nervous system (CNS): 
neurons, astrocytes and oligodendrocytes (reviewed, Temple & Alvarez-Buyella 
1999, Kennea & Mehmet 2002). Although the adult CNS has a relatively poor ability 
to regenerate functional tissue after injury, it has been possible to isolate neural stem 
cells from two areas of the brain: the sub ventricular zone (Lois & Alvarez-Buylla 
1993) and the subgranular zone of the hippocampus (Seaburg & van der Kooy 2002, 
Song et al. 2002a). Whilst proliferation competent cells are resident in other areas of 
the brain, they do not generate neurons (Homer et al. 2000, Komack & Rakic 2001).
Clusters of dividing neural stem cells have been found to associate closely with the 
vasculature, suggesting that adult neurogenesis is likely to occur within an angiogenic 
environment (Palmer et al. 2000). A recent in vitro study has shown that endothelial 
cells (but not smooth muscle cells) of the vasculature release soluble factors which 
inhibit differentiation and stimulate self-renewal of neural stem cells (Shen et al. 
2004). In addition, it has been demonstrated that differentiated astrocytes regulate 
neural stem cells in the adult hippocampus by stimulating them to undergo neuronal 
specification (Song et al. 2002b). These findings suggest that as in the intestinal 
(reviewed, Kaeffer 2002) and skin (Blanpain et al. 2004) epithelia, stem cell 
behaviour is critically determined by interaction with other, differentiated phenotypes.
1.33 Adult stem cell metaplasia
Adult urodele amphibians have a remarkable ability to regenerate complex anatomical 
structures, including whole limbs, jaws, heart and the lens and retinas of eyes. This 
process occurs through re-specification of differentiated cells into tissue-specific, 
replication-competent progenitor cells (reviewed, Brockes & Kumar 2002). The 
demonstration that a viable animal can be generated from the nucleus of a 
differentiated adult cell is unequivocal evidence that mammalian adult nuclei can also 
undergo developmental reprogramming, and, albeit under particular experimental 
conditions, even regain totipotency (Wilmut et al. 1997). However, it is not known 
whether embryonic lineage commitment is ever recapitulated in the absence of such
experimental manipulation, or whether all mammalian adult cells, including stem 
cells, are normally lineage restricted.
Metaplasia is defined as the process whereby one differentiated or precursor cell type 
is converted to another. Transdifferentiation is a form of metaplasia restricted to 
already-differentiated cells (reviewed, Tosh & Slack 2002). In the embryo, 
differentiated liver cells can be derived from transdifferentiation of differentiated 
pancreatic cells (Tosh et al. 2002, Shen at al. 2003). In the adult, the differentiated 
glomerular and tubular cells of the kidney are capable of reverting to a more primitive 
mesenchymal phenotype in response to injury, and subsequently of regenerating 
limited amounts of functional tissue (reviewed, Meguid El Nahas 2003). And in 
tissue culture, differentiated post-mitotic myotubes derived from immortalised mouse 
cells can also be induced to dedifferentiate and re-enter the cell cycle, either in 
response to forced over-expression of the homeobox gene Msxl (Odelburg et al.
2000), or after treatment with the purine-based chemical myoseverin (Rosania et al.
2000). When generated by forced Msxl over-expression, these re-derived progenitors 
have been reported to differentiate into cells of both the myogenic, and adipogenic 
and oesteogenic lineages (Odelburg et al. 2000). Whilst there are a few other 
examples of adult metaplasia in vivo, notably within epithelial lineages (Slack 1985, 
1986), recent studies have particularly focused on the unique ability of bone marrow- 
derived cells to contribute to a variety of non-haematopoietic tissues.
It has been demonstrated that intravenously grafted bone marrow cells can at low 
frequency contribute to skeletal muscle (Ferrari et al. 1998, Brazelton et al. 2003, 
Camargo et al. 2003), myocardium (Orlic et al. 2002, Alvarez-Dolado et al. 2003, 
Nygren et al. 2004), liver (Lagasse et al. 2000, Korbling et al. 2002, Vassilopoulos et 
al. 2003, Wulf et al. 2003, Alvarez-Dolado et al. 2003, Camargo et al. 2004a), lung 
(Krause et al. 2001), skin (Krause et al. 2001, Korbling et al. 2002, Kataoka et al. 
2003), gastrointestinal tract (Krause et al. 2001, Korbling et al. 2002), and in the 
brain, neuron-type cells (Brazelton et al. 2000, Mezey et al. 2000), Purkinje neurons 
(Weimann et al. 2003a, 2003b, Alvarez-Dolado et al. 2003) and microglial and 
perivascular cells (Hess et al. 2004). Whilst the use of whole bone marrow grafts in 
many of these studies made it difficult to identify the precise subset of cells involved, 
some workers report transplantation of a single, genetically-marked cell to show that
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defined HSC can both clonally repopulate the haematopoietic system, and contribute 
to liver, lung, gastrointestinal tract and skin (Krause et al. 2001) or to skeletal muscle 
fibres (Camargo et al. 2003, Corbel et al. 2003). In all of the above studies, 
engraftment potential was maximised by whole body irradiation of recipients. In an 
alternative approach, circulatory cell metaplasia has also been investigated using mice 
surgically joined in parabiotic pairs. In the absence of whole body irradiation, it was 
found that despite substantial evidence of blood chimaerism, the contribution of HSC 
progeny to other tissues was almost non-existent (Wagers et al. 2002).
In tissue culture, bone marrow cells can adopt the phenotype of embryonic stem cells 
as a result of spontaneous nuclear fusion (Ying et al. 2002, Terada et al. 2002). Data 
from several studies have demonstrated that in vivo, many apparent metaplastic events 
are also attributable to fusion, whereby bone marrow cells form heterokaryons with 
Purkinje neurons (Weimann et al. 2003, Alvarez-Dolado et al. 2003), or are 
incorporated into already multinucleate differentiated phenotypes such as hepatocytes 
(Vassilopoulos et al. 2003, Alvarez-Dolado et al. 2003, Camargo et al. 2004a), 
skeletal muscle fibres (Camargo et al. 2003) and cardiomyocytes (Alvarez-Dolado et 
al. 2003, Nygren et al. 2004). In skeletal muscle (Camargo et al. 2003) and liver 
(Camargo et al. 2004a) lineage-tracking strategies have been used to show that 
cytoplasmic fusion occurs through intermediate precursor cells of the myeloid lineage, 
probably macrophages (Camargo et al. 2003, Camargo et al. 2004a, reviewed, 
Camargo et al. 2004b). Another study found that bone marrow-derived cells present 
in damaged myocardium failed to express markers of cardiac differentiation, and 
retained their haematopoietic lineage commitment. The number of cells present in 
injured hearts was found to decrease with time (Balsam et al. 2004). Taken together, 
these findings seem to imply that bone marrow cells do not undergo genuine 
metaplasia, and do not generate non-haematopoietic tissues via tissue-specific, 
replication-competent progenitor cells (reviewed, Vassilopoulos & Russell 2003, 
Camargo et al. 2004b).
The use of lineage non-specific markers (such as Y chromosome or other 
ubiquitously-expressed genetic markers) in a large proportion of studies has led to a 
paucity of data where stochastic cell fusion can be excluded as the mechanism by 
which cells contributed to other tissues (reviewed, Vassilopoulos & Russell 2003,
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Camargo et al. 2004b). Nevertheless, it has been demonstrated that bone marrow 
cells can adopt the anatomical position (Gussoni et al. 1999, Fukada et al. 2002, 
LaBarge & Blau 2002, Dreyfus et al. 2004) and phenotypic expression profile 
(Dreyfus et al. 2004) of satellite cells, the committed precursors of differentiated 
muscle. And in addition, it has been shown that bone marrow cells can generate 
hepatic SP, which may have the ability to participate in liver regeneration (Wulf et al. 
2003). Functional studies will be required to resolve these apparent anomalies.
1.4 Regeneration of adult skeletal muscle
1.41 Evidence for the regenerative ability of adult muscle
The most striking descriptions of adult skeletal muscle regeneration are derived from 
the early grafting experiments of Studitsky and Carlson (reviewed, Carlson 1986). 
Studitsky and his colleagues developed an experimental protocol whereby the muscle 
of a small animal was removed, finely minced to a “semi-liquid porridge” state, and 
then grafted back into the muscle bed. Remarkably, they found that within a few 
weeks, the minced tissue regenerated a model of the removed muscle consisting of 
bundles of innervated myofibres that were, moreover, capable of contraction in 
response to nervous stimuli. This phenomenon was demonstrated in the biceps 
brachii muscles of chicks and pigeons and the gastrocnemius muscles of rats and 
mice. In addition, it was shown that in some cases, not only autografts (grafts of 
tissue back into the same animal), but also homografts (grafts between siblings) were 
capable of re-forming functional tissue (Studitsky 1964). These findings were 
subsequently reproduced in similar experiments by Carlson, using frog (Carlson 1968) 
and rat (Carlson 1968, Carlson & Gutmann 1972) gastrocnemius autografts, and rat 
gastrocnemius homografts (Carlson 1970).
Studitsky’s group also developed the technique of free muscle grafting (Bosova 1962, 
cited in Carlson 1986), in which a muscle is completely excised from its bed, and then 
either replaced, or sutured into a different site in the same host. The severing of 
associated tendons, nerves and blood vessels causes the muscle to undergo a 
reproducible series of degenerative and regenerative changes, during which myofibres 
become necrotic, are phagocytosed by macrophages, and are subsequently replaced by 
immature myotubes that develop into mature innervated myofibres. In the rat, this
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cycle of degeneration and regeneration takes about two months, whereas in larger 
animals such as the cat, it takes about six months (Carlson et al. 1979, reviewed, 
Carlson 1986). In humans, immunohistochemical examination of biopsies derived 
from clinically transplanted muscles has demonstrated the presence of newly-formed 
myofibres several months post-operatively, implying that the process of regeneration 
also persists for an extended period in comparison to rodent muscles (Yoshimura et 
al. 1998b). There is, however, a lack of published data that describes the regenerative 
ability of normal human muscles, presumably because of the practical problems of 
conducting such studies.
Mouse skeletal muscles appear to have the ability to regenerate themselves 
repeatedly. After fifty weekly injections of the myotoxic drug bupivacaine, the TA 
muscles of wild-type mice were found to have maintained a total myofibre number 
equivalent to that in non-injured muscles (Luz et al. 2002).
Skeletal muscle maintains some regenerative ability even after irradiation. In the rat, 
it has been reported that whilst 1.5 Gray (Gy) of local irradiation disables the normal 
regenerative ability of muscle tissue, it is not sufficient to suppress the regenerative 
ability of minced muscle autografts (Studitsky 1988). In the mouse, local treatment of 
juvenile mouse muscles with 18 Gy irradiation results in a long-term growth and 
repair deficit (Wakeford et al. 1991, Quinlan et al. 1995). But when irradiated 
muscles are severely damaged by injection of the myotoxin notexin, they retain the 
ability to regenerate effectively (Heslop et al. 2000). If mouse muscles are locally 
treated with a larger dose of 25 Gy irradiation, this regenerative response is largely 
lost (Heslop et al. 2000). Taken together, these findings imply that adult rodent 
skeletal muscle employs at least two efficient regenerative mechanisms, one of which 
is sensitive to irradiation, and one of which is relatively resistant to irradiation but 
requires the stimulus of acute damage.
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1.42 The role of satellite cells in muscle regeneration
(a) The contribution of satellite cells to skeletal muscle regeneration
Satellite cells are believed to be the main source of new myonuclei in regenerating 
muscles (Moss & Leblond 1971, Snow 1978, Lipton & Schultz 1979, reviewed, 
Partridge 2002a). A few hours after 3H-thymidine was administered to growing rats, 
electron microscopy (EM) studies showed that label could be identified in satellite 
cell nuclei, but never myonuclei. The spontaneous appearance of labelled myonuclei 
at later timepoints demonstrated that the labelled satellite cells had subsequently 
contributed to myofibres (Moss & Leblond 1970, 1971). In minced muscle 
autografts, whilst myonuclei rapidly become pyknotic, 3H-thymidine-labelled satellite 
cells remain viable and are retained beneath the relatively persistent basal laminae of 
myofibres (Snow 1977a, 1977b). Satellite cells also survive minced or whole muscle 
homografting, and are similarly the likely source of regeneration (Snow 1978, Schultz 
et al. 1988). Autografts of clonal cell cultures were used to demonstrate that isolated 
satellite-derived cells could participate in the repair and growth of myofibres in vivo 
(Lipton & Schultz 1979). In explants of minced 3H-thymidine-treated muscles, 
labelled satellite cells were found to be the origin of proliferating MPC, and 
subsequently, differentiated myotubes (Trupin et al. 1982). The development of 
single myofibre isolation techniques provided the first definitive demonstration that in 
tissue culture, mouse (Rosenblatt et al. 1996), rat (Bischoff 1986) and human 
(Bonavaud et al. 2002) anatomically-defined satellite cells are capable of generating 
MPC and differentiated myofibres in the absence of any other proliferative 
phenotypes (Bischoff 1986, Rosenblatt et al. 1996, Bonavaud et al. 2002).
The definitive anatomical position of satellite cells (Mauro 1961) is necessarily lost 
by cells that fulfil their regenerative function in becoming activated and proliferating 
to generate differentiation-competent MPC which are outside the satellite cell niche. 
For this reason, although functional data is frequently attributed to satellite cells, in 
most cases, the link between satellite cell, MPC and regenerated myofibre is largely 
circumstantial (reviewed, Partridge 2003).
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(b) Quiescence and activation
In growing muscles, satellite cells are metabolically and mitotically active as 
indicated by their abundant cytoplasm and numerous mitochondria (Schultz 1976), 
and their spontaneous incorporation of labels such as 3H-thymidine (Moss & Leblond 
1970, 1971, Snow 1977b, 1978) and BrdU (Schultz 1996). In uninjured adult 
muscles, myonuclei turn over slowly, at a rate of 1-2% per week (Schmalbruch & 
Lewis 2000), and satellite cells comprise <5% of total muscle nuclei (Bischoff 1994). 
Accordingly, adult satellite cells are metabolically inactive (Schultz 1976) and 
mitotically quiescent (Schultz et al. 1978). Phenotypic markers of quiescent satellite 
cells include Pax7 (Seale et al. 2000, Zammit et al. 2002, 2004a), another 
transcription factor, Sox8 (Schmidt et al. 2003), CD34 (Beauchamp et al. 2000), c- 
met (Comelison & Wold 1997) and the adhesion protein M-cadherin (Irintchev et al. 
1994, Kuschel et al. 1999). Single cell analysis failed to detect Myf5 mRNA in 
quiescent satellite cells (Comelison & Wold 1997). However, in the gene-targeted 
Myf5nLacZ/+ mouse (Tajbakhsh et al. 1996a), most quiescent satellite cells have 
detectable levels of Myf5-P-gal fusion protein (Beauchamp et al. 2000, Heslop et al.
2001). The C2C12 immortalised mouse myoblast cell line (Yaffe & Saxel 1977) is 
frequently used to model myogenesis. In the C2C12 cells, Myf5 protein is high in Go 
and transiently decreases during Gi (Kitzmann et al. 1998).
Quiescent satellite cells express a truncated isoform of CD34 lacking an intracellular 
domain, which in the full length isoform, contains three potential phosphorylation 
sites. Satellite cell activation is characterised by a transient switch to expression of 
the full length isoform by alternative splicing. Full length CD34 is then rapidly 
down-regulated and neither isoform is expressed after the early stages of activation 
(Beauchamp et al. 2000). Proliferating C2C12 cells do not express CD34 protein. 
However, when differentiation is induced, a subset of cells form a reserve population 
which remains mononucleate, down-regulates expression of Myf5 and MyoD 
proteins, and expresses CD34 protein. These cells are usually seen in close 
association with differentiated myotubes and may be analogous to satellite cells 
(Beauchamp et al. 2000).
Quiescent satellite cells are activated in vivo in response to myofibre damage or 
denervation (Snow 1977a, 1977b, 1983, Schmalbruch & Lewis 2000, reviewed,
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Bischoff 1994) and in vitro, on exposure to serum mitogens (Bischoff 1996, Zammit 
et al. 2002, 2004), HGF (Tatsumi et al. 1998, Sheehan et al. 2000, Anderson & 
Pilipowicz 2002), fibroblast growth factor (FGF) (Bischoff 1986) or nitric oxide 
(Anderson & Pilipowicz 2002). Satellite cell activation is initially characterised by 
upregulation of Myf5 and MyoD mRNA and protein expression (Comelison & Wold 
1997, Cooper et al. 1999, Zammit et al. 2002, 2004a), which precedes mitotic activity 
as defined by expression of proliferating cell nuclear antigen (PCNA), or 
incorporation of BrdU into DNA precursors (reviewed, Sabourin & Rudnicki 2000). 
Activated satellite cells rarely express MyoD in the absence of Myf5 (Zammit et al.
2002). In C2C12 cells, MyoD protein is absent in Go but peaks in mid-Gi (Kitzmann 
etal. 1998).
In vivo, satellite cells undergo several rounds of proliferation to generate a pool of 
MPC (reviewed, Bischoff 1994, Sabourin & Rudnicki 2000). In tissue culture, it has 
been shown that the discrete populations of satellite cells associated with isolated 
single myofibres each have the proliferative competence to completely replace the 
parent myofibre within four days (Zammit et al. 2002). Satellite-derived cells can 
migrate to foci of damage within the same muscle (Schultz et al. 1985), or outwards 
to the periphery of the muscle to escape ischaemia (Schultz et al. 1988), but do not 
contribute to regeneration of adjacent damaged muscles in the absence of a physical 
bridge (Schultz et al. 1986). MPC grafts generate muscle that is mainly localised to 
the transplant site. However, several months after grafting, small numbers of donor- 
derived myofibres can be identified in adjacent muscles, suggesting that satellite cells 
have a limited inter-muscle migratory ability (Watt et al. 1987, Jockusch & Voigt
2003).
(c) Differentiation and fusion
Satellite cell-derived MPC commit to differentiation and exit the cell cycle (Andres & 
Walsh 1996, Zammit et al. 2004a), before terminally differentiating and fusing into 
myofibres (Moss & Leblond 1971, Robertson et al. 1993, Rosenblatt et al. 1995). 
The early stage of commitment to differentiation is characterised by the expression of 
myogenin and Mrf4 mRNA and protein (Smith et al. 1994, Yablonka-Reuveni & 
Rivera 1994, Comelison & Wold 1997, reviewed, Charge & Rudnicki 2003). 
Myogenin+ cells are capable of one or two further population doublings, before
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exiting the cell cycle concomitant with the expression of p21 inhibitor (Andres & 
Walsh 1996). MyoD is initially co-expressed with myogenin, but is later down- 
regulated (Fuchtbauer & Westphal 1992). MyoD'/' muscles contain elevated numbers 
of morphologically-normal satellite cells. However, the inability of these cells to 
progress through the normal developmental program of MRF expression results in 
significant regenerative impairment (Megeney et a l 1996). The regulation of 
myoblast cell cycle progression is thought to be controlled by the winged helix 
transcription factor, myocyte nuclear factor (MNF) (Garry et al. 1997, 2000). Mice 
deficient in MNF have impaired muscle regeneration (Garry et al. 2000). M-cadherin 
protein is required for differentiation (Zeschnigk et a l  1995), but is down-regulated 
after fusion (Irintchev et al. 1994). Interference with M-cadherin protein expression 
prevents fusion of myoblasts in vitro (Zeschnigk et al. 1995). Like M-cadherin, Sox8 
is expressed by quiescent satellite cells. However, Sox8 is down-regulated prior to 
differentiation, and fusion is inhibited by forced Sox8 expression. This suggests that 
Sox8 has a role in maintaining the proliferative competence of satellite cells (Schmidt 
et al. 2003).
Examination of regenerating skeletal muscles at the ultrastuctural level has shown that 
fusion occurs between myoblast and myoblast, myoblast and myotube, myotube and 
myotube, and at later timepoints, myotube and more highly-differentiated myofibre 
(Robertson et al. 1990, 1993). Whilst mature myofibres are mainly peripherally 
nucleated, in the mouse, newly-regenerated myofibres can be identified by their 
distinctive central nucleation (Coulton et a l  1988). Rouger et a l  (2004) recently 
provided evidence for the existence of two different populations of turkey myoblasts 
which fuse differently both in vitro, and in vivo after autografting of labelled cells. A 
subset of slowly-proliferating clones were found to fuse mainly with each other 
whereas highly-proliferative clones fused mainly with other mature myofibres 
(Rouger et a l  2004).
Similarly to embryonic muscle progenitors, the progeny of adult mouse satellite cells 
have been demonstrated to have intrinsic commitment to different patterns of MyHC 
expression. Satellite cells committed to slow myosin expression are preferentially 
associated with slow myofibres (Rosenblatt et a l  1996). In contrast, human satellite
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cell-derived myoblasts are not committed to expressing particular MyHC isoforms 
(Bonavaud et al. 2001).
In vitro, satellite cells also have the ability to adopt alternative non-muscle fates and 
differentiate along adipogenic or oesteogenic lineages (Asakura et al. 2001).
1.43 Evidence for resident MPC outside the satellite cell niche
The ability to exclude Hoechst dye defines the SP subset of bone marrow, a purified 
population of HSC (Goodell et al. 1996). A similar protocol has been used to obtain a 
Hoechst dye-excluding subset from skeletal muscle tissue, termed muscle SP 
(Gussoni et al. 1999, Jackson et al. 1999). In contrast the main population (MP) of 
Hoechst dye-retaining muscle cells, muscle SP has been demonstrated to have both 
myogenic and haematopoietic potential (Gussoni et al. 1999, Jackson et al. 1999, 
Asakura et al. 2002, McKinney-Freeman et al. 2003), and also has other 
characteristics which suggest it is distinct from the satellite cell compartment 
(Asakura et al. 2002).
Muscle SP is negative for expression of satellite cell markers such as desmin, Pax7 
and Myf5, positive for expression of the satellite and endothelial cell marker CD34, 
and positive for expression of HSC markers such as Sca-1 and CD45 (Asakura et al. 
2002, McKinney-Freeman et al. 2003), neither of which are expressed by 
anatomically-defined satellite cells (Zammit & Beauchamp 2001, Asakura et al.
2002). The haematopoietic activity of muscle SP is entirely localised to CD45+ cells 
(McKinney-Freeman et al. 2003). In vitro, the unsorted population is capable of both 
myogenic and haematopoietic differentiation, satellite cells of only myogenic 
differentiation, and muscle SP of spontaneous haematopoietic differentiation, and of 
myogenic differentiation only after co-culture with already-committed myogenic cells 
(Asakura et al. 2002). Whilst satellite cells cannot be grafted intravenously 
(Sampaloesi et al. 2003), muscle SP delivered via the vasculature can enter muscle 
tissue and undergo myogenic differentiation (Gussoni et al. 1999, Asakura et al. 
2002).
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Muscle SP has functional and phenotypic characteristics which suggest it forms a 
separate population to bone marrow SP. In competitive haematopoietic repopulation 
assays, muscle SP is 22 times less potent than bone marrow SP (McKinney-Freeman 
et al. 2003). Muscle SP is negative for expression of bone marrow SP antigens such 
as vascular endothelial growth factor-A and Tal-1 (Majka et al. 2003), and CD3, CD4, 
CD8 and c-kit (Benchaouir et al. 2004).
The haematopoietic fraction of muscle SP has been shown to originate from bone 
marrow (Majka et al. 2003). However, a long-term study found that though bone 
marrow-derived cells are present in skeletal muscle, they do not make a significant 
contribution to the whole fraction of muscle SP. This implies that muscle SP is 
primarily derived from a tissue-resident source (Rivier et al. 2004). It has been 
demonstrated that a Hoechst dye-excluding SP population exists in state of dynamic 
equilibrium within the C2C12 immortal cell line (Benchaouir et al. 2003). Similarly 
to both bone marrow SP and muscle SP, C2C12 SP expresses Sca-1 and CD34 
(Benchaouir et al. 2003). Significantly, however, it does not express canonical 
haematopoietic markers such as CD45 (Benachaouir et al. 2003), which define the 
haematopoietic fraction of muscle SP (McKinney-Freeman et al. 2003). Taken 
together, the results of these studies (Majka et al. 2003, Rivier et al. 2004, Benchaouir 
et al. 2004) imply that in principal, the haematopoietic and myogenic activities of 
muscle SP might reside in separate subpopulations with distinct origins. Recent 
studies by Rudnicki’s group, however, suggest that muscle-resident CD45+ cells are 
not always restricted to the haematopoietic lineage. CD45+ Sca-1+ muscle-derived 
cells purified from uninjured muscles were found to be uniformly non-myogenic. But 
when CD45+ Sca-1+ cells were sorted from injured muscles, they expressed muscle- 
specific markers such as desmin and Pax7, and underwent spontaneous differentiation 
into myotubes. This suggests that damage induces the myogenic specification of a 
previously uncommitted CD45+ Sca-1+ population (Polesskaya et al. 2003). PaxTA 
muscles have significantly reduced numbers of satellite cells, but still contain 
populations of CD45+ Sca-1+ cells (Seale et al. 2000). Myogenic specification of 
PaxTA CD45+ Sca-1+ muscle-derived cells can be induced by viral infection with the 
Pax7 gene, which in vivo, is sufficient to induce regeneration of new myotubes (Seale 
et al. 2004).
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1.44 The contribution of circulatory cells to adult muscle
The idea that cells from the circulation could contribute to skeletal muscle was 
introduced by Bateson et al. (1967), who showed that there was a period of delay 
between the intravenous injection of 3H-thymidine and the incorporation of label into 
regenerated myonuclei, implying that putative muscle precursors could acquire 
radioactive label outside the tissue, and then migrate into it (Bateson et al. 1967, 
commentary, Partridge 1998). The possibility that rapidly-cycling cells could have 
incorporated label, and then released it a few hours later to be reutilised by other cells, 
renders the authors’ interpretation of the data equivocal (reviewed, Sloper & Partridge 
1980). Later, however, Ferrari et al. (1998) provided an unequivocal demonstration of 
the integrity of the concept using bone marrow grafts derived from transgenic 3F- 
nLacZ-2E mice, in which nuclear P-gal reports expression of the skeletal muscle 
fibre-specific myosin light chain 3F gene (Ferrari et al. 1998, commentary, Partridge 
1998). It was found that small numbers of bone marrow cells were incorporated into 
regenerating myofibres and expressed the transgene both when the graft was inserted 
directly into muscle tissue, and when it was delivered systemically (Ferrari et al. 
1998). The results of numerous subsequent studies have supported this finding, 
demonstrating that bone marrow-derived cells can both contribute to differentiated 
muscle fibres (Bittner et al. 1998, Ferrari et al. 2001, Gussoni et al. 2002, Corti et al.
2002, LaBarge & Blau 2002, Fukada et al. 2002, Brazelton et al. 2003, Corbel et al.
2003, Camargo et al. 2003, Dreyfus et al. 2004, Shi et al. 2004) and enter the satellite 
cell compartment (Fukada et al. 2002, LaBarge & Blau 2002, Dreyfus et al. 2004). 
There have also been shown to be differences between different muscles in the 
frequency with which bone marrow-derived cells are incorporated (Brazelton et al.
2003). Whilst most of these data were obtained using mouse models, one study 
demonstrated the long-term persistence of donor-derived myofibres in a human 
muscular dystrophy patient who had received bone marrow transplantation (Gussoni 
et al. 2002). In mice, it has been shown that lethally-irradiated recipients 
haematopoietically reconstituted with single defined HSC can incorporate graft- 
derived cells into regenerating skeletal muscle fibres (Camargo et al. 2003, Corbel et 
al. 2003), and at lower frequency, non-regenerating fibres (Corbel et al. 2003), 
although there is little evidence that HSC can give rise to committed myogenic 
progenitors (Camargo et al. 2003). The rarity of such myogenic differentiation events
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may explain why other workers have failed to identify myogenic activity in the 
haematopoietic fraction of human bone marrow (Shi et al. 2004), although myogenic 
potential has been identified in the whole population (Gussoni et al. 2002, Bossolasco 
et al. 2004) and its stromal fraction (Shi et al. 2004).
The observation that cells of the myeloid lineage can enter the satellite cell 
compartment is in fact not new; 25 years ago Trupin et al. (1979) reported the 
presence of macrophages under the basal lamina of myofibres in regenerating rat 
muscles, which they described as satellite cell ‘mimics’. More recently, the finding 
that long-term exercise regimes augment numbers of graft-derived myofibres has been 
cited as evidence that bone marrow-derived satellite cells are capable of subsequent 
participation in regeneration (LaBarge & Blau 2002). However, it is also feasible that 
the frequency of bone marrow-derived myofibres increases over time as a result of 
further recruitment from the circulation, rather than by clonal expansion of graft- 
derived satellite cells. Myogenesis can occur concomitantly with angiogenesis after 
muscle tissue damage (Scholz et al. 2003). The very low incidence of bone marrow- 
derived myogenic activity reported by all workers (Ferrari et al. 1998, 2001, Gussoni 
et al. 2002, Corti et al. 2002, LaBarge & Blau 2002, Brazelton et al. 2003, Corbel et 
al. 2003, Camargo et al. 2003, Dreyfus et al. 2004, Shi et al. 2004), even in highly 
regenerative environments (Gussoni et al. 2002, Ferrari et al. 2001, Camargo et al. 
2003, Corbel et al. 2003) accords well with the finding of a lineage tracking 
experiment which showed that HSC-derived skeletal muscle is generated 
stochastically through myeloid, rather than satellite cell or other proliferative MPC 
intermediates (Camargo et al. 2003, reviewed, Camargo et al. 2004b). However, on 
entry into muscle tissue, bone marrow-derived cells are reported to silence expression 
of CD45, implying a reduced commitment to the myeloid lineage (Rivier et al. 2004). 
And conversely, other recent studies have identified human CD45+ desmin+ bone 
marrow-derived cells which differentiate into muscle in vitro in the absence of other 
myogenic cell types (Bossolasco et al. 2004), and also human AC133+ (a 
haematopoietic cell surface antigen of unknown function) circulatory cells which 
generate muscle with relatively high efficiency after grafting, and may also give rise 
to satellite cells (Torrente et al. 2004). Similarly, a small proportion of mouse bone 
marrow cells has been shown to express the MRFs Myf5 and MyoD, and to undergo 
myogenic differentiation in vitro (Bhagavati & Xu 2004). This endogenous
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commitment to the myogenic lineage (albeit of a small subset) implies that MPC can 
sometimes derive from bone marrow and that the process of myogenic recruitment, 
though inefficient, may occur via a physiological rather than merely stochastic 
process.
1.45 The origin of postnatally-renewed satellite cells
(a) Evidence that functional satellite cells are renewed from a tissue-resident 
source
Exposure of mouse muscles to high local doses of irradiation results in a long-term 
growth deficit (Wakeford et al. 1991, Quinlan et al. 1995) and sustained depletion of 
replication-competent satellite cells (Heslop et al. 2000). For this reason, though a 
detailed examination of the functional attributes of bone marrow-derived satellite cells 
is lacking, it seems unlikely that circulatory cells can generate precursors with any 
significant myogenic stem cell potential (commentary, Partridge 1998).
In young animals, following growth (Schultz 1996), and after the perturbation of 
injury and regeneration (Schultz 1984, Morlet et al. 1989, Reimann et al. 2000), 
satellite cell numbers are maintained, and muscle tissue retains the potential to 
respond to subsequent regenerative events (Schultz & Jaryszak 1985, Morlet at al. 
1989, Luz et al. 2002). However, satellite cell numbers decline with age (Gibson & 
Schultz 1983, Kadi et al. 2004, Sajko et al. 2004), and the proliferative competence of 
MPC becomes diminished both with age (Sadeh 1988), and after repeated bouts of 
regeneration (Schultz & Jaryszak 1985). There is therefore good circumstantial 
evidence suggesting firstly, that functional satellite cells have a finite potential for 
renewal, and secondly, that they are derived from a tissue-resident source, either 
outside or within their own niche (Fig. 1.2).
(b) Renewal from resident cells located outside the satellite cell compartment
A study by Heslop et al. (2000) showed that proliferation-competent satellite cells are 
not present in single myofibre cultures derived from mouse muscles treated with 18 
Gy irradiation. However, when irradiated muscles are damaged and then allowed to 
regenerate, some single myofibres derived from regenerated muscles have associated 
satellite cells capable of proliferation in vitro. Muscles exposed to 25 Gy irradiation
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and subsequently damaged have a (very) limited capacity to regenerate, but do not 
harbour replication-competent satellite cells (Heslop et al. 2000). In addition, it has 
been shown that a minority of turkey MPC are resistant to the effects of 25 Gy 
irradiation, and after an extended period in culture, can enter the cell cycle and 
undergo proliferation (Mozdziak et al. 1996). The findings of Heslop et al. (2000), 
which suggest that satellite cells are derived from a source outside the compartment, 
but within the tissue, were cited as evidence that CD45+ Sca-1+ putative muscle stem 
cells are tissue-resident, rather than derived from the circulation (Polesskaya et al.
2003). CD45+ Sea-1+ cells spontaneously express the satellite cell determinant, Pax7, 
after damage (Polesskaya et al. 2003), and moreover can be induced to undergo 
myogenic commitment by infection with Pax7 (Seale et al. 2004). Hypothetically, 
CD45+ Sca-1+ cells could therefore be a source of functional satellite cells, and 
perhaps be derived from the same population as the radiation resistant cells. 
However, the lack of data describing the phenotypic characteristics of radiation- 
resistant cells (Heslop et al. 2000) and the anatomical location of the progeny of 
CD45+ Sca-1+ cells (Polesskaya et al. 2003, Seale et al. 2004) make any such 
relationship unassessable. Nonetheless, the finding that Sca-1+ SP cells exist in a state 
of dynamic equilibrium within the C2 line (Benachaouir et al. 2003) suggests that 
satellite cells could periodically exit their anatomical niche and adopt a Sca-1+ (non­
satellite cell) phenotype.
(c) Evidence that satellite cells self-renew
An early study found that in vivo, some of the progeny of 3H-thymidine-labelled 
satellite cells did not fuse into myofibres, but retained their satellite cell status (Moss 
& Leblond 1971). Several studies have shown that grafts of MPC into mouse muscles 
both generate differentiated tissue, and maintain a reserve population of 
undifferentiated MPC (Yao & Kurachi 1993, Morgan et al. 1994, Blaveri et al. 1999, 
Gross & Morgan 1999, Heslop et al. 2001). Two studies showed that MPC could 
generate anatomically-defined satellite cells (Blaveri et al. 1999, Heslop et al. 2001), 
either when the donor cells were heterogeneous primary neonatal myoblasts (Heslop 
et al. 2001), or an immortalised satellite cell-derived cell line (Blaveri et al. 1999), the 
latter showing that the progeny of a single satellite cell can adopt divergent fates. It 
has been demonstrated that transplanted conditionally-immortalised MPC maintain 
some myogenic potential after serial passage through several muscles, with intervals
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of in vitro expansion (Morgan et al. 1994). However, the somewhat limited ability of 
transplanted MPC to respond to regenerative events in vivo (Gross & Morgan 1999) 
implies that cells cannot undergo significant clonal expansion outside the tissue 
culture environment. In the absence of immortalisation, the ability of a transplanted 
satellite-derived cell to undergo self-renewal in vivo is not known.
In tissue culture, clonal populations of MPC also adopt divergent fates on 
differentiation (Barroffio et al. 1996, Yoshida et al. 1998, Zammit et al. 2004a). 
Upon induction of differentiation by serum deprivation, most C2C12 cells initiate 
expression of myogenin, withdraw from the cell cycle, terminally differentiate and 
fuse into myotubes. However, a subset down-regulate expression of Myf5 and MyoD, 
but do not express myogenin or undergo fusion, and retain the ability to proliferate 
when re-stimulated with serum (Yoshida et al. 1998). These reserve cells also express 
the satellite cell marker, CD34 (Beauchamp et al. 2000). Similarly, primary 
myoblasts isolated from human muscle tissue generate a reserve population on 
differentiation, which can, however, be re-stimulated to proliferate, differentiate and 
yield up to four further cohorts of reserve cells (Baroffio et al. 1996). Recently, it has 
been demonstrated that a similar phenomenon occurs with satellite cells associated 
with isolated myofibres in suspension culture (Zammit et al. 2004a). In response to 
serum stimulation, satellite cells initially proliferate to generate small clonal 
populations. Within each clone, most cells commit to differentiation as defined by 
expression of myogenin and cell cycle withdrawal, but a minority are recalcitrant to 
differentiation and retain robust expression of Pax7 protein (Zammit et al. 2004a). 
Satellite cells derived from PaxTf~ mice express MyoD, proliferate and differentiate 
normally in tissue culture. However, numbers of satellite cells in PaxT/~ mice decline 
as animals reach maturity (Oustanina et al. 2004). Taken together, the data from these 
two studies suggest that the satellite adult satellite cell pool might be maintained by a 
process of self-renewal of which Pax7 is a key regulator (Oustanina et al. 2004, 
Zammit et al. 2004a).
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(d) Evidence that satellite cells are renewed by a stem cell subset
Studies of isolated single myofibres have found that the satellite cell compartment is 
phenotypically heterogeneous. Beauchamp et al. (2000) showed that while the 
majority of satellite cells express Myf5, CD34 and M-cadherin, about 20% do not 
express any of these markers. It has been hypothesised that these negative cells may 
represent a more primitive, stem cell-like population which functions to renew the 
compartment (Beauchamp et al. 2000, reviewed, Zammit & Beauchamp 2001). On 
exposure to serum, 98% of satellite cells in single myofibre preparations 
synchronously activate and express MyoD protein; however, the remaining 2% appear 
to resist activation (Zammit et al. 2002). Whether these cells represent a deeply- 
quiescent stem cell subset, or are merely replication-incompetent, remains unclear.
Studies of regeneration in vivo have suggested that satellite cells also exhibit 
functional heterogeneity (Rantanen et al. 1995, Schultz 1996, Rouger et al. 2004). 
Rantanen et al. (1995) found that while some stem cell-like satellite cells underwent 
proliferation in response to injury, other satellite cells upregulated myogenin 
expression within eight hours, implying a prior commitment to differentiation. In the 
muscles of growing rats, 80% of the satellite cell compartment was found to be 
labelled after five days of continuous BrdU infusion (Schultz 1996). The remaining 
20% represented slower-cycling subset which incorporated BrdU more slowly, and 
was speculated to continuously renew the main population (Schultz 1996). Similarly, 
Rouger et al. (2004) have shown that proliferative heterogeneity exists between 
clones of myoblasts isolated from turkey muscles. After eleven days in culture, 50% 
of clones were found to gave rise to >64 nuclei and were termed slowly-proliferating 
clones. 8% of clones gave rise to >256 nuclei and were termed highly-proliferative 
clones. The proliferative characteristics of clones were maintained both in vitro after 
co-culture with heterogeneous primary cells and in vivo after autografting. In vivo, 
slowly-proliferating clones were thought to give rise satellite cells more frequently 
than highly-proliferative clones (Rouger et al. 2004), though since neither phenotypic 
markers nor electron microscopy were employed, this observation is not robust. It is 
conceivable that the slow-cycling subsets identified by Schultz (1996) and Rouger et 
al. (2004) may correspond to the phenotypically unmarked population identified in 
the mouse satellite cell compartment by Beauchamp et al. (2000).
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An alternative interpretation of these data is that rather than forming distinct subsets, 
all satellite cells are essentially similar but are behaviourally and phenotypically 
asynchronous. Whilst the majority of HSC are quiescent at any one timepoint, they 
are recruited back into the cell cycle at regular intervals (Bradford et al. 1997, 
Cheshier et al. 1999). Myoblast cell lines adopt divergent fates upon differentiation 
(Yoshida et al. 1998, Blaveri et al. 1999) and generate subsets which are slowly- 
proliferating in vitro, but nevertheless have the potential to undergo extensive 
proliferation in vivo (Beauchamp et al. 1999). In addition, C2C12 cells can generate 
reversible SP (Benchaouir et al. 2003) and tumorigenic (Morgan et al. 2002) 
phenotypes, demonstrating that extreme behavioural diversity is possible within a 
single myoblast clone.
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Fig. 1.2 The origin of postnatally-renewed satellite cells. The satellite cell 
compartment is maintained throughout adult life, but its major source of renewal has 
not been unequivocally established. The phenotypic (Beauchamp et al. 2000) and 
behavioural (Schultz 1996) heterogeneity of satellite cells predicts the existence of a 
stem cell-like subset which may function to renew the compartment (A). In vitro 
(Baroffio et al. 1996, Zammit et al. 2004a) and in vivo (Heslop et al. 2001), myoblasts 
maintain reserve populations upon differentiation, suggesting that satellite cell progeny 
can return to quiescence and thereby self-renew (B). Satellite cells could also be 
renewed by other resident phenotypes such as radiation-resistant MPC (Heslop et al.
2000), muscle SP (Asakura et al. 2002) or CD45+ Sca-1+ cells (Polesskaya et al. 2003) 
(C), or alternatively, by a circulatory phenotype (LaBarge & Blau 2002, Dreyfus et al.
2004) (D). It is not known whether these alternative phenotypes generate muscle via 
committed intermediate progenitors, or whether they fuse directly into myofibres 
without prior myogenic commitment (C, D).
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1.5 Skeletal muscle myopathy
1.51 Myopathies involving the dystrophin-glycoprotein complex
The dystrophin-glycoprotein complex (DGC) is a large complex of transmembrane 
and membrane-associated proteins that connects the subsarcolemmal cytoskeleton of 
myofibres with the extracellular matrix (reviewed, Rando 2001, Durbeej & Campbell 
2002). The major components of the DGC are dystrophin (Campbell & Kahl 1989), 
the a- and P- dystroglycans (Ervasti et al. 1990), the a-, P-, 5- and y-sarcoglycans 
(Ibraghimov-Beskrovnaya et al. 1992), a-dystrobrevin (Grady et al. 1999), the a l- , pi 
and p2-syntrophins (Adams et al. 1993), sarcospan (Crosbie et al. 1997), dysferlin, 
calveolin-3 and the a5- and a7-integrins (reviewed, Durbeej & Campbell 2002) (Fig. 
1.2). The peripheral membrane protein a-dystroglycan binds to laminin-2 in the basal 
lamina, and in the extracellular matrix, to the heparan sulphate proteoglycans perlecan 
and agrin (which are also present in the basal lamina) and the chondroitin sulphate 
proteoglycan, biglycan. In addition, a-dystroglycan is associated with the 
extracellular domain of the transmembrane protein P-dystroglycan. p-dystroglycan 
binds to dystrophin which binds to the cytoskeletal protein, actin. Whilst the function 
of the DGC is not fully understood, it is believed have a structural role, protecting 
muscle cells from contraction-induced injuries (reviewed, Rando 2001, Durbeej & 
Campbell 2002). It is also involved in extracellular signalling (reviewed, Rando 
2002). Mutations which cause disruption of the DGC component proteins lead to 
muscular dystrophies of varying severity (reviewed, Durbeej & Campbell 2002). In 
two examples, mutations in the gene encoding P-sarcoglycan cause the 2E form of 
limb-girdle muscular dystrophy (LGMD) (Lim et al. 1995, Bonneman et al. 1995), 
and mutations in the gene encoding dystrophin lead to DMD and its milder allelic 
form, Becker’s muscular dystrophy (BMD) (Hoffman et al. 1987). Pathologically 
similar dystrophies are also generated by disruption of the matrix proteins to which 
the DGC binds. Mutations in the gene encoding laminin a2 chain are the genetic 
basis of congenital muscular dystrophy (CMD) (Sunada et al. 1994, Xu et al. 1994) 
(Fig. 1.3).
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Fig. 1.3 The dystrophin-glycoprotein complex. Reproduced from Durbeej & Campbell 
(2002).
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1.52 DMD
DMD is a lethal X-linked primary myopathy (Dubowitz 1985, Morgan et al. 1989, 
Hoffman & Schwartz 1991) characterised by the near-absence of dystrophin protein in 
skeletal muscles (Bonilla et al. 1988, Hoffman et al. 1988). It was first described in 
detail in the 19th Century, most notably by the physician G.B.A. Duchenne (Duchenne 
1868 cited in Bogdanovich et al. 2004, Dubowitz 1992, reviewed, Tyler 2003). DMD 
is both the most severe and the most common of the myopathies involving the DGC, 
affecting one in every 3,500 live male births (Hoffman & Schwartz 1991, Dubowitz 
1992).
In humans, the functional significance of dystrophin protein in skeletal muscles is 
demonstrated by the acute pathology resulting from its absence (Hoffman et al. 1988). 
Muscle histology in DMD patients is almost normal before the onset of clinical 
symptoms of at 3-5 years of age. The preliminary stage of the disease is characterised 
by the presence of focal groups of necrotic myofibres, muscle hypertrophy and 
abnormally high levels of muscle creatine kinase, an indicator of ongoing 
degeneration. In the second, pathological phase, repeated cycles of degeneration 
exhaust the regenerative capacity of skeletal muscle tissue (Dubowitz 1985, Dubowitz 
1992, Rafael et al. 1997, Decary et al. 2000) and fibrotic mechanisms cause the 
progressive replacement of contractile muscle tissue with collagenous connective 
tissue (Dubowitz 1985, Dubowitz 1992, Rafael et al. 1997). This process results in 
severe joint contractures, loss of ambulation at around 10-12 years of age and 
respiratory problems, the culmination of which usually cause death during the third 
decade of life (Dubowitz 1985, Dubowitz 1992). The absence of dystrophin protein 
in the heart and brain also results in cardiomyopathy (Cziner & Levin 1993, Finsterer 
& Stollberger 2003) and cognitive impairment (Anderson et al. 2002, Wicksell et al.
2004).
1.53 Animal models of DMD
(a) Homologues of dystrophin and DMD in non-human species
Homologues of the human dystrophin gene (Hoffman et al. 1987a, 1987b) have been 
identified not only in vertebrates including mice (Hoffman et al. 1987a, 1987b), dogs 
(Cooper et al. 1988) and zebrafish (Bolanos-Jimenez et al. 2001) but also in
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invertebrate models such as the fruit fly Drosophila melanogaster (Neumann et al.
2001) and the nematode worm Caenorhabditis elegans (Bessou et al. 1998). This 
conservation is indicative of the species-wide functional significance of dystrophin 
protein which is further demonstrated by the similarly universal, though differential, 
pathological reaction to its mutation or absence (reviewed, Collins & Morgan 2003). 
Whilst the effects of dystrophin deficiency in humans are profoundly debilitating from 
an early age, they are not recapitulated in the C57Bl/10-rad£c (mdx) mouse model 
(Bulfield et al. 1984) which, despite being a genetic and biochemical homologue of 
DMD (Hoffman et al. 1987a, 1987b), has a normal lifespan and muscle pathology 
which does not become debilitating until old age (Dangain & Vrbova 1984, Tanabe et 
al. 1986, Cullen & Jaros 1988, Dubowitz 1992, reviewed, Partridge 1997). This 
species-specific response to dystrophin deficiency is informative regarding the 
function of the protein, suggesting that the disease state occurs as a consequence of 
secondary pathological mechanisms partly dependant on the host environment (Cullen 
& Jaros 1988, reviewed, Partridge 1997).
(b) The mdx mouse
Before the identification of the dystrophin locus in 1987 (Hoffman et al. 1987), 
several unauthenticated models of murine dystrophy were employed in DMD 
research, on the basis of their pathological similarities to the human disease. The 
most significant of these were the C57B1/6 J-dy2J (dy/dy) mouse (Meier & Southard 
1970) and the mdx mouse (Bulfield et al. 1984). The genetic basis of dy/dy murine 
dystrophy was eventually found to be a mutation in the gene encoding laminin M- 
chain (Sunada et al. 1994, Xu et al. 1994), showing it to be a genetic model of human 
CMD. With the identification of the dystrophin gene, however, it was revealed that 
human DMD and murine mdx dystrophy have a common locus (Hoffman et al. 1987a, 
1987b).
Mdx is a spontaneous mutant that was identified within a wild-type C57B1/10 colony 
from its elevated concentration of plasma creatine kinase (Bulfield et al. 1984). 
Creatine kinase peaks between two and eight weeks of age, during which period 
muscle pathology also becomes most pronounced and is characterised by the 
appearance of numerous necrotic foci and newly-regenerated centrally-nucleated 
myofibres (Tanabe et al. 1986, Coulton et al. 1988, reviewed, Partridge 1997). Mdx
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pathology is thought to model DMD most closely between weeks three and four, 
during which time several cycles of degeneration and regeneration occur (Dangain & 
Vrbova 1984, Tanabe et al. 1986, reviewed, Partridge 1997). After this period, tissue 
efficiently regenerates and only mild myopathy persists in most muscles (Tanabe et 
al. 1986), although more severe pathology again becomes evident from 15 months 
onwards (Pastoret & Sebille 1993). Regeneration is accompanied by myofibre 
hypertrophy, with mdx muscles having significantly greater masses than wild-type 
equivalents (Marshall et al. 1989, Pastoret & Sebille 1993, Lynch et al. 2001). 
Though less pronounced than in DMD, fibrosis is also a feature of mdx myopathy, 
with collagen accumulation characteristic of affected muscles (Bulfield et al. 1984, 
Marshall et al. 1989, Morrison et al. 2000). The pathological response of different 
muscles is surprisingly distinct, with some, such as the masseter (Muller et al. 2001) 
and extraocular muscles (Karpati & Carpenter 1986, Karpati et al. 1988), being 
almost completely spared, and others, such as the diaphragm and gastrocnemius, 
affected severely in older animals (Stedman et al. 1991, Muller et al. 2001, Coirault et 
al. 2003). The diaphragm in particular has acute pathology comparable to that seen in 
the limb muscles of human DMD patients, and by age 2 years, has only 13.5% of the 
strength of the wild-type (Stedman et al. 1991, Muller et al. 2001). Before the onset 
of pathology at about 2 weeks of age, there is evidence that hindlimb muscles such as 
the EDL are insensitive to acute mechanical injury (Grange et al. 2002). However, in 
mature animals, not only the diaphragm (Stedman et al. 1991) but relatively non- 
pathological hindlimb muscles such as the TA are more susceptible to contraction- 
induced injury than in the wild-type (Dellorusso et al. 2001). Mdx muscles exhibit 
hypertrophy that is not solely attributable to fibrosis (Pastoret & Sebille 1993), and 
has been suggested as the reason for excised juvenile EDL and soleus muscles 
showing no decrease in power output compared to wild-type muscles (Lynch et al.
2001). However, mdx mice do not adapt to voluntary exercise as well as wild-type 
controls, showing little increase in hindlimb muscle strength or decrease in 
fatiguability over time (Carter et al. 1995); consequently, even moderate exercise may 
accelerate the course of the disease (De Luca et al. 2003).
It has been postulated that mdx pathology is moderated by the partial functional 
replacement of dystrophin by the homologous protein utrophin (Rybakova et al.
2002). Mice which are null for both dystrophin and utrophin (mdx/utrn^) have an
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acute phenotype and exhibit certain characteristics of human DMD which are not seen 
in the mdx mouse, including severe growth retardation, spinal curvature, joint 
contraction and premature death (Deconinck et al. 1997). In addition, it has been 
shown that early expression of utrophin in mdx mice can ameliorate dystrophic 
pathology to some extent (Squire et al. 2002).
There is evidence that dystrophic pathology such as that which develops in the later 
stages of mdx myopathy is in part attributable to the failure of the regenerative process 
(Sadeh et al. 1985, Schultz & Jaryszak 1985, Bockhold et al. 1998, Heslop et al. 
2000, Reimann et al. 2000, Luz et al. 2002, Eamshaw et al. 2002). Although mdx 
muscle fibres initially develop normally, the differentiation of regenerated fibres is 
compromised (Eamshaw et al. 2002). Studies of cultured single myofibres by 
Bockhold et al. (1998) found that the numbers of proliferating satellite cells migrating 
from each fibre decline with age in both wild-type and mdx isolates. In the wild-type 
this decline is linear, and though by 550 d the satellite cell population is substantially 
depleted, virtually all emanating cells are of the myogenic lineage as defined by 
expression of the intermediate filament protein desmin. In mdx isolates the number of 
proliferative satellite cells increases with age up to 50 d, when it is three-fold greater 
than wild-type controls. Thereafter numbers of myogenic cells decline, but never 
recede below wild-type values. Significantly, however, there is an age-related 
increase in the number of non-myogenic cells, probably fibroblasts, which derive 
from cultured mdx myofibres. The results of this study therefore suggested that it is 
the combination of excess fibrinogenesis with normal age-related myogenic satellite 
cell decline, rather than myogenic cell decline alone, which is responsible for 
regenerative failure in muscular dystrophies (Bockhold et al. 1998). Nevertheless, 
murine mdx myopathy is at best an imprecise model of its human counterpart DMD 
(Dangain & Vrbova 1984, Tanabe et al. 1986, Cullen & Jaros 1988, reviewed, 
Partridge 1997). When wild-type rodent or mdx muscles are subjected to repeated 
rounds of damage by the myotoxic agent bupivacaine (Sadeh et al. 1985, Schultz & 
Jaryszak 1985, Luz et al. 2002), or to cryodamage (Reimann et al. 2000) their 
regenerative capacity is substantially compromised, suggesting that as in human DMD 
patients, the satellite cell compartment of rodents can be depleted with sufficient 
pressure. A study by Heslop et al. (2000) found that numbers of radiation-resistant 
muscle stem cells, a postnatal source of satellite cells, were greatly reduced in older
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mdx mice compared to wild-type controls. Taken together, these studies suggest that 
although there is no overt difference in absolute numbers of satellite cells (Bockhold 
et al. 1998, Reimann et al. 2000) their potential for continued renewal is depleted 
(Heslop et al. 2000), and that mdx muscle tissue therefore manifests physiologically 
similar (though less advanced) regenerative exhaustion to DMD muscle.
(c) Canine and feline models
Spontaneous mutations of the dystrophin gene resulting in X-linked muscular 
dystrophy have been identified in several breeds of domestic dog, including the 
Golden Retriever (Cooper et al. 1988), the Rottweiler (B. Cooper cited in Partridge 
1997) and the German short-haired pointer (Schatzberg et al. 1999). The Golden 
Retriever muscular dystrophic (GRMD) dog is the best characterised of these (Cooper 
et al. 1988).
In contrast to both mdx and DMD myopathies, GRMD pathogenesis manifests in 
utero with the development of lingual muscle lesions (Valentine et al. 1988, Nguyen 
et al. 2002), and neonatal GRMD puppies exhibit extensive necrosis of limb, trunk 
and neck muscles (Nguyen et al. 2002). Creatine kinase levels continue to increase 
steadily from birth onwards, reaching a plateau at 100X normal by six to eight weeks 
of age (Valentine et al. 1988), concurrent with the time of postnatal muscle 
maturation in dogs (Cozzi et al. 2001). Transforming growth factor-p 1 levels are also 
elevated and are thought to be involved in the initiation of fibrosis (Passerini et al.
2002). Severe fibrosis and contractures in joints such as the tarsus develop by 6 
months of age (Valentine et al. 1988, Komegay et al. 1994). Similarly to DMD 
patients, young GRMD dogs frequently die from cardiac or respiratory failure, though 
some survive to reach several years of age (Nguyen et al. 2002).
In cats, dystrophin deficiency results in hypertrophic feline muscular dystrophy 
(HFMD) (Kohn et al. 1993). As its name suggests, a defining feature of HFMD 
myopathy is pronounced muscle hypertrophy, which can culminate in lethal 
oesophageal obstruction and kidney failure (Kohn et al. 1993, Gaschen & Burgunder
2001). Although HFMD skeletal muscle undergoes repeated rounds of degeneration 
and regeneration, it does not develop the debilitating fibrosis that is characteristic of
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DMD and GRMD (Kohn et al. 1993, Gaschen & Burgunder 2001), and is therefore 
closer to mdx dystrophy than its human counterpart.
(d) Non-mammalian models
Small animal models of DMD have been developed in the zebrafish (Guyon et al. 
2003, Bassett et al. 2003, reviewed, Basset & Currie 2003) and the nematode C. 
elegans (Bessou et al. 1998). Zebrafish are attractive as models of myopathy because 
they have a high skeletal muscle content and express orthologues of most human 
DGC proteins which also have similar membrane localisation (Chambers et al. 2001, 
Guyon et al. 2003). Gene-targeting technologies are not currently available, but 
equivalent experiments can be carried out using oligonucleotide analogues 
(morpholinos) which disrupt translation of specific mRNA transcripts. This technique 
has been used to create dystrophin-deficient zebrafish which have an unstable DGC, 
bent morphology and lower activity (Guyon et al. 2003). In addition, a mutation 
called sapje in the zebrafish dystrophin orthologue has been shown to be responsible 
for a lethal embryonic phenotype attributed to the failure of muscle end attachments 
(Bassett et al. 2003).
The nematode worm C. elegans moves by contraction of longitudinal striated muscles 
which express a dystrophin orthologue called dys-1 (Bessou et al. 1998), that interacts 
with other DGC proteins (Gieseler et al. 1999, Chamberlain & Benian 2000). 
Mutations of dys-1 result in hypercontraction, increased sensitivity to the 
neurotransmitter acetyl choline, and hyperactivity (Bessou et al. 1998).
1.54 Myoblast transfer therapy
Haematopoietic reconstitution by transplantation of bone marrow cells has been used 
with some success as a treatment for disorders of the lymphohaematopoietic system 
(Faber-Langendoen et al. 1993, Cavazzana-Calvo et al. 2000). The rationale behind 
myoblast transfer therapy (MTT) is that the biochemical and pathological defects in 
DMD patients could be similarly treated by reconstitution of affected muscles with 
grafts of normal donor or genetically-corrected host MPC (reviewed, Smythe et al. 
2001, Partridge 2002b, 2003).
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The experiments of Studitsky and Carlson established the principle that minced 
muscle derived from one animal could regenerate new functional muscle tissue when 
grafted into the muscle bed of a second animal (Studitsky 1964, Carlson 1968, 1970). 
It was subsequently shown that isolated populations of muscle cells could also 
participate in regeneration after grafting directly into the muscles of rodents (Jones 
1979, Lipton & Schultz 1979, Watt et al. 1982, Law et al. 1988). The ability of 
grafted cells to fuse into host myofibres (Partridge et al. 1978) was exploited as a 
means of inserting foreign genes into host muscle tissue (Watt et al. 1984a, Morgan et 
al. 1988), including the normal dystrophin gene in the muscles of mdx mice (Partridge 
et al. 1989). Importantly, grafts of normal MPC were found to generate myofibres 
expressing membrane-localised dystrophin protein, thus locally ameliorating both the 
genetic and biochemical defects (Partridge et al. 1989). It was subsequently also 
shown that normal muscle cell isolates grafted into the dystrophic muscles of dy/dy 
mice can restore expression of the absent laminin a2 protein (Vilinquin et al. 1996).
The promising results of early animal studies were the inspiration behind clinical 
trials of MTT as a therapy for DMD (Law et al. 1991, 1992, Gussoni et al. 1992, 
Karpati et al. 1993, Tremblay et al. 1993, Mendell et al. 1995, Miller et al. 1997), and 
later, BMD (Neumeyer et al. 1998). The majority of these trials reported that MTT 
did not result in the restoration of functionally significant amounts of dystrophin 
protein expression (Gussoni et al. 1992, Karpati et al. 1993, Tremblay et al. 1993, 
Mendell et al. 1995, Miller et al. 1997, Neumeyer et al. 1998), though unexpectedly, 
administration of the immunosuppressive agent cyclosporine was found to augment 
muscle strength in treated boys (Miller et al. 1997). Later re-analysis of 6 month 
post-MTT muscle biopsies from one trial, using a fluorescence in situ hybridisation 
method, revealed that although a few myoblasts had persisted in all muscles, many 
cells had failed to differentiate into functional tissue (Gussoni et al. 1997). A major 
factor in the failure of MTT is likely to have been the substantial immune reaction 
elicited against the transplanted cells, despite careful selection of histocompatible 
donors (Huard et al. 1992, Roy et al. 1993). Beneficial effects from MTT were 
reported by one group (Law et al. 1991, 1992), but these studies omitted to control for 
the potential therapeutic effects of cyclosporine, and in subsequent independent 
verification no donor-derived dystrophin could be identified in patient muscle 
biopsies (Partridge etal. 1998).
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The apparent lack of success of clinical trials of MTT could be at least partly 
attributable to the extreme disparity between the mdx mouse model and the human 
DMD patient (reviewed, Partridge 1997, 2002b). Apart from other obvious innate 
differences such as size, muscle formation in mouse models is usually optimised by 
prior treatment of the graft site with irradiation (Morgan et al. 1990, Kinoshita et al. 
1994, Gross et al. 1999), cryodamage (Morgan et al. 1987, Wemig et al. 1991, 
Irintchev et al. 1997) or myotoxins (Huard et al. 1994, Kinoshita et al. 1994, Pye et 
al. 2004), none of which are feasible for use in human patients. In addition, many of 
the animal studies of MTT were carried out in immunodeficient hosts, such as mdx 
mice bred onto a nude background (Partridge et al. 1989), or the severe combined 
immune deficient (SCID) mouse (Huard et al. 1994). Studies of MTT in 
immunocompetent mice found that grafted myoblasts elicited a robust immune 
response as indicated by the infiltration of lymphocytes, macrophages, granulocytes 
and natural killer cells (Guerrette et al. 1995, Irintchev et al. 1995, Wemig et al. 1995, 
Hodgetts et al. 2000, Skuk et al. 2002), even when, as in human MTT trials, the donor 
cells were matched for host histocompatibility (Wemig & Irintchev 1995). As well as 
causing massive and rapid donor cell death (Fan et al. 1996, Hodgetts et al. 2000), the 
process of graft rejection has been shown to be damaging to the host tissue (Irintchev 
et al. 1995, Wemig & Irintchev 1995). The immunosuppressive drugs Cyclosporin A 
(Watt et al. 1984b, Irintchev et al. 1995) and FK506 (Kinoshita et al. 1994) improve 
the success of MTT in immunocompetent mice; FK506 has also been used to support 
efficient MTT in monkeys (Kinoshita et al. 1996, Skuk et al. 2000).
It has been demonstrated that the majority of myoblasts rapidly die following 
transplantation, irrespective of whether the host is immunocompetent or 
immunocompromised (Fan et al. 1996, Beauchamp et al. 1999, Hodgetts et al. 2000). 
A small subset survives to subsequently proliferate and expand the pool of 
differentiation-competent MPC (Beauchamp et al. 1999, Cousins et al. 2004). 
Beauchamp et al. (1997) developed a model system whereby male cells were labelled 
with 14C-thymidine and grafted into female host mice. Y chromosome was used as a 
conserved marker to quantify the amount donor genome present, and 14C scintillation 
counts were used to estimate cell survival (Beauchamp et al. 1997). This system was 
used to show that donor-derived muscle originates from a ‘stem cell-like’
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subpopulation of cells that in tissue culture, are divide slowly and therefore do not 
incorporate radioactive label, but after grafting undergo extensive proliferation 
(Beauchamp et al. 1999). Similarly, labelling of primary cultures with unique 
retroviral inserts showed that muscle regeneration from grafted myoblasts is 
oligoclonal (Cousins et al. 2004). Unlike mouse cells (Hauschka et al. 1979, Morgan 
et al. 1994) human myoblasts do not form cell lines, and have a finite proliferative 
capacity (‘Hayflick’s limit’), undergoing senescence after about twenty population 
doublings (reviewed, Di Donna et al. 2000). It is possible that the sometimes very 
extensive expansion of cells prior to MTT in DMD patients (Law et al. 1992) resulted 
in a transplanted population that was already close to senescence, and therefore 
incapable of proliferation equivalent to that of the myogenic subset of grafted mouse 
cells. In addition, it has been suggested that the tissue culture environment itself has a 
negative effect on subsequent survival in vivo, perhaps by making cells more 
immunogenic (reviewed, Smythe et al. 2000).
Even under optimised experimental conditions, the efficiency of MTT rarely exceeds 
parity i.e. the number of donor-derived myonuclei is approximately equivalent to the 
original number of grafted cells (reviewed, Partridge 2003). Muscle formation is 
mainly localised to the graft site, and is not augmented with time (Morgan et al. 
1993). Before MTT could have clinical application, the problems associated with cell 
survival, proliferation, differentiation and dispersal would need to be addressed 
effectively (reviewed, Smythe et al. 2001, Partridge 2003).
1.55 Gene therapy of DMD
The most encompassing therapeutic solution to DMD would be to insert a normal 
copy of the dystrophin gene into the patient’s muscle cells, and thereby restore 
sufficient protein expression to ameliorate pathology. At 2.4 Mb, dystrophin is the 
largest known mammalian gene, consisting of 79 exons which produce 14 kb of 
mature mRNA and generate a 427 kDa protein (Roberts et al. 1993).
Its exceptionally large size makes the dystrophin gene difficult to accommodate in 
most vector systems (reviewed, Wells & Wells 2002, Kapsa et al. 2003, Bogdanovich 
et al. 2004). However, in an early study it was shown that full-length human
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dystrophin cDNA could be ligated into plasmid vectors and subsequently expressed in 
both cultured cells and mouse muscles, albeit at very low levels (Acsadi et al. 1991). 
More recently, the efficiency of expression in comparable experiments has been 
increased by use of hyaluronidase pre-treatment and electrotransfer (Gollins et al. 
2003, Ferrer et al. 2004) or semisystemic delivery through limb blood vessels (Liang 
et al. 2004). In an alternative approach, it has been shown that deletion of parts of the 
rod domain of dystrophin can be used to create ‘mini-dystrophin’ genes that both 
retain some function and are small enough to ligate into viral vectors (Wang et al. 
2000, Roberts et al. 2002, reviewed, Wells & Wells 2002). Intramuscular injection of 
full-length human dystrophin cDNA is currently being employed in a clinical trial of 
gene therapy for DMD, conducted at the Pitie-Salpetriere Hospital in Paris 
(Thioudellet et al. 2002, Romero et al. 2002).
Both mdx and DMD muscles contain small numbers of ‘revertant’ muscle fibres that 
express near-normal levels of dystrophin protein (Hoffman et al. 1990, Lu et al. 
2000). In the mdx, revertant fibres are formed by alternative processing of mRNA 
transcripts to skip the expression of up to 30 exons and yield a smaller, but functioned 
protein (Lu et al. 2000). This endogenous phenomenon has been recapitulated by the 
use of antisense oligoribonucleotides to modify processing of dystrophin pre-mRNA 
and induce expression of a functional, alternatively-spliced dystrophin protein (Mann 
et al. 2001). The use of block copolymers as transfection reagents has been shown to 
increase the efficiency of this approach to the extent that substantial structural and 
functional improvements can be measured in treated mdx muscles (Lu et al. 2003).
1.6 Myotoxic agents
1.61 Use of myotoxic agents in the study of muscle regeneration
The progressive clinical decline of DMD patients is in part attributable to the failure 
of effective muscle regeneration (Dubowitz 1985, Dubowitz 1992, Rafael et al. 1997, 
Decary et al. 2000), a characteristic of human myopathies which is not adequately 
modelled by small animal homologues of muscular dystrophy such as the mdx mouse 
(Dangain & Vrbova 1984, Tanabe et al. 1986, Cullen & Jaros 1988, reviewed, 
Partridge 1997). Myotoxic agents that cause severe damage muscle tissue have been 
employed to generate better models of regeneration in adult rodent muscles.
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Commonly used myotoxic preparations include the local anaesthetic bupivacaine, 
aqueous solutions of barium chloride, and snake venoms such as notexin and 
cardiotoxin (reviewed, Harris 2003). Although structurally diverse, all of these agents 
appear to elicit toxicity by interfering with cellular ion transportation, in particular of 
calcium.
1.62 Notexin
Notexin is a toxic phospholipase A2 purified from the venom of the Australian Tiger 
snake Notechis scutatus scutatus (Halpert & Eaker 1976, Dixon & Harris 1996, 
reviewed, Harris 2003). When injected into skeletal muscle tissue, notexin binds to 
the sarcolemmas of slow (oxidative) myofibres where its hydrolytic activity induces 
the formation of small lesions. As a result of the consequent loss of ion gradients, 
parts of the myofibres hypercontract, the weakened intervening areas rupture and 
complete degeneration occurs (Dixon & Harris 1996, Harris et al. 2003, reviewed, 
Harris 2003). The cytoplasmic protein desmin is rapidly degraded with an estimated 
half-life of 1 h, whilst other structural proteins such as dystrophin and the contractile 
proteins actin and myosin have estimated half-lives of up to 9 h as determined by 
Western blotting or Coomassie blue staining of protein gels (Harris et al. 2003). By 6 
h after injection, serum creatine kinase activity has increased by 5 or 6-fold, and 
remains elevated for more than 24 h (Pluskal et al. 1978). The muscle 
microcirculation and the basal laminae of myofibres remain intact (Harris & Cullen 
1990).
It has been reported that fast glycolytic muscle fibres are relatively resistant to the 
effects of notexin (Harris et al. 1975, reviewed, Harris 2003). Nevertheless, notexin 
has been shown to bind to the sarcolemmas of fast fibres (Dixon & Harris 1996), and 
several studies have successfully used notexin to induce degeneration and 
regeneration in mouse TA muscles, which have a predominantly fast fibre-type profile 
(Lefaucheur & Sebille 1995, Gross & Morgan 1999, Heslop et al. 2000).
Proliferating myoblasts rapidly accumulate around notexin-induced lesions (Klein- 
Ogus & Harris 1983, Dux et al. 1993, reviewed, Harris 2003), implicating them as the 
source of subsequent regeneration. This observation has been cited as evidence that 
satellite cells are insensitive to the effects of notexin (reviewed, Harris 2003).
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1.63 Cardiotoxin
Cardiotoxins are polypeptides of 60-65 amino acids long which are derived from the 
venoms of cobras, and are general cytotoxins related to acetyl choline receptor- 
binding a-neurotoxins. Cardiotoxin is a pore-forming agent that causes depolarisation 
and degradation of the sarcolemmas of myofibres (Ownby et al. 1993, reviewed, 
Harris 2003). The basal lamina remains intact and acts as a scaffold for subsequent 
regeneration within the intact tube. 24 h after injection, mitochondria surviving 
within the tube are visibly swollen (Ownby et al. 1993). It is thought that failure of 
mitochondrial respiration, resulting from inactivation of calcium-dependant proteases 
and subsequent Ca2+ overload, is a major factor in the final stages of degeneration 
(reviewed, Harris 2003). This hypothesis is supported by the finding of an in vitro 
study which showed that cardiotoxin caused depolarisation of chick skeletal muscle 
cells, and that this effect was reduced by the addition of Ca2+ ions (Chen & Harvey 
1993). Data from another in vitro study, using human and equine skeletal muscle cell 
cultures, showed that cardiotoxin causes breakdown of phospholipids and production 
of free fatty acids. This suggests that activation of endogenous phospholipase C 
activity may be involved in the degenerative process (Fletcher et al. 1991).
1.64 Bupivacaine
Bupivacaine {'Marcaine’) is a local anaesthetic which causes necrosis and apoptosis 
of muscle fibres, but is thought to be non-toxic to other tissue components (Foster & 
Carlson 1980, Zink et al. 2003). Degeneration of myofibres and neuromuscular 
junctions occurs with 4 h of injection. Whilst the myofibres themselves regenerate 
effectively, significant ultrastructural changes to the neuromuscular junctions persist 
for several weeks (Nishizawa et al. 2003). Bupivacaine has been shown to both 
induce Ca2+ release from the sarcoplasmic reticulum and inhibit its uptake (Komai & 
Lokuta 1999, Zink et al. 2002). In addition, the contractile proteins become sensitised 
to Ca2+ (Zink et al. 2002). Increased cytosolic concentration of Ca2+ occurs 
concurrently with the release of cytochrome C and mitochondrial depolarisation 
(Irwin et al. 2002). The volume density of mitochondria declines, reaching its lowest 
value 24 h after injection (Nishizawa et al. 2003). Whilst intact fibres from the 
oxidative flexor digitorum brevis (FDB) and soleus muscles are sensitive to 
bupivacaine, fibres from the glycolytic oesophageal and EDL muscles are relatively
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resistant to its activity. These findings suggest that oxidative metabolism is a major 
factor in bupivacaine toxicity, mediated through mitochondria (Irwin et al. 2002).
In tissue culture, bupivacvaine is rapidly toxic to rat myotubes and inhibits myoblast 
fusion, although differentiation resumes normally on removal of the drug. This 
implies that it is relatively non-toxic to undifferentiated MPC (Schultz & Lipton 1978, 
Stygall et al. 1979).
1.65 Barium chloride
Injection of aqueous barium chloride solution into skeletal muscle causes necrosis of 
muscle fibres (Caldwell et al. 1990, Wells et al. 1998), but does not appear to affect 
the basement membrane, which acts as a scaffold for subsequent regeneration 
(Caldwell et al. 1990). The myonecrosis caused by barium chloride has been used to 
increase the efficiency with which plasmid (Wells et al. 1998) and retroviral (Fassati 
et al. 1995, 1996) DNA can be introduced into muscle fibres, and to augment muscle 
formation by human myoblasts grafted into mouse muscles (Pye et al. 2004).
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1.7 Aims of study
The ability of satellite cells to contribute to differentiated myofibres is beyond doubt 
both in vivo (Moss & Leblond 1971) and in vitro (Rosenblatt et al. 1995). However, 
since other phenotypes also contribute to myonuclei (Ferrari et al. 1998, Seale et al. 
2002, Camargo et al. 2003, Polesskaya et al. 2003) the precise role of satellite cells 
remains incompletely defined. Importantly, the mechanism by which the adult 
satellite cell compartment is renewed is not well understood (Fig. 1.2), and is 
fundamental to determining whether satellite cells function as adult stem cells, or are 
a population of intermediate progenitors that are the progeny of a separate stem cell 
population.
Current understanding of adult muscle regeneration is largely based on studies of 
whole muscles, in which the precise cellular source of regeneration is difficult to 
pinpoint, and on in vitro and in vivo studies of cell isolates, in which artefacts may be 
generated by the tissue culture environment itself, and moreover where satellite cells 
are removed from their physiological niche beneath the basal lamina and are difficult 
to distinguish from other cell types originally resident within the tissue. In both 
approaches it is difficult to formally correlate functional data with unequivocally 
identifiable in vivo phenotypes. All available data describing satellite cell behaviour 
are derived either from tissue culture experiments, studies of whole muscles, or 
transplantation studies of myoblasts which are removed from their endogenous niche, 
or perhaps never were within the satellite cell niche. A formal investigation of the 
potential of satellite cells has therefore been lacking.
Since satellite cells are defined by their anatomical position beneath the basal lamina 
of myofibres, they can only be isolated within preparations of intact single myofibres 
(Rosenblatt et al. 1995). Previously, studies of satellite cells in such preparations 
have been carried out in vitro (Rosenblatt et al. 1995, Zammit et al. 2002, 2004a). In 
the present study, single myofibres have been grafted into mouse muscles to 
investigate the behaviour of defined and discrete populations of satellite cells in vivo.
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Overall aim:
This work has aimed to analyse the stem cell potential of satellite cells by 
formally investigating their contribution to skeletal muscle regeneration.
Specific aims:
1) To investigate the ability of the discrete population of satellite cells associated 
with a single intact myofibre to contribute to muscle after grafting, and to 
compare this ability with that of myogenic cells not maintained in association 
with myofibres.
2) To compare the myogenic potential of satellite cells associated with single 
myofibres derived from three different hindlimb muscles: the EDL, soleus and 
TA.
3) To investigate the ability of satellite cells to undergo a physiological process of 
self-renewal.
4) To investigate the response of defined satellite cells to muscle tissue damage.
70
Chapter 2 
Materials and Methods
2.1 Mouse strains
All animals were bred and housed in the Biological Services Unit, Clinical Sciences 
Centre, Hammersmith Hospital, Imperial College Faculty of Medicine unless 
otherwise stated. Animal breeding and procedures were carried out in accordance 
with the Animals (Scientific Procedures) Act of 1986.
2.11 C57Bl/10ScSn (C57B1/10) mouse
Mice of the inbred strain C57Bl/10ScSn were obtained from Harlan. This particular 
wild-type strain was selected because it forms the background of the mdx mutant 
strain.
2.12 C57Bl/10ScSn-#«d,.r nu/nu (mdx-nude) mouse
The mdx mouse is a genetic and biochemical homologue of DMD that spontaneously 
arose within a C57Bl/10ScSn colony (Bulfield et al. 1984). The mdx mutation in the 
dystrophin gene results in the near-absence of dystrophin protein (Partridge 1997). 
Host mdx mice were bred onto a nude background (Partridge et al. 1989). Nude mice 
fail to develop a mature immune system as a result of absent thymus glands and are 
therefore immunotolerant of grafted cells.
2.13 3F-/iLacZ-2E transgenic mouse
The 3F-nlacZ-2E transgenic mouse contains seven copies of a construct consisting of 
2 kb upstream of the myosin light chain (MLC)-3F transcriptional start site, nlacZ- 
S V40 poly(A) in frame in the second MLC3F-specific exon, 1 kb of MLC3F sequence 
3' of nlacZ, and a 260-bp 3' MLC1F/3F enhancer (Kelly et al. 1995). (3-gal expression 
faithfully recapitulates fast myosin expression in the nuclei of all fast muscle fibres,
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and is absent in the nuclei of slow muscle fibres and satellite cells (Kelly et al. 1995, 
Beauchamp et al. 2000).
2.14 Myf5nLacZ/* mouse
The Myf5nlacZJ* mouse has n/acZ-SV40poly(A) RNApolII/Neo targeted to the first 
exon of the Myf5 gene such that p-gal is produced as a fusion protein with the first 13 
amino acids of Myf5. There is also a small deletion in the Myf5 gene. M yfinlacZJnLacZ 
homozygotes have early neonatal mortality as a consequence of abnormal rib 
development impairing respiratory effort (Tajbakhsh et al. 1996a). Heterozygous 
Myf5nlacZ/+ mice are viable. Myf5-p-gal fusion protein is expressed by both myonulcei 
and satellite cells during the perinatal period. In adults, Myf5-p-gal protein is 
expressed in the majority of satellite cell nuclei and also in the myonuclei of recently­
regenerated muscle fibres (Tajbakhsh et al. 1996a, Beauchamp et al. 2000). 
Myf5nLacZ/+ mice were distinguished from negative littermates by identification of p- 
gal expression in the muscle of tail tip amputations.
2.15 Pax3GFP/+ mouse
In the Pax3GFP/+ mouse, a gene encoding green fluorescent protein (GFP) replaces the 
first exon of the Pax3 gene in one allele, with the other allele encoding functional 
Pax3 protein. The original gene-targeted line is a conditional knock-in. Pax3GFP/+ 
viable heterozygotes are generated by crossing the gene-targeted line with a flip 
mouse. Cytoplasmic GFP expression recapitulates expression of the Pax3 gene 
(personal communication, F. Relaix). Cells derived from the Pax3GFP/+ mouse were 
obtained from Dr. D. Montarass of the Pasteur Institute, Paris.
2.16 H -2 ^ -tsA58 mouse
tsA58 transgenic mice express the tsA58 thermolabile mutant of the SV40 
large T antigen, an immortalizing gene, under the control of the inducible H-21v 
promoter (Jat et al. 1991). Thermolabile tsA58 protein is expressed by cell isolates 
cultured in the presence of interferon-y (IFN-y) and is functional at 33°C. Cells 
cultured under these ‘permissive’ conditions thus become conditionally immortalized. 
Cell lines can be readily derived from the skeletal muscle tissue of both homozygote 
and heterozygote /7-2^-tsA58 mice (Jat et al. 1991, Morgan et al. 1994).
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Homozygotes were paired with C57B1/10 and Myf5nlacZ/+ mice to obtain double 
heterozygotes, facilitating the generation of strain-specific satellite cell-derived lines.
2.2 Muscle cell culture protocols
All media were obtained as tissue culture grade. All procedures were carried out 
aseptically and excepting dissections, under a laminar flow hood. Sera and 
collagenase Type 1 were batch tested for myoblast and single myofibre culture.
2.21 Isolation and culture of single myofibres
Single myofibres were prepared from the EDL, TA and soleus muscles of mice 
according to the method described by Rosenblatt et al. (1995), with minor 
modifications.
(a) Media
All media were prepared on the day of use.
Collagenase solution: Collagenase Type 1 (Sigma) was freshly prepared at 2 mg/ml in 
Dulbecco’s modified Eagle’s medium (containing glucose 4500 mg/1) (DMEM) 
(Gibco) and sterilized by passing through a 0.2 pm filter (Sartorius).
Serum rinse: Serum rinse was prepared from DMEM supplemented with 10% (v/v) 
horse serum (HS) (Gibco) and passed through a 0.2 pm filter.
Serum-free medium: Serum-free medium was prepared from DMEM supplemented 
with 4 mM L-glutamine (L-glu) (Sigma) and 1% (v/v) penicillin and streptomycin 
solution (pen/strep) (Sigma).
Plating medium: Plating medium was prepared from DMEM supplemented with 4 
mM L-glu, 1% (v/v) pen/strep, 10% (v/v) HS and 0.5% (v/v) chick embryo extract 
(CEE) (PAA Laboratories), passed through a 0.2 pm filter to remove debris, and 
warmed to 37 °C before use.
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(b) Isolation of viable single myofibres from mouse muscles
Mice were killed by cervical dislocation. Hindlimbs were finely shaved using a 
scalpel blade, rinsed with 70% ethanol, pinned out on a dissecting board and the skin 
removed. Using curved Vanna scissors and fine forceps, relevant muscles were 
dissected intact (Fig. 2.1) by handling the tendons only and avoiding all application of 
tension. Dissected muscles were immediately placed in separate bijoux containing 2 
ml of collagenase solution. Muscles were incubated at 35 °C in a shaking water bath 
for 1 h- 1 h 30 (EDL or soleus muscles) or 2-3 h (TA muscles), until myofibres were 
visibly starting to detach.
50 mm x 18 mm non-tissue culture Petri dishes (Sterilin) (to which cells are non­
adherent) were rinsed with filtered HS and 8 ml of serum-free medium was added and 
incubated at 37 °C/ 5% CO2 for at least 30 min prior to use. Muscles were transferred 
into prepared dishes after digestion. Single myofibres were liberated by trituration of 
muscles with a customized wide-mouthed, heat-polished Pasteur pipette that had been 
flushed with serum rinse to prevent cell adherence. Using a finer Pasteur pipette, 
groups of -30 single myofibres were serially passed through 2-4 further dishes to 
remove debris and contaminating cell types. Only intact myofibres (those that were 
long, straight and without areas of hypercontraction or adherent debris) were used; all 
damaged myofibres were immediately discarded. Prepared myofibres were incubated 
at 37 °C/ 5% CO2 before culture, fixation or grafting.
(c) Maintenance of single myofibres as adherent cultures
Single myofibres were maintained as adherent cultures in Primaria® 6-well and 24- 
well plates (Beckton Dickinson) (for optimal primary cell adherence) and 8-well Lab- 
Tek® chamber slides (Nalge Nunc International) which had been previously coated 
with the basement membrane matrix Matrigel (BD Biosciences) (1 mg/ml in DMEM) 
for 45 min at 37 °C. After removal of excess substrate, single myofibres were gently 
placed in separate wells (24-well plates or chamber slides) or evenly spaced at 6-10 
myofibres/ well (6-well plates). Plating medium (250 pi for chamber slides, 0.5 ml 
for 24-well plates, 1.5 ml for 6-well plates) was added down the side of each well to 
avoid disturbing the myofibre, and cultures immediately transferred to an incubator 
maintained at 37 °C/ 5% CO2.
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Fig. 2.1. Anatomical location of EDL, TA and soleus muscles in the mouse hindlimb. 
Partial dissection of EDL and TA muscles from the right hindlimb (A-B) and soleus 
muscle from the contralateral left hindlimb (C-D).
2.22 Isolation and culture of primary myoblasts
This protocol was developed to obtain cell suspensions from adult mouse TA, soleus 
and EDL muscles. Depending on the muscle of origin, 2-4 x 104 cells were typically 
obtained per mg of tissue of which 35-57% were myoblasts as defined by 
immunocytochemical detection of the intermediate filament protein, desmin (2.74), an 
early marker of the myogenic lineage (Li et al. 1994).
(a) Media
Growth medium: Growth medium was prepared from DMEM supplemented with 4 
mM L-glu, 1% (v/v) pen/strep solution, 20% (v/v) heat-inactivated foetal calf serum 
(HI-FCS) (PAA Laboratories) and 2% (v/v) CEE. HI-FCS was prepared by 
incubating foetal calf serum at 60 °C for 30 min (to remove complement), and passing 
through a 0.2 Jim filter before use.
Collagenase Type 1 solution: prepared as previously described (2.21).
Trypsin solution: Trypsin 10X stock solution (25 mg/ml porcine trypsin) (Sigma) was 
prepared at 2.5 mg/ml in Hanks’ Balanced Salts solution without calcium and 
magnesium (HBSS) (Gibco) adjusted to 25 mM HEPES using 1M HEPES buffer 
(Sigma).
(b) Preparation of cell suspension
Muscles were dissected free of connective tissue, weighed and transferred to the 
laboratory in serum-free medium (2.22a). Muscle tissue was finely minced using 
scissors and digested in 5 ml collagenase Type 1 solution for 10 min at 35 °C in a 
shaking water bath. Minced muscle was triturated for 1 min using a wide-mouthed 
Pasteur pipette (pre-rinsed with growth medium) and the tissue allowed to re-settle. 
The resultant cell suspension, which in this 1st fraction is mainly non-myogenic cell 
types, was aspirated and discarded. The remaining tissue was digested in 5 ml trypsin 
solution for 10 min at 37 °C, triturated for 1 min, and the resultant 2nd cell suspension 
decanted into 5 ml growth medium to inhibit further enzymatic digestion. After a 
second round of trypsin digestion, the resultant 2nd and 3rd cell fractions were pooled 
and passed through a 40 pm cell sieve to remove debris. Cells were pelleted by
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centrifugation for 10 min at 350 RCF and re-suspended in growth medium. A viable 
cell count (c) was performed before either culture (d) or cryopreservation (2.24).
(c) Viable cell count
100 pi Trypan blue dye (0.5% w/v in PBS) was added to a 200 pi aliquot of cell 
suspension. Dye-excluding cells were counted in the marked area of a Mod-Fuchs 
Rosenthal haemocytometer chamber (BDH) (depth 0.2 mm) and the number of viable 
cells in the original sample calculated.
(d) Culture of primary myoblasts
Primary mouse myoblasts were seeded in growth medium at 103 cells/ cm2 in tissue 
culture flasks (25 cm2, 75 cm2 or 175 cm2) (BD Falcon) coated with Matrigel (0.1 
mg/ml in DMEM) as previously (2.21c). Culture at this relatively low density 
prevents terminal differentiation. Flasks were incubated at 37 °C/ 5% CO2. Growth 
medium was replaced every 48-72 h.
Cultures were passaged at 30-40% confluence (-104/ cm2). Growth medium was 
removed and cells briefly washed with phosphate buffered saline (PBS). Cells were 
detached by incubation with trypsin-EDTA solution (-20 pi/ cm2) (containing 0.5 g 
porcine trypsin and 0.2 g EDTA/ 1) (Sigma) for 3-5 min at 37 °C. Detached cells 
were resuspended in at least three times the volume of growth medium, pelleted by 
centrifugation, resuspended in growth medium and a viable cell count performed (c) 
before re-seeding in fresh flasks.
2.23 Culture of conditionally immortal myoblast cell lines
(a) Derivation of satellite cell-derived cell lines
Conditionally immortal satellite cell-derived cell lines were obtained from H-21^b- 
tsA58/C57Bl/10 and /7-2/^-tsA5%/Myf5nLacZ/+ double heterozygote mice (2.16). 
Single myofibres were isolated and cultured for 48 h in 24-well plates as previously 
described (2.21) by which time numerous satellite cells had migrated and started to 
proliferate. Myofibres were then removed, and cultures transferred to permissive 
conditions (b).
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(b) Culture under conditions permissive for tsA58 expression
Cells were maintained as previously described (2.22) except that growth medium was 
supplemented with interferon-y (IFN-y) (Life Technologies) (20 U/ml) and cultures 
incubated at 33 °C/ 10% CO2. Under these conditions, H-21^-tsA58-derived 
myoblasts undergo immortalization (2.16), proliferate rapidly (Morgan et al. 1994) 
and can be maintained for 40+ passages without losing the ability to differentiate.
(c) Culture under conditions non-permissive for tsA58 expression
Cultures were maintained in the absence of IFN-y and at 37 °C/ 5% CO2, as 
previously described for primary myoblasts (2.22). Under these conditions, functional 
tsA58 protein is not expressed (2.16) and immortalized myoblasts cease to proliferate 
after ~1 further population doubling, but retain the ability to differentiate (Morgan et 
al. 1994).
(d) Cloning by dilution method
This method was used to obtain single cell-derived lines. Myoblasts were seeded at 
an average density of 1 cell/ well in 96-well plates (Falcon) and cultured under 
permissive conditions as previously described (a). After 6 h, wells containing single 
cells were marked. After ~6 d in culture, resultant clonal cultures were passaged
(2.22) and expanded.
2.24 Induction of differentiation
(a) Medium
Fusion medium: Fusion medium was prepared from DMEM supplemented with 4 
mM L-glu, 1% pen/strep solution (v/v) and 5% HS (v/v).
(b) Culture conditions for differentiation
Cells were seeded at 2 x 104/ cm2 in flasks or chamber slides coated with Matrigel 
(0.1 mg/ml in DMEM) as previously described (2.21). Cells were cultured at 37 °C/ 
5% CO2 for 24 h in growth medium (2.22), during which time they had approximately 
doubled in confluence and started to align and elongate. Growth medium was 
replaced with fusion medium and cultures incubated for a further 72 h, by which time
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myoblasts had differentiated and fused to form multinucleate contractile myotubes. 
Cells in primary single myofibre cultures were induced to differentiate after reaching 
an approximately similar density by replacing plating medium with fusion medium 
and culturing for a further 72 h.
2.25 Cryopreservation of cells
(a) Medium
Freezing medium: Freezing medium was prepared from growth medium (2.23a) 
supplemented with 10% (v/v) dimethyl sulphoxide (Sigma) and sterilized by passing 
through a 0.2 pm filter.
(b) Storage of cells under liquid nitrogen
Cells were suspended at 105-106/ ml in freezing medium and aliquoted into 1 ml 
cryovials (Nalgene). Cells were initially frozen to -80 °C in an isopropanol cell 
freezer, ensuring a steady temperature decline of 1 °C/ min. Cryovials were then 
placed under liquid nitrogen at -196 °C.
2.3 Viral infection of cell cultures
2.31 LNPOZ retroviral vector
The LNPOZ retroviral vector contains both p-gal and neomycin resistance (neo) 
genes driven by the viral long terminal repeat (LTR). It also contains a poliovirus 5’ 
non-translated region (NTR) which acts as an internal ribosme entry site and thus 
promotes efficient expression of the P-gal and neo genes from polycystronic message 
(Adam et al. 1991).
Frozen stocks of LNPOZ retroviral supernatant produced from the high titre 
ecotrophic packaging cell line, AmpliGPE (Takahara et al. 1992), were obtained from 
Dr J.E. Morgan.
79
Fig. 2.2. The LNPOZ retroviral vector. LTR= long terminal repeat; \j/ = viral encapsidation 
sequence (psi site); neo = neomycin resistance gene; PO = poliovirus 5 ’ non-translated region 
(internal ribosomal entry site), p-gal = fi-galactosidase reporter gene; A (n) = polyadenylation 
sequence.
2.32 Infection of satellite-derived cells with LNPOZ retroviral vector
(a) Media
Retroviral medium: Retroviral medium was prepared from LNPOZ retroviral 
supernatant diluted 1:5 (v/v) in growth medium (2.22). This titre infects up to 70% of 
cells in proliferating myoblast cultures, although the number of insertions per nucleus 
is not known (J. Morgan, personal communication). To aid the binding of viral 
particles to the surface of cells, Polybrene™ (hexadimethrine bromide, Sigma) was 
added at 8 pg/ml. Medium was sterilized by passing through a 0.2 pm filter. 
Retroviral supernatant was thawed and retroviral medium prepared immediately 
before use to prevent any loss of viral titre.
Antibiotic selection m edium: Antibiotic selection medium was prepared from DMEM 
supplemented with 20% (v/v) HI-FCS, 2% (v/v) CEE, 4 mM L-glu and the neomycin 
analogue, G418 (Sigma) at 600 pg/ml. Medium was sterilized by passing through 0.2 
pm filter before use. To determine the appropriate concentration of G418 for efficient 
selection, H-2K1’-tsA58 myoblasts were maintained in selection media containing 
different concentrations of G418 for 2 weeks. 600 pg/ml was found to be the 
minimum concentration required to give 100% cell mortality at this timepoint (data 
not shown).
80
(b) Infection of cell cultures with LNPOZ retrovirus
Single myofibres were isolated from the EDL muscles of //-2^-tsA58/C57Bl/10 
mice (2.16) and maintained as adherent cultures as previously described (2.21). Single 
myofibres were removed after 2 d in culture, by which time satellite cells had 
migrated and started to proliferate. To retrovirally infect satellite cell-derived cells, 
plating medium was removed and cultures incubated with retroviral medium for 2 h at 
37 °C/5% CO2. After infection, retroviral medium was replaced with growth medium
(2.22) and cells cultured under permissive conditions as previously described (2.23).
(c) Antibiotic selection and production of cell lines
After 72 h in culture post-infection, cells were passaged (2.22) and maintained under 
permissive conditions as previously described (2.23), except that antibiotic selection 
medium was used in place of growth medium. After 2 weeks, aliquots of cells were 
seeded in chamber slides, cultured for 48 h and fixed (2.71). X-gal staining (2.77) 
was used to confirm the presence of (3-gal activity in the cytoplasm of infected cells. 
Immunocytochemistry for desmin protein (2.74) was used to confirm that infected 
cells were of the myogenic lineage (Li et al. 1994). Myogenic satellite cell-derived 
cell lines with cytoplasmic (3-gal expression were produced by dilution cloning (2.23) 
of G418-selected cultures.
2.33 GFP lentiviral vector
Frozen stocks of concentrated GFP lentiviral vector (RRL.ppt.hPGK.GFP.pre.sin.-18) 
produced in the human embryonic kidney cell line, 293T, were obtained from Ms. K. 
Brimah. This vector expresses cytoplasmic-localising eGFP and is similar to that 
described by Piacibello et al. (2002), except that expression is under the control of the 
hPGK promoter. It is incorporated into human and mouse cells independent of cell 
cycle stage, and so efficiently infects both quiescent and post-mitotic phenotypes.
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LTR hPGK GFP WPRE LTR
■
Fig. 2.3. GFP lentiviral vector. LTR= long terminal repeat, GFP= GFP reporter gene, hPGK= 
hPGK promoter, W PRE= mRNA-stabilising post-transcriptional regulatory e lem ent from 
woodchuck hepatitis virus.
2.34 Infection of isolated myofibres with G FP lentiviral vector
(a) Medium
Lentiviral medium
Lentiviral medium was prepared from lentiviral stock diluted 1:250 in plating medium 
(2.21). To aid the binding of viral particles to the surface of cells, Polybrene™ was 
added at 8 pg/ml. Medium was sterilized by passing through a 0.2 pm  filter. 
Lentiviral stock was thawed and lentiviral medium prepared immediately before use 
to prevent any loss of viral titre.
(b) Infection of satellite cells with GFP lentivirus
An equal volume of freshly-prepared lentiviral medium was added to single myofibres 
suspended in plating medium (2.21), to give a final titre of 1:500 lentivirus. This titre 
has been found to label >99% of satellite cells in single myofibre preparations 
(personal communication, K. Brimah). Single myofibres were incubated at 37 °C/5% 
CO 2 for 2 h, and then removed from the medium and washed by serial transfer 
through four dishes of warmed serum-free medium (2.21).
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2.4 Assays of cell behaviour
2.41 BrdU assay for DNA synthesis
Replicating cells in myoblast cultures were identified by assaying incorporation of 
BrdU (5-bromo-2'-deoxyuridine) into DNA precursors during mitosis, according to 
the protocol of Kaufman & Foster (1988). Conditionally-immortal myoblasts were 
seeded in chamber slides and cultured as previously described (2.23). Cultures were 
labeled overnight with 4 |iM BrdU (Sigma) added to growth medium, and then fixed 
with 95% ethanol (2.71). Fixed cultures were treated with 2 M HC1 for 30 min at RT, 
and then neutralized with 3 x 20 min washes in 50 mM NaCl / 100 mM Tris HC1 (pH 
7.4). Myoblasts that had recently undergone DNA synthesis were identified by 
immunocytochemistry for BrdU (2.74), and their percentage of the total population 
calculated after counting -100 cells under a light microscope.
2.42 Myoblast differentiation assay (fusion index)
Myoblasts were cultured in chamber slides under conditions optimized for 
differentiation as previously described (2.24). After 96 h, cultures were fixed with 
formalin (2.71) and nuclei stained with haemotoxylin (2.78). Fusion index was 
calculated as the percentage of nuclei within myotubes (defined as cells with >3 
nuclei).
2.5 Animal protocols
2.51 Host mice for cell grafting experiments
Graft recipients were mcbc-nude mice (2.12) aged 24 d at the time of grafting, during 
the peak of dystrophic necrosis (Partridge 1997). When mdx muscle is grafted with 
wild-type muscle precursor cells, donor-derived muscle formation can be identified 
using immunohistochemistry for dystrophin protein (Partridge et al. 1989).
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2.52 Anaesthesia and analgesia
(a) Anaesthesia
For irradiation (2.53), mice were lightly anaesthetised for humane restraint by 
subcutaneous injection of 50 pi of Hypnorm (79 pg/ml fentanyl citrate, 2.5 mg/ml 
fluanisone) (Janssen-Cilag Ltd) and Midazolam (1.25 mg/ml midazolam) (CP 
Pharmaceuticals Ltd) prepared in sterile water. For cell grafting (2.54, 2.55) and 
muscle damage (2.56) procedures, inhalable isoflurane (Schering-Plough Animal 
Health) was used to achieve stable anaesthesia. After all protocols, mice were 
maintained on a heated pad and given dampened food on the floor of the cage until 
full recovery.
(b) Analgesia
Mice used in muscle damage experiments (2.56) were given buprenorphine (0.05 
mg/kg) (Vetergesic®, Reckitt & Colman Products Ltd) analgesia by subcutaneous 
injection before recovery from anaesthesia.
2.53 Ablation of the satellite cell compartment by local irradiation
To ablate the satellite cell compartment of replication-competent satellite cells and 
create an optimized environment for donor-derived muscle formation, 3 d before 
grafting the hindlegs of anaesthetized (2.52) host mice were exposed to 18 Gy y- 
irradiation delivered at 0.7 Gy/min from an IBL 637 irradiator (CIS Biointemational) 
(Gross et al. 1999). The bodies of mice were shielded by 4 cm lead.
2.54 Grafting of myoblasts into mouse muscles
Host mice were anaesthetized (2.52) and hindlegs held in position with tape. The skin 
of each hindleg was swabbed with 70% ethanol and a small incision made in the skin 
overlying the base of each TA muscle. 4 pi of viable (2.22) myoblasts, suspended at 
high known density in growth medium (2.22) were drawn into a 5 pi Hamilton 
syringe and inserted into the TA muscle under microscopic observation. Where 
necessary, the incision was closed with suture silk.
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2.55 Grafting of single myofibres into mouse muscles
Fine needles were prepared from glass PCR pipettes drawn out in a hot flame. 
Freshly prepared single myofibres, suspended in 2-4 pi serum-free medium (2.21) 
were drawn into needles and inserted into recipient muscles as previously described 
(2.54). The needle was flushed out under microscopic observation to confirm the 
absence of the myofibre.
2.56 Model of acute muscle damage
The myotoxic snake venom, notexin (reviewed, Harris 2003), was used to induce 
acute damage to engrafted muscles.
4 weeks after grafting (2.54, 2.55), host mice were anaesthetized (2.52) and 10 pi 
purified notexin (Latoxan) (10 pg/ml in PBS) injected into engrafted TA muscles 
using a 5 pi Hamilton syringe (2 x 5 pi injections into the same site). In some 
experiments, notexin was injected at the time of grafting; here only 5 pi was used 
since the much smaller muscles of these younger mice were found to expel greater 
volumes.
2.6 Tissue preparation for histological analyses
2.61 Removal and storage of muscles
(a) Reagent
Gum tragacanth: Gum tragacanth (Sigma) (6% w/v) was slowly dissolved in sterile 
water for several hours at room temperature, and then heated overnight at 60 °C. 
Aliquots were stored at 4 °C until use.
(b) Removal of muscles for histology and immunohistochemistry
Mice were killed by cervical dislocation. Relevant muscles were dissected, bisected 
and mounted in gum tragacanth on cork discs. Muscles were snap frozen in 
isopentane cooled in liquid nitrogen and then stored at -80 °C.
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2.62 Preparation of cryosections
A Leica CM 1800 cryostat maintained at -18 °C was used to obtain cryosections of 
frozen muscles. 3-4 7 fim sections were cut at 100 jim intervals and collected onto 
silane-coated glass slides. After air-drying for 45 minutes, slides were wrapped in foil 
and stored at -80 °C before staining.
2.7 Staining of cells and tissue sections
2.71 Fixation methods
(a) 4% paraformaldehyde
Aliquots of 4% paraformaldeyde (PAF) in PBS were prepared, stored at -20 °C and 
defrosted immediately before use. Cells and tissues were fixed for 5 min at RT and 
then washed for 3 x 10 min with PBS. For fixation of single myofibres, 4% PAF was 
warmed to 37 °C and added directly to the culture medium at a final concentration of 
2-3%.
(b) Methanol/ acetone
Ice-cold methanol/ acetone (1:1) was used to fix cell cultures on ice for 10 min. For 
adherent myofibre cultures, fixative was added directly to the culture medium to a 
final concentration of -90% (v/v). Fixed cultures were washed for 3 x 10 min with 
PBS.
(c) 95 % ethanol
Cultures were fixed with ice-cold 95% ethanol for 10 min on ice, and then washed for 
2 x 10 min with PBS.
(d) 0.5 % gluteraldehyde
Cold 0.5% gluteraldehyde in PBS was used to fix cells and tissues on ice for 10 min, 
before rinsing and then washing for 10 min with 2mM MgCl2 in PBS.
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(e) Formalin
10% buffered formalin solution was used to fix tissues at room temperature for 10 
min, before thorough washing in distilled water.
2.72 Primary antibodies for protein immunochemistry
Target protein Clone Species Source/ ref. Dilution Fixation
method
desmin D33 (monoclonal) mouse Dako 1:50-
1:100
methanol/
acetone
dystrophin P7 (polyclonal) rabbit DrQ.L. Lu 1:500 none
Pax7 (monoclonal) mouse Hybridoma bank 1:50 4% PAF
MyoD (monoclonal) mouse Dako 1:50 4% PAF
MyoD sc-760 (polyclonal) rabbit Santa Cruz 1:50 4% PAF
myogenin sc-576 (polyclonal) rabbit Santa Cruz 1:50 4% PAF
P-gal (polyclonal) rabbit Molecular
Probes
1:50 4% PAF
GFP (polyclonal) rabbit Molecular
Probes
1:100 4% PAF
SV40 T antigen Ab-2 (monoclonal) mouse Oncogene 1:100 4% PAF
BrdU M0744
(monoclonal)
mouse Dako 1:20 95%
ethanol
neonatal
myosin
BF34 tissue culture
supernatant
(monoclonal)
mouse Borrione et al. 
(1988)
1:15 none
slow  myosin NOQ7.5.4D
(monoclonal)
mouse Sigma 1:50 none
fast myosin MY32 (monoclonal) mouse Sigma 1:40 none
laminin (polyclonal) rabbit Sigma 1:50 4% PAF
Table 2.1. Primary antibodies.
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2.73 Antibodies for secondary detection
Target Species Detection
method
Source Dilution Blocking method
Mouse Ig goat AlexaFluor 488 
(green)
Molecular
Probes
1:200 20% goat serum
Mouse Ig goat AlexaFluor 594 
(red)
Molecular
Probes
1:200 20% goat serum
Rabbit Ig goat AlexaFluor 594 
(red)
Molecular
Probes
1:200 20% goat serum
Rabbit Ig swine TRITC (red) Dako 1:100 10% swine serum 
and 10% goat 
serum
Rabbit Ig goat AlexaFluor 488 
(green)
Molecular
Probes
1:200 20% goat serum
Mouse Ig goat Horse radish 
peroxidase
Dako 1:200 5% HS
Table 2.2. Secondary antibodies for fluorescent and peroxidase detection of mouse and 
rabbit immunoglobulins (Ig).
2.74 Immunocytochemistry of cell cultures
Immunocytochemistry was performed directly on cells and adherent single myofibres 
cultured in chamber slides or 24-well plates, and on cells spotted onto silane-coated 
glass slides and air-dried. Cells were fixed (2.71), and to reduce background caused 
by non-specific antibody binding, incubated for 20 min with blocking solution 
prepared from the pertinent serum (2.73) in PBS. The primary antibody (2.72) was 
diluted in the same blocking solution and applied to cultures for 1 h at room 
temperature (RT), followed by washing for 3 x 10 min in PBS and a further 1 x 10 
min in blocking solution. The secondary antibody (2.73) was diluted in blocking 
solution and applied for 45 min at RT, followed by washing for 4 x 10 min in PBS. 
For immunofluorescent detection, stained cultures were air-dried for 1 h at RT and 
then mounted with coverslips and Fluorescent mounting medium (Dako) containing
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the fluorescent nuclear counterstain 4',6-diamidino-2-phenylindole (DAPI) at 100 
ng/ml. Peroxidase detection was performed using Sigmafast® 3,3’-diaminobenzidine 
and urea hydrogen peroxidase tablet sets (Sigma) dissolved in 5 ml PBS and applied 
to cells for 5 min at RT. Cells were rinsed 3 times with distilled water (dFUO), air-
/«v
dried and mounted with aqueous mounting medium (Faromount , Dako) and 
coverslips.
For detection of nuclear proteins, blocking was preceded by permabalisation of fixed 
cells with Triton X 100 (Sigma) (0.1% v/v in PBS) followed by washing in PBS for 3 
x 10 min.
In some experiments, 2 primary antibodies raised in different species were applied 
together and differentially detected using immunofluorescence.
2.75 Immunocytochemistry of single myofibres
Immunocytochemistry of single myofibres in suspension was performed similarly to 
that of cell cultures (2.74), but with certain modifications. 10% FCS was added to the 
appropriate blocking solution (Table 2.2), and to antibody preparations. Primary 
antibodies were applied overnight at 4 °C. For detection of nuclear proteins, blocking 
was preceded by permeablisation of fixed myofibres with Triton X 100 (0.5% v/v in 
PBS). Single myofibres were individually placed on silane-coated slides and air-dried 
for a few minutes before mounting (2.74).
2.76 Immunohistochemistry of muscle tissue sections
Slides were thawed and sections were ringed with a water-repellent pen. 
Immunohistochemistry performed on fixed (2.71) or unfixed cryosections (2.62) as 
described for cell cultures (2.74). Unfixed sections were rehydrated with PBS for 5 
min at RT prior to staining.
2.77 X-gal staining for localisation of p-gal activity
This protocol was based on that described by Gross & Morgan (1999), with minor 
modifications.
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(a) Reagents
Detergent solution: Detergent solution was prepared from PBS with 2 mM MgCk, 
0.02% (v/v) IGEPAL CA-630 (Sigma) and 0.01% (w/v) sodium deoxycholate.
X-gal stock: X-gal stock was prepared from 5-bromo-4-chloro-3-indolyl-B-D- 
galactopyronoside (BDH) 40 mg/ml in dimethyl sulphoxide.
X-gal diluant: X-gal diluant was prepared from PBS with 2 mM MgCl2, 0.02% (v/v) 
IGEPAL CA-630, 0.01% (w/v) sodium deoxycholate, 5 mM K3Fe(CN)6 and 5 mM 
K4Fe(CN)6.
(b) Protocol
Cell cultures and tissue sections were fixed with 0.5% gluteraldehyde (2.71) and 
incubated in detergent solution for 10 min on ice. Single myofibres in suspension 
were fixed with 4% PAF only (2.71). A solution of the chromogenic (3-gal substrate, 
X-gal, was prepared by diluting X-gal stock to 1 mg/ml in X-gal diluant. Slides and 
single myofibres in suspension were incubated in X-gal solution overnight at 37 °C, 
rinsed 3 times with distilled water, briefly air-dried and mounted with aqueous 
mounting medium and coverslips. Single myofibres isolated from 3¥-nLacZ-ZE mice 
were incubated in X-gal solution for 2 h only. The bright blue reaction product of X- 
gal localises (3-gal activity to the nuclei or cytoplasm of cells.
2.78 Haematoxylin and eosin staining
(a) Use of haematoxylin and eosin to stain animal tissues
Haematoxylin is a basic dye which stains acidic structures a purplish blue colour. It 
has an affinity for organelles with high DNA or RNA content, such as nuclei, 
ribosomes and rough endoplasmic reticulum. Eosin is an acidic dye which has affinity 
for basic proteins such as those abundant in the cytoplasm, staining them pinkish red. 
When animal tissues such as skeletal muscle are stained with haematoxylin and eosin 
(H & E), nuclei therefore appear blue and cytoplasm pink (Burkitt et al. 1993).
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(b) Reagents
Haemotoxvlin: Gill’s haematoxylin (containing ethylene glycol) (BDH) was used.
Eosin: Eosin stain was prepared from Eosin (1% w/v) (Sigma), Erythrosin B (0.4% 
w/v) and Phloxine B (0.2% w/v) (Sigma) in dH20, and passed through filter paper 
before use.
(c) Staining of tissue sections with Ft & E
Cryosections were thawed and fixed with formalin (2.71). Slides were stained with 
haemotoxylin for 3 min, and then washed in tap water until it ran clear. Slides were 
stained with eosin for 1 min, and again washed in tap water. Dehydration was 
performed by incubating in 70% ethanol (30 secs), 90% ethanol (30 secs) and 100% 
ethanol (2 x 30 secs). Slides were then incubated in the histological clearing agent 
Histo-Clear™ (National Diagnostics) (2 x 30 secs). Slides were air-dried and 
mounted with DPX mounting medium (R.A. Lamb Lab. Supplies).
2.79 Microscopy and image capture
(a) Light microscopy
Brightfield microscopy of fixed cells and tissues was carried out using a Zeiss 
Axiophot microscope and Metamorph® software. Light microscopy and image 
capture of live cell cultures was carried out using an Axiovert 100 microscope and 
Sirius software.
(b) Fluorescence microscopy
Fluorescence microscopy and image capture was performed using a Zeiss Axiophot 
microscope and Metamorph® software.
Microsoft Photoshop 7 was used to make minor adjustments to some images.
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Chapter 3 
The myogenic potential of satellite cell grafts
3.1 Background and aim of study
3.11 Background to work
When grafted into the skeletal muscle of a new host, isolated myoblasts can 
participate in regeneration to form new differentiated muscle fibres (Watt et al. 1982, 
Partridge et al. 1989). However, the efficiency with which new tissue is formed is 
extremely low, rarely exceeding parity (reviewed, Partridge 2003), and does not 
reflect the latent regenerative capacity of the endogenous precursor population of 
skeletal muscles (Studitsky 1962, Carlson 1970, Heslop et al. 2000, Luz et al. 2002). 
This disparity suggests that although myoblast cell lines can be expanded extensively 
in vitro, most cells lose their proliferative competence when subsequently returned to 
an in vivo environment. The only cells of any lineage that have been demonstrated to 
maintain robust stem cell function after grafting are HSC, which by definition, can 
clonally repopulate the entire lymphohaematopoietic system of a lethally-irradiated 
mouse (Till & McCulloch 1961, Smith et al. 1991, Osawa et al. 1996).
Satellite cells are believed to be the main source of new myonuclei in regenerating 
muscles, and the ability of their progeny to contribute to differentiated muscle both in 
vitro (Rosenblatt et al. 1995) and in vivo (Moss & Leblond 1971) is unequivovcal. 
Nevertheless, grafting experiments have failed to determine whether satellite cells are 
most appropriately defined as stem cells, with the ability to generate large numbers of 
differentiation-competent progenitors (Lajtha 1979, Moore 1979, Morrison et al. 
1997, Anderson et al. 2001) or as intermediate progenitor cells, with a more modest 
proliferative capacity (Elwood 2004).
The majority of myogenic cells resident in muscle are thought to be radiation- 
sensitive (Wakeford et al. 1991, Quinlan et al. 1995), but a subset is resistant to the 
effects of radiation and can be recruited into an active myogenic program in response 
to acute damage (Heslop et al. 2000). Whilst this subset has been demonstrated to
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give rise to new satellite cells (Heslop et al. 2000), it has not been established whether 
radiation-resistant cells themselves form a small subset of the satellite cell 
compartment, or whether they comprise a separate population.
There is increasing evidence that stem cell function is critically dependent on 
interaction with other differentiated cell types present in the tissue (Song et al. 2002b, 
Kaeffer 2002, Shen et al. 2004, Blanpain et al. 2004). Whilst the definitive 
anatomical position of satellite cells (Mauro 1961) involves intimate association with 
myonuclei, the functional significance of this relationship has been little investigated. 
The single myofibre isolation technique (Rosenblatt et al. 1995) allows defined 
populations of satellite cells to be isolated and studied within their endogenous niche 
beneath the basal lamina of intact myofibres. Carefully prepared single myofibre 
isolates (Rosenblatt et al. 1995) are extremely pure. When maintained as adherent 
cultures, only about 1 in 50 wild-type myofibres generate any desmin- (non muscle) 
cells (Rosenblatt et al. 1995, Bockhold et al. 1998). Immunocytochemistry of 
isolated myofibres fails to identify associated cells expressing the endothelial marker 
Sca-1 (Asakura et al. 2002, Zammit & Beauchamp 2002), and microscopic 
examination shows that gross contaminants such as capillaries are not present. In 
contrast, preparations of single myofibres from mdx muscles frequently generate 
desmin- cells (Bockhold et al. 1998) and sometimes have adherent capillaries. In 
preparations derived from non-dystrophic muscles, however, the single myofibre 
isolation technique is a reliable method for obtaining defined satellite cells that are 
both maintained in their endogenous niche, and are free from vascular or connective 
tissue contaminants.
Louise Heslop developed a novel technique in which isolated single myofibres were 
grafted into mouse muscles, allowing the myogenic potential of defined populations 
of satellite cells to be studied in vivo. Using grafts derived from EDL and soleus 
muscles, it was found that whilst most grafted myofibres apparently disappeared 
without trace, 13% of EDL myofibres and 34% of soleus myofibres were capable of 
giving rise to new muscle. Soleus myofibre grafts were found to generate between 8 
and 200 new myofibres, whereas EDL myofibre grafts generated 101-300 new 
myofibres (L. Heslop, PhD thesis 2001). The small numbers of satellite cells 
originally present in the graft must necessarily have undergone very extensive
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proliferation prior to differentiation into muscle. The findings of this preliminary 
study were cautiously interpreted as evidence for the existence of a rare, stem cell-like 
subset of satellite cells restricted to a small proportion of myofibres (T. Partridge, 
personal communication).
3.12 Aims of work
The objective of these experiments was to investigate the myogenic potential of 
satellite cells derived from different adult and juvenile muscles, and to generate 
quantitative data describing the relative myogenic potentials of grafts of single 
myofibres, conventionally-isolated primary myoblasts and a conditionally- 
immortalised satellite cell-derived myoblast cell line. An additional investigation 
aimed to determine the status of satellite cells as radiation-resistant or radiation- 
sensitive MPC.
3.13 Note on genetic markers of grafted cells
Most experiments described in this chapter use grafts derived from the 3F-nLacZ-2E 
mouse (2.13), in which p-gal activity reports fast myosin expression in the nuclei of 
fast muscle fibres (Kelly et al. 1995). In mdx-nude (2.12) muscles engrafted with 3F- 
nLacZ-ZE cells, donor-derived muscle can be identified by the muscle-specific 
expression of two marker proteins, P-gal and dystrophin. The nLacZ transgene 
becomes silenced in long term cultures of myogenic cells (J. Morgan, personal 
communication). For this reason, in a myogenic cell line, retroviral infection with a 
LacZ gene was used as an alternative genetic labelling strategy.
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3.2 Grafts of immortalised satellite cell-derived MPC
3.21 Aim
The objective of this study was to investigate the efficiency of muscle formation by 
grafts of different numbers of conditionally-immortalised MPC.
3.22 Preparation of a LacZ satellite cell-derived cell line
A cell line was generated from H-21^-tsA58 satellite cells retrovirally labelled with a 
cytoplasmic-localising LacZ gene. Single myofibres were isolated (2.21) from the 
EDL muscles of a 43-day-old male H -H ^-tsA58/ C57 Bl/10 heterozygotic mouse 
(2.16), and cultured individually in the wells of 24-well plates (Fig. 3.1). After 24 h, 
examination of cultures by light microscopy showed that small numbers of satellite 
cells (0-4) had emanated from adherent myofibres. Myofibres were then removed. 
Cultures were infected with LNPOZ retrovirus (2.31, 2.32), and subsequently 
maintained under conditions permissive for expression of the tsA58 immortalising 
antigen (2.23), expanded, and passaged into flasks. The LNPOZ retrovirus expresses 
a LacZ gene, and a neomycin resistance gene that can be used as a selectable marker 
(2.31). Five single myofibre-derived cultures of infected cells (SF1-SF5) were 
selected for two weeks in medium containing the neomycin analogue, G418 (2.32). 
Two cultures, SF1 and SF3, yielded antibiotic-resistant cells. Aliquots of selected 
cells were seeded in chamber slides and either stained with X-gal to localise P-gal 
activity (2.77), or immunocytochemically stained for expression of desmin protein 
(2.74), a skeletal muscle lineage marker (Li et al. 1994). 100% of cells in SF1 and 
SF3 expressed desmin, suggesting that they were homogeneous cultures of skeletal 
myoblasts. 100% of cells in SF1 exhibited cytoplasmic P-gal expression, showing 
that the retrovirus had successfully integrated. None of the G418-resistant cells in 
SF3 expressed P-gal, suggesting that either (a) a clone had spontaneously developed 
G418 resistance in the absence of retroviral integration, or (b) that the retrovirus had 
integrated successfully but only the neomycin resistance gene, and not the LacZ gene, 
was expressed. Dilution cloning (2.23) was used to obtain 12 single cell-derived lines 
(SF1A-SF1K) from SF1 passage number (P) 11. X-gal staining (2.77) and desmin 
immunocytochemistry (2.74) of six of the expanded clones confirmed that 100% of 
cells expressed p-gal and desmin. Fusion assays (2.42) were used to compare the 
potential of the six clones to differentiate into myotubes in vitro', SF1K was found to
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have the highest fusion index (63%) (Fig. 3.2). BrdU assays (2.41) showed that 
>99% of SF1K cells incorporated the label after culture under permissive conditions 
for 96 h, and >99% of cells did not incorporate label after culture under non- 
permissive conditions for 96 h. This demonstrated that the clone was conditionally 
immortalised, but unlikely to be transformed.
3.23 Muscle formation by different numbers of MPC
SF1K satellite-derived MPC were used to investigate the amounts of muscle formed 
by different numbers of grafted cells. The legs of 12 21-day-old mdjc-nude host mice 
were exposed to 18 Gy y-irradiation (2.53) to ablate the satellite cell compartment of 
replication-competent cells (Heslop et al. 2000), and create an optimised environment 
for donor-derived muscle formation (Gross et al. 1999). SF1K cells were expanded in 
vitro, and immediately before grafting, trypsinised, washed in growth medium, and a 
viable cell count performed (2.22). Cell suspensions of various densities were 
prepared. 3 d post-irradiation, host mice were anaesthetised (2.52) and cells grafted 
into the TA muscle of each hindleg (2.54). 5 legs were injected with growth medium 
only. 20 legs were grafted with 5 x 102 (n=5), 5 x 103 (n=4), 5 x 104 (n=4) or 5 x 105 
(n=6) cells. After 3 weeks, engrafted muscles were removed, bisected, mounted and 
frozen in isopentane cooled in liquid nitrogen (2.61). Using a cryostat, two 7 jxl serial 
sections were taken at 100 pm intervals throughout approximately 2/3 of the muscle 
body, and collected onto silane-coated glass slides (2.62). Donor-derived muscle was 
identified by localisation of p-gal activity in sections stained with X-gal (2.77). 
Numbers of donor-derived (p-gal expressing) myofibres (Fig. 3.3) were counted in 
representative mid-body sections.
There was a complete absence of p-gal expression in control muscles injected with 
growth medium only. Grafts of 5 x 10 cells formed 2.6 (±5.3) myofibres; grafts of 5 
x 103 cells formed 4.1 (±3.1) myofibres; grafts of 5 x 104 cells formed 70.8 (±111.1) 
myofibres, and grafts of 5 x 105 cells formed 271.6 (±156.5) myofibres (Fig. 3.4). 3/5 
grafts of 5 x 10 cells and 1/4 grafts of 5 x 10 cells formed no donor-derived muscle.
The Mann-Whitney test (see Appendix) was used to compare numbers of P-gal+ 
myofibres formed by the different numbers of grafted cells. There were significant
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differences (p=<0.05) between the amount of muscle formed by grafts of 5 x 102 cells 
and grafts of 5 x 105 cells, and between the amount of muscle formed by grafts of 5 x 
103 cells and grafts of 5 x 105 cells. Differences between other groups were not 
statistically significant (Mann-Whitney, p=>0.05). There was, however, a large 
difference between the mean amounts of muscle formed by grafts of 5 x 104 cells and 
grafts of 5 x 105 cells; the lack of statistical significance between these data sets is 
probably due to high standard deviations from the mean (SD).
Calculation of the grafting efficiency (the number of myofibres formed per grafted 
cell) showed that though grafts of larger numbers of cells formed greater numbers of 
donor-derived myofibres, grafts of smaller numbers of cells generated new muscle 
with greater relative efficiency (Table 3.6).
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Fig. 3.1. Single myofibres in culture. Examples of satellite cell-derived myoblasts are 
arrowed. Original magnification x50 (A) or x200 (B).
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Fig. 3.2. Characteristics of SF1K conditionally immortalised satellite cell-derived clone. 
Fluorescence immunocytochemistry to detect expression of the myogenic lineage 
marker desmin (A-C) and under permissive conditions, the immortalising antigen tsA58 
(D-F). X-gal staining to localise cytoplasmic p-gal activity (G). Differentiated myotubes 
stained with haematoxylin to calculate fusion index (H). Original magnification x400 (A- 
G) or x100 (H)
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Fig. 3.3. Identification of donor-derived muscle in an irradiated mdx-nude TA muscle 
grafted with 5 x 105 clone SFIK conditionally-immortalised cells. After staining in X-gal 
solution, myofibres containing myonuclei derived from the graft are identifiable by 
cytoplasmic p-gal activity. Original magnification x100.
100
450
400
"O
CD
£ 350o
CDX2
|  100CD
c|  150
2 200
>, 250
E
50
0
0 5 x1 0 (2 ) 5 x1 0 (3 ) 5 x1 0 (4 ) 5 x1 0 (5 )
Number of cells in graft
Fig. 3.4. Bar graph showing muscle formation by different numbers of grafted immortalised 
MPC. Different numbers of SFIK cells, which have cytoplasm ic P-gal expression, were 
grafted into irradiated mdx-nude mouse muscles. After 3 weeks, the numbers of (3-gal+ 
myofibres were counted in representative sections of engrafted muscles. These data show 
that the amount of muscle formed is proportional to the number of cells implanted, but not 
directly so. Error bars represent SD.
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3.3 Grafts of primary MPC isolated from different muscles
3.31 Aim
The objective of this study was to investigate the comparative efficiency of muscle 
formation by primary MPC derived from three different hindlimb muscles: the EDL, 
soleus and TA.
3.32 Preparation of cell isolates from 3F-wLacZ-2E muscles
Cells isolates (2.22) were prepared from the muscles of ten 42-day-old 3F-nLacZ-2E 
mice (2.13) (five males and five females from two litters). TA, soleus and EDL 
muscles were dissected free of connective tissue and tendons, and muscle groups 
separately pooled. Muscles were minced and enzymatically disaggregated to obtain 
cell suspensions. >95% of isolated cells were viable as defined by exclusion of 
Trypan blue dye (2.22). 10 pi of each cell suspension was spotted onto a silane- 
coated slide and air-dried at RT. The remaining cells were preserved in aliquots under 
liquid nitrogen. The percentage of myogenic cells in each isolate was determined by 
desmin immunocytochemistry of air-dried cells (2.74) (Fig. 3.5). The smooth muscle 
cells of the vasculature also express desmin protein, and may have made a minor 
contribution to counts. The number of myogenic cells obtained from different muscle 
groups is shown in Table 3.1.
EDL soleus TA
Number of m uscles 20 20 20
Mean weight (mg) 2.03 3.15 25.00
Viable cells per mg 
tissue
2.65 x 104 3.94 x 104 7.5 x 10a
Desmin* cells 
(% of total)
36.85% 35.25% 53.70%
Desmin+ cells per 
mg tissue
9.78 x 10a 1.38 x 104 4.03 x 10a
Mean desmin* cells 
per m uscle
1.99 x 104 4.37 x 104 1.01 x 10s
Table 3.1. Isolation of putative myogenic cells from the muscles of 42-day-old 3F-nLacZ-2E 
mice.
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Fig. 3.5. Immunocytochemical detection of desmin protein in air-dried cells derived 
from enzymatic disaggregation of 3F-nLacZ-2E soleus muscles. Air-drying causes  
cells to lose their normal morphology but desmin protein remains detectable, in 35.25% 
of cells in this sample (arrows). Peroxidase secondary detection method, 
counterstained with haematoxylin. Original magnification x200.
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3.33 The myogenic potential of MPC isolated from different muscles
This experiment aimed to compare the myogenic potential of enzymatically- 
disaggregated cells isolated from EDL, soleus and TA muscles. The legs of fourteen 
21-day-old mdx-nude host mice were exposed to 18 Gy y-irradiation three days prior 
to grafting (Gross et al. 1999) (2.53). On the day of grafting, cell isolates were 
thawed, washed in growth medium, and suspensions prepared such that 5 x 104 
desmin+ cells were contained in 4 pi growth medium. Therefore whilst the total 
number of grafted cells differed slightly between isolates derived from different 
muscles, the total number of putative myogenic cells within each graft was constant. 
Mice were anesthetised (2.52) and 4 pi cells (EDL isolates n=8; soleus isolates n=7; 
TA isolates n=8) or growth medium (n=5) was grafted into each TA muscle (2.54).
After 3 weeks, engrafted muscles were removed, bisected, mounted and frozen in 
isopentane cooled in liquid nitrogen (2.61). Using a cryostat, three serial 7 pi sections 
were taken at 100 pm intervals throughout approximately 2/3 of the muscle body, and 
collected onto silane-coated glass slides (2.62). In the first set of sections, nuclear p- 
gal activity was localised by staining in X-gal (2.77). In the second set of sections, 
expression of dystrophin protein was localised using fluorescence 
immunohistochemistry (2.76). For each engrafted muscle, the number of donor- 
derived myofibres was calculated by counting p-gal+ and dystrophin+ fibres in 
representative mid-body serial sections. In muscles injected with growth medium 
only, no P-gal activity was detected, but there were 2.4 (±2.9) dystrophin+ revertant 
fibres. Muscles engrafted with cells each contained P-gal+ fibres that corresponded
with dystrophin4- fibres in serial sections (Fig. 3.6).
U
Grafts of EDL cell isolates formed 110.8 (±19.0) dystrophin+ myofibres of which 69.0 
(±27.9) were P-gal+; grafts of soleus cell isolates formed 110.7 (±70.9) dystrophin4- 
myofibres of which 68.6 (±65.3) were p-gal+; and grafts of TA cell isolates formed 
122.6 (±138.1) dystrophin4- myofibres of which 62.4 (±39.4) were p-gal+ (Fig. 3.7).
104
Dd ys tro p h in
F
d ys tro p h in
Fig. 3.6. Identification of donor-derived muscle formation in irradiated mdx-nude TA 
muscles engrafted with 5 x 104 primary myoblasts isolated from the EDL (A-B) soleus 
(C- D) or TA (E- F) muscles of adult 3F-nLacZ-2E mice. Donor-derived muscle is 
identifiable by X-gal staining to localise p-gal activity (A, C, E) and in serial sections, 
fluorescence immunohistochemistry for dystrophin protein, counterstained with DAPI 
(B, D, F). 3 week timepoint. Original magnification x100.
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Fig. 3.7 . Bar graph showing muscle formation by grafts of 5 x 104 prim ary desm in+ cells 
derived from different muscles of 42-day-old 3F-nLacZ-2E mice. A fter 3 weeks, engrafted 
muscles were removed and numbers of (3-gal+ and dystrophin* myofibres counted in 
representative m id-body sections. In each case, clusters of dystrophin+ myofibres contained 
both (3-gaT and (3-gal- myofibres. There was no statistically-significant difference (Mann- 
W hitney, p=>0.05) between the quantities of new muscle formed by cells derived from  the 
different muscle groups. Error bars represent SD.
In each case, there was found to be a greater number of dystrophin+ myofibres than (3- 
gal+ fibres (Figs. 3.6 & 3.7). The muscles of m dx  mice contain small numbers of 
endogenous dystrophin+ ‘revertant’ myofibres that occur both singly and in small 
clusters (Hoffman et al. 1990, Lu et al. 2000). Increases in the number of revertant 
myofibres is partially suppressed after irradiation. After local irradiation at 21-days- 
old, 42-day-old mdx TA muscles typically contain less than twenty revertant 
myofibres, with a maximum of ten in a single cluster (personal communication, Q. 
Lu). The contribution of revertant myofibres cannot, therefore, wholly explain the 
deficit of (3-gal expression within large clusters of dystrophin+ myofibres in engrafted 
muscles. The 3F-nLacZ-2E transgene becomes silenced in long-term cell cultures, 
both in vitro and in vivo (J. Morgan, personal communication). In all probability, the
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greater proportion of dystrophin* (3-gaT myofibres were therefore donor-derived, but 
failed to express the transgene.
There were no statistically significant differences (Mann-Whitney, p=>0.05) between 
the numbers of dystrophin+ myofibres or numbers of P-gal+ myofibres formed by 
grafts of cell isolates derived from the different muscles. In addition, the overall 
grafting efficiencies (the number of myofibres formed divided by number of 
myogenic cells grafted) were very similar (Table 3.6). These data show that MPC 
populations derived from adult EDL, soleus and TA muscles have equivalent 
myogenic potential after grafting into the same host environment.
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3.4 Grafts of single myofibres derived from adult muscles
3.41 Aim
The objective of this study was to investigate the efficiency of muscle formation by 
grafts of single viable myofibres isolated from EDL, soleus and TA muscles.
3.42 Counts of Pax7+ satellite cells associated with single myofibres
This experiment aimed to determine the number of satellite cells associated with 
myofibres isolated from different muscles of adult mice, and thereby generate 
background data necessary for the analysis of subsequent grafting experiments. 
Single myofibres were isolated from the EDL, soleus and TA muscles (Fig 2.1) of 42 
to 49-day-old 3F-nLacZ-2E mice (2.21). Myofibres from mouse 1 and mouse 2 were 
stained in X-gal solution to localise P-gal activity (2.77), and fluorescence 
immunocytochemistry was used to detect expression of Pax7, a marker of quiescent 
satellite cells (Seale et al. 2000, Zammit et al. 2004), and laminin, a major component 
of the basal lamina of myofibres (reviewed, Sanes 2003) (Fig 3.8). Satellite cells 
could therefore be identified by their absence of P-gal activity (Beauchamp et al. 
2000), their expression of Pax7 protein (Seale et al. 2000, Zammit et al. 2004), and 
their anatomical position with respect to the basal lamina (Mauro 1961). Myofibres 
from mouse nos. 3, 4, 5, 6 and 7 were not stained in X-gal solution and were 
immunostained for expression of Pax7 protein only. Counts were made of the number 
of Pax7+ satellite cells associated with each myofibre (Tables 3.2,3.3,3.4).
The 3F transgene is expressed in the myonuclei of fast (glycolytic) myofibres (Kelly 
et al. 1995). Here, p-gal was found to be expressed ubiquitously in the myonuclei of 
myofibres isolated from the fast EDL and TA muscles of mouse 1 and mouse 2. A 
proportion of soleus myofibres stained only weakly, or not at all, in X-gal solution, 
demonstrating lack of fast myosin expression and implying a slow (oxidative) 
phenotype. The blue product of X-gal staining quenched fluorescence in myonuclei, 
hence in fast myofibres only the nuclei of satellite cells were strongly labelled by 
DAPI (Fig. 3.8). Since confocal microscopy was not used for this study, the position 
of some Pax7+ satellite cells was equivocal with respect to the basal lamina, as 
visualised by laminin immunostaining. However, the basal lamina appeared to
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overlay all Pax7+ cells whose position in the plane of view made unequivocal 
anatomical localisation possible (Fig. 3.8).
Previous studies have identified the number of satellite cells associated with single 
myofibres isolated from Myf5nLacZ/+ EDL muscles to be 4.4 to 4.5 as identified by 
immunostaining for M-cadherin, CD34 or Myf5-P-gal fusion protein (Beauchamp et 
al. 2000) or 7.62 as identified by expression of Myf5-(3-gal fusion protein using X-gal 
staining (Zammit et al. 2002). In 3¥-nLacZ-2E EDL myofibres stained in X-gal, the 
number of nuclei not expressing P-gal but identifiable by DAPI immunofluoresence 
has been calculated as 5.56 (Beauchamp et al. 2000). Thus counts made in this study 
of 7.23 (±2.19) Pax7+ satellite cells per EDL myofibre (Table 3.2) broadly agree with 
data previously generated by other workers using different markers.
No. of myofibres Mean Pax7+ satellite cells
m ouse 1 25 6.64 (±3.66)
m ouse 2 18 6.39 (±3.31)
m ouse 3 15 11.07 (±3.69)
m ouse 4 8 5.63 (±2.77)
m ouse 7 12 6.33 (±2.10)
Total 77 7.23 (SE ±2.19)
Table 3.2. The numbers of Pax7+ satellite cells associated with single myofibres isolated from 
the EDL muscles of 42 to 49-day-old 3F-nLacZ-2E mice.
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Fig. 3.8. Identification of satellite cells associated with single myofibres isolated from 
3F-nLacZ-2E  muscles. Arrows mark the nucleus of a satellite cell and asterisks mark 
examples of myonuclei. Staining in X-gal solution localises p-gal activity to myonuclei 
(A). The nucleus of a satellite cell does not express p-gal (A) but is detectable by Pax7 
immunocytochemistry (B) and DAPI staining (C), and is beneath the basal lamina as 
visualised by laminin immunocytochemistry (B). Original magnification x400.
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In single myofibres isolated from the soleus muscles of Myf5nLacZ/+ mice, a previous 
study identified the number of satellite cells identified by expression of Myf5-p-gal 
fusion protein to be 26.23 per myofibre (Zammit et al. 2002). In the present study, 
Pax7 immunostaining of 3F-nLacZ-2F soleus single myofibres yielded a slightly 
lower count of 22.08 (±5.11) satellite cells per myofibre (Table 3.3). This difference 
could be attributable to heterogeneity of antigen expression, inter-strain variability 
(though the gene-targeted Myf5nhacZ and the 3F-nLacZ-2E transgenic were generated 
on the same wild-type background, C57 Bl/6), or the relatively small sample number 
in the present study.
No. of myofibres Mean Pax7+ satellite cells
m ouse 1 18 24.06 (±10.71)
m ouse 2 13 24.08 (±8.55)
m ouse 5 9 15.22 (±5.24)
Total 40 22.08 (SE ±5.11)
Table 3.3. The numbers of Pax7+ satellite cells associated with single myofibres isolated from 
the soleus m uscles of 42 to 49-day-old 3F-nLacZ-2E mice.
There are no published data describing the number of satellite cells associated with 
TA single myofibres. Unpublished counts on Myf5nLucZ/+ TA myofibres found the 
mean number of satellite cells expressing Myf5-p-gal fusion protein to be 13.7 per 
myofibre (personal communication, P.S. Zammit). In this experiment, the number of 
satellite cells as identified by Pax7 expression on 3F-nlacZ-ZE TA myofibres was 
rather lower, at 9.66 (±0.02) (Table 3.4). Whilst the sample number was not big, the 
low standard error between the three animals implies that the data are representative.
I l l
No. of myofibres Mean Pax7+ satellite ce lls
m ou se 1 16 9.75 (±5.74)
m ou se 2 24 9.50 (±4.88)
m ou se 6 10 9.90 (±4.95)
Total 50 9.66 (SE ±0.02)
T abie 3.4. The numbers of Pax7+ satellite cells associated with single myofibres isolated from 
the TA muscles of 42 to 49-day-old 3F-n/_acZ-2E mice.
The numbers of Pax7+ satellite cells associated with single myofibres derived from 
different muscles are shown in Fig. 3.9. The Mann-Whitney test was used to compare 
counts of Pax7+ satellite cells associated with single myofibres derived from the three 
different muscles. The differences between numbers of EDL and soleus satellite cells, 
and between numbers of soleus and TA satellite cells, were found to be extremely 
significant (p=<0.0001), and the difference between numbers of EDL and TA satellite 
cells was found to be significant (p=0.0139).
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Fig. 3.9. Counts of Pax7+ satellite cells associated with myofibres isolated from the EDL, 
soleus and TA muscles of 42 to 49-day-old 3F-nLacZ-2E mice. Error bars represent SE.
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3.43 Preparation and grafting of single myofibres
Single myofibres were isolated from the EDL, soleus and TA muscles (Fig. 2.1) of 42 
to 49-day-old young adult 3F-nLacZ-2E mice as described (2.21). Individually- 
selected perfect myofibres were washed by passing through 3 dishes of warmed 
serum-free medium and then kept in small groups of about 20-30 to prevent 
entanglement. A maximum of 30 minutes was allowed between myofibre preparation 
and transfer to the procedure room for grafting (2.55). Usually, the use of small 
groups of 4-8 mice meant that the grafting procedure could be completed in less than 
1 h. A small proportion of myofibres did not survive outside the incubator for this 
period of time and developed kinks or areas of hypercontraction, and were 
immediately discarded. To prepare the graft, a single myofibre was drawn into a glass 
needle such that it laid undamaged and unbent within the body of the needle, 
confirmed by visual inspection. The graft was then inserted into the recipient muscle 
under microscopic observation. Any fluid expelled from the injection site was re­
drawn into the needle and re-inserted. To confirm that the myofibre had exited the 
needle and not become stuck to the inside, or hypercontracted and lodged in its tip, the 
needle was flushed out several times under the microscope. If this process yielded a 
damaged myofibre, a fresh intact myofibre was drawn up and the grafting process 
repeated. This process aimed, as far as practicably possible, to graft presumptively 
quiescent satellite cells that had had minimal exposure to the tissue culture 
environment, and were maintained within their endogenous niche below the basal 
lamina of intact myofibres. Immediately after isolation, about 10% of satellite cells in 
single myofibre preparations are activated as defined by immunohistochemical 
detection of MyoD protein. After a 6 h exposure to serum mitogens, 80-90% become 
activated by the same criterion (Zammit et al. 2002). It is therefore likely that by the 
time the graft was inserted into the host site, it contained both quiescent satellite cells 
and cells that were in the early stages of activation.
Single myofibre grafts were inserted into the TA muscles (2.55) of 24-day-old mdx- 
nude mice, which had been exposed to 18 Gy irradiation 3 days previously (2.53). 
Engrafted muscles were removed after 3 weeks and processed for 
immunohistochemistry (2.61). 3 serial 7 pm sections were collected at 100 pm
intervals throughout the entire TA muscle body (about 30-40 levels) (2.62). The first
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set of sections was stained in X-gal solution to localise p-gal activity (2.77). The 
second set of serial sections was immunohistochemically stained for dystrophin 
protein (2.76). The maximum number of p-gal+ and dystrophin+ myofibres were 
counted in single serial sections. The number of dystrophin+ myofibres was usually 
greater than, and never less than, the number of p-gal+ myofibres. As previously 
discussed (3.42), this difference is probably partly attributable to the presence of 
endogenous revertant myofibres and partly to the nLacZ transgene becoming silenced 
after extensive proliferation. Typically, the products of grafts formed clusters of 
dystrophin+ myofibres which included both p-gal+ and p-gal” myofibres. The 
numbers of dystrophin+ myofibres probably slightly over-estimate, whilst the numbers 
of P-gal+ myofibres almost certainly under-estimate, the quantity of donor-derived 
muscle formation. Hence both sets of data are presented together.
3.44 The myogenic potential of EDL single myofibre grafts
A total of 34 single myofibre grafts derived from the EDL muscles of four donor 
animals were carried out. 11/34 (32%) of engrafted muscles contained both 
dystrophin expression and p-gal activity (Figs. 3.10 & 3.11). The quantity of donor- 
derived muscle ranged from 2 dystrophin+ myofibres of which 1 was P-gal+, to 189 
dystrophin* myofibres of which 72 were P-gal+. Dystrophin immunohistochemistry 
was not carried out on muscles that had no detectable p-gal activity. In total, an 
estimated 238 EDL satellite cells (based on 34 EDL single myofibres with an average 
of 7 associated satellite cells) were grafted in this study, generating a total of 298 P- 
gal+ myofibres and 526 dystrophin+ myofibres. Therefore the absolute efficiency of 
muscle formation was 1.25 p-gal+ myofibres and 2.21 dystrophin+ myofibres per 
grafted satellite cell. If grafts that generated no donor-derived muscle are excluded 
from the calculation, the efficiency was 3.87 p-gal+ myofibres and 6.26 dystrophin+ 
myofibres per satellite cell. Similarly, in the single graft that made the most muscle, 
the estimated efficiency was 10.14 P-gal* myofibres and 27.00 dystrophin+ myofibres 
per satellite cell (Table 3.6).
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Fig. 3.10. Identification of donor-derived muscle formation in an irradiated mdx-nude TA 
muscle engrafted with a single viable myofibre isolated from the EDL muscle of a 42- 
day-old adult 3F-nLacZ-2E mouse. Donor-derived muscle is identifiable by X-gal 
staining to localise p-gal activity (A), and in a serial section, fluorescence 
immunohistochemistry for dystrophin protein, counterstained with DAPI (B). 3 week 
timepoint. Original magnification x100.
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Fig. 3.11. Histogram showing muscle formation by individual grafts of single m yofibres 
derived from the EDL muscles of 42 to 49-day-old 3F-r?LacZ-2E mice. Ranked in order of the 
num ber of dystrophin+ myofibres. Muscles were harvested 3 weeks post-grafting. Counts 
were made of the maximum numbers of dystrophin+ and (3-gar myofibres in single serial 
sections of engrafted muscles. 11/34 (32%) of engrafted muscles contained both (3-gal activity 
and dystrophin expression. Clusters of dystrophin* myofibres contained both (3-gal* and (3- 
ga f myofibres. Engrafted muscles with no detectable (3-gal activity were not stained for 
dystrophin. Pooled data from 4 experiments.
Each TA myofibre has approximately 600 myonuclei (J.D. Rosenblatt & T.A 
Partridge, unpublished data). Although many myofibres expressing donor markers 
are likely to have been host/donor mosaics (Partridge et al. 1978, Yang et al. 1997, 
Blaveri et al. 1999), a conservative estimate of a 25% donor contribution would 
suggest that within the 3 week time-course, some grafted EDL satellite cells had the 
potential to clonally generate several thousand differentiation-competent progeny.
The previous study carried out by Heslop under similar conditions found that grafts of 
EDL myofibres generated muscle in only 13% of cases, but that almost all successful 
grafts generated >100 new myofibres (L. Heslop, PhD Thesis 2001). In contrast to 
this finding, the present study found that 32% of EDL myofibre grafts generated
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identifiable donor-derived products. The quantity of new muscle formed was highly 
variable, with only a small number of grafts generating >100 myofibres (Fig. 3.11).
3.45 The myogenic potential of soleus single myofibre grafts
A total of 20 grafts derived from three donor animals were carried out. 15/20 (75%) 
of grafts generated donor-derived muscle which ranged in quantity from 2 dystrophin+ 
myofibres of which 1 was p-gal+, to 159 dystrophin+ myofibres of which 142 were p- 
gal+. Since slow myofibres do not express p-gal at detectable levels, it was not known 
whether the products of soleus slow myofibre grafts would be identifiable by p-gal 
activity. For this reason, fluorescence immunohistochemisty for dystrophin protein 
was carried on all engrafted muscles. However, large numbers of dystrophin+ 
myofibres were only identified in association with P-gal activity (Figs. 3.12 & 3.13), 
showing that all successful grafts generated at least some new myofibres that 
expressed fast myosin.
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dystrophin
Fig. 3.12. Identification of donor-derived muscle formation in an irradiated mdx-nude 
TA muscle engrafted with a single viable myofibre isolated from the soleus muscle of 
a 42-day-old adult 3F-nLacZ-2E mouse. Donor-derived muscle is identifiable by X- 
gal staining to localise p-gal activity (A), and in a serial section, fluorescence 
immunohistochemistry for dystrophin protein, counterstained with DAPI (B). 3 week 
timepoint. Original magnification x100.
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Fig. 3.13. Histogram showing muscle formation by individual grafts of single myofibres 
derived from the soleus muscles of 42 to 49-day-old 3F-nLacZ-2E  mice. Ranked in order of 
the num ber of dystrophin* myofibres. Muscles were harvested 3 weeks post-grafting. Counts 
were made of the maximum numbers of dystrophin+ and P-gal+ myofibres in single serial 
sections of engrafted muscles. 15/20 (75%) of engrafted muscles contained both p-gal activity 
and dystrophin expression. Clusters of dystrophin+ myofibres contained both P-gal+ and P- 
g a f  myofibres. Pooled data from 3 experiments.
The Heslop study found that 34% of soleus myofibre grafts generated new muscle. 
The number of new myofibres formed ranged from 8 to 200 and had an approximately 
normal distribution. Whilst the results of the present study differ from the finding of 
Heslop in that grafted myofibres generated new muscle an increased efficiency of 
75%, they concur with Heslop in similarly showing a large range in the numbers of 
new myofibres formed (Fig. 3.13).
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3.46 The myogenic potential of TA single myofibre grafts
A total of 42 grafts from three donor animals were carried out. 14/42 (33%) of 
engrafted muscles contained donor-derived myofibres identifiable by p-gal activity. 
The quantities of donor-derived muscle formed ranged from 1 to 11 p-gal+ myofibres, 
and had an approximately normal distribution (Fig 3.15). Due to prepared slides 
being lost, only 6/42 engrafted muscles were stained for dystrophin protein. Of these, 
2/6 engrafted muscles respectively contained 11 dystrophin+ myofibres of which 2 
were P-gal+, and 7 dystrophin+ myofibres of which 4 were P-gal+ (Fig. 3.14). The 
results of previously-described experiments suggest that alone, counts of p-gal+ 
myofibres are an under-estimate of the total donor contribution to engrafted muscles. 
Notwithstanding, it is notable that out of a total of 42 grafts, no TA myofibre graft 
generated more than 11 new myofibres. These data suggest that satellite cells with the 
potential to generate large amounts of differentiated tissue are absent from the TA 
muscle. Alternatively, they may occur at a frequency too low to be detectable by this 
protocol, with which only small total numbers of cells can be analysed.
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Fig. 3.14. Identification of donor-derived muscle formation in an irradiated mdx-nude 
TA muscle engrafted with a single viable myofibre isolated from the soleus muscle of 
a 42-day-old adult 3F-nLacZ-2E mouse. Donor-derived muscle is identifiable by X- 
gal staining to localise p-gal activity (A), and in a serial section, fluorescence 
immunohistochemistry for dystrophin protein, counterstained with DAPI (B). 3 week 
timepoint. Original magnification x100.
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Fig. 3.15. Histogram showing muscle formation by individual grafts of single m yofibres 
derived from the TA muscles of 42 to 49-day-old 3F-nLacZ-2E mice. Ranked in order of the 
num ber of (3-gal+ myofibres. Muscles were harvested 3 weeks post-grafting. Counts were 
made of the maximum number (3-gal+ myofibres in a single sections of each engrafted 
muscle. 14/42 (33%) of engrafted muscles contained (3-gal activity. Pooled data from  3 
experiments.
3.47 Summary: comparison of the myogenic potential of the satellite 
cell populations of different muscles
Since myofibres isolated from different muscles have different numbers of associated 
satellite cells, it might be predicted that they would generate different quantitites of 
muscle after grafting. However, despite the fact that soleus myofibres have about 
three times as many satellite cells as EDL myofibres (3.42), the Heslop study found 
that successful soleus myofibre grafts only generated about a third as many new 
myofibres as successful EDL myofibre grafts (L. Heslop, PhD thesis 2001). In the 
present study, however, successful grafts of EDL and soleus myofibres generated 
similar mean amounts of |3-gal+ myofibres and dystrophin+ myofibres, but successful 
grafts of TA myofibres generated substantially smaller numbers of (3-gal+ myofibres
0  beta-gal
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(counts of dystrophin+ myofibres were not taken for most TA myofibre engrafted 
muscles) (Table 3.5). Thus these data show that the amount of new muscle formed is 
not directly proportional to the number of cells present in the graft. However, the 
frequency of successful grafts (the number of grafts generating at least 1 p-gal+ 
myofibre divided by the total number of grafts), did appear to be proportional to the 
number of satellite cells originally present in the graft, since soleus myofibres, which 
have 22 associated satellite cells (3.42), generated muscle more than twice as 
frequently as EDL or TA myofibres, which have 7 and 10 associated satellite cells 
respectively (3.42). It is possible that technical failure was responsible for the failure 
of a proportion of grafts, but there is no obvious reason why the failure rate should 
have been lower for soleus myofibre grafts than it was for EDL or TA myofibre 
grafts. Assuming that some EDL and TA myofibres were successfully grafted, but 
generated no muscle, these data suggest that only a proportion of satellite cells were 
recruited into an active myogenic program.
EDL single  
myofibre
soleus single  
myofibre
TA single  
myofibre
Satellite cells per graft8 7 22 10
No. of grafts 34 20 42
Percentage of successfu l0 
grafts
32% 75% 33%
Mean p-gal* myofibres 
formed by successfu l 
grafts
27.1 (±37.2) 32.5 (±43.1) 4.9 (±3.2)
Mean dystrophin* 
myofibres formed by 
su ccessfu l grafts
47.8 (±59.4) 53.5 (±49.0) ND
8 Mean Pax7+ satellite cells per single myofibre (3.41). b Grafts with P-gal* nuclei.
Table 3.5. Comparison of the quantities of muscle formed by grafts of single myofibres 
derived from the EDL, soleus and TA muscles of 42 to 49-day-old 3F-nLacZ-2E  mice. ND= 
not done.
123
When the data are expressed as the total number of myofibres formed per total grafted 
satellite cells, EDL satellite cells were found to generate new muscle with slightly 
higher overall efficiency than soleus satellite cells. Both EDL and soleus satellite 
cells generated new muscle with much greater efficiency than TA satellite cells 
(Table 3.6). In addition, the maximum grafting efficiency (the maximum number of 
new myofibres formed by a single graft divided by the number of satellite cells 
present in the graft) was much greater for EDL single myofibre grafts than for either 
soleus or TA myofibre grafts (Table 3.6).
The numbers of P-gal+ myofibres formed by grafts of single myofibres derived from 
EDL, soleus and TA muscles were compared using the Kruskal-Wallis test (see 
appendix). The differences between the three groups were found to be extremely 
significant (p= 0.0003). The differences were further analysed using Dunn’s multiple 
comparisons test (see appendix). This showed that the difference in muscle formation 
between grafts of EDL myofibres and grafts of soleus myofibres was significant 
(p=<0.01) and the difference in muscle formation between grafts of soleus myofibres 
and grafts of TA myofibres was very significant (p=<0.001). There was no 
statistically-significant difference (p=>0.05) between muscle formation by grafts of 
EDL myofibres and muscle formation by grafts of TA myofibres. However, 
differences between these two data sets are clearly apparent both from plots (Figs. 
3.11 & 3.15), and from the mean amounts of muscle formed (Table 3.5). The 
absence of statistical significance is probably due to the large numbers of zeros in 
both data sets.
The results of this study show that satellite cells in single myofibre grafts have a stem 
cell-like myogenic potential and exhibit patterns of behaviour which vary according to 
their muscle of origin.
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SF1K
clone
SF1K
clone
SF1K
clone
SF1K
clone
EDL
primary
soleus
primary
TA
primary
EDL
myofibre
soleus
myofibre
TA
myofibre
No. myogenic cells per graft 5x10^ 5 x 10a 5 x 104 5 x 10b 5 x 104 5 x 104 5 x 104 7a 22a 10a
No. of grafts 5 4 4 6 8 7 8 34 20 42
Total myogenic cells in all grafts 2.5 x 
103
2 x 104 2 x 10b 3 x 10e 4 x 10b 3.5 x 10b 4 x 10b 238 440 420
Total p-gal* myofibres formed by all grafts 13 15 351 1400 552 480 499 298 487 69
Total dystrophin* myofibres formed by all 
grafts
ND ND ND ND 886 775 980 526 802 ND
Overall efficiency of all grafts0 0.0052 0.0008 0.0018 0.0005 0.0022 0.0021 0.0029 2.2108 1.8227 0.1643
Max. p-gal* myofibres formed by single 
graft
12 8 265 453 167 228 122 71 142 11
Max. dystrophin* myofibres formed by a 
single graft
ND ND ND ND 420 338 523 189 159 ND
Max. efficiency of a single graft0 0.0240 0.0016 0.0053 0.0009 0.0084 0.0068 0.0105 27.0000 7.2273 1.1000
a Mean Pax7+ satellite cells per single myofibre (3.41). b Efficiency= the total donor-derived myofibres formed divided by the total myogenic cells grafted.
Table. 3.6. Comparison of the efficiency of muscle formation generated from adult myogenic cells grafted into irradiated mcfx-nude TA muscles. Engrafted 
muscles were removed after 3 weeks. ND= Not done.
3.48 Fibre types formed by single myofibre grafts
All successful grafts of single myofibres derived from 3F-nLacZ-2E soleus muscles 
generated myofibres that expressed the nLacZ transgene, implying that the satellite 
cells associated with slow myofibres were able to express fast myosin after 
differentiation (3,44). To further investigate whether the satellite cells in single 
myofibre grafts remained committed to the fibre-type of their parent myofibre, serial 
sections from some engrafted muscles were stained with an antibody that recognised 
fast myosin isoforms and an antibody that recognised slow myosin (2.76, Table 2,1). 
Staining of sections from control wild-type muscles showed that the anti-fast myosin 
antibody bound to all myofibres in the glycolytic TA and EDL muscles, and to about 
60% of myofibres in the oxidative soleus muscle (Fig. 3.16). The anti-slow myosin 
antibody bound to about 50% of myofibres in the oxidative soleus muscle and to 
occasional myofibres in glycolytic EDL and TA muscles (Fig. 3.16). In the TA 
muscle, most slow-myosin+ myofibres were present in the superficial part. Therefore, 
as expected, control TA and EDL muscles contained mainly fast myofibres with a few 
slow/fast hybrids, and soleus muscles contained fast myofibres, slow/fast hybrids and 
slow myofibres.
In total, 11 muscles successfully-engrafted with soleus myofibres, 2 muscles 
engrafted with EDL myofibres, and 2 muscles engrafted with TA myofibres were 
examined. Whilst 7/15 grafted myofibres generated fast myosin isoforms only, 8/15 
grafted myofibres generated both fast and slow myosin isoforms (Table 3.7, Fig. 
3.16). All individual myofibres generated by all grafts expressed fast myosin, 
suggesting that in many fibres, expression of the nLacZ transgene did not faithfully 
report expression of the 3F gene. Expression of slow myosin was always localised to 
slow/fast hybrid myofibres; no exclusively slow myofibres were observed in any of 
the 15 engrafted muscles examined. With one exception, fast/slow hybrid myofibres 
formed <6% of the total myofibres derived from each graft (Table 3.7). These data 
suggest that whilst discrete satellite cell populations are capable of contributing to 
myofibres with different patterns of myosin isoform expression, they do not remain 
committed to the expression profile of their fibre type of origin, but probably adopt 
the expression profile of the engrafted muscle. The data do not exclude the possibility 
that the satellite cells which contributed to slow/fast hybrid myofibres were
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themselves derived from parent myofibres which expressed slow myosin. It was 
therefore not possible to resolve whether the products of grafted satellite cells 
acquired the fibre-type profile of the host tissue and were not committed to expressing 
particular myosin isoforms (Hughes & Blau 1992, Bonavaud et al. 2001), or whether 
they had a degree of prior commitment to a particular pattern of myosin isoform 
expression (Rosenblatt et al. 1996), as has been previously suggested by other studies.
Single
myofibre graft
Total
dystrophin*
myofibres
dystrophin* 
fast myosin* 
slow myosin'
dystrophin* 
fast myosin' 
slow  myosin*
dystrophin* 
fast myosin* 
slow  myosin*
so leus 1 86 97.7% 0 2.3%
so leu s 2 34 100% 0 0
so leu s 3 84 100% 0 0
so leus 4 109 100% 0 0
so leus 5 159 99.4% 0 0.6%
so leu s 6 41 100% 0 0
so leu s 7 42 100% 0 0
so leus 8 23 95.7% 0 4.4%
so leu s 9 25 96.0% 0 4.0%
so leu s 10 128 96.9% 0 3.1%
so leu s 11 42 95.2% 0 4.8%
EDL 1 96 82.3% 0 17.7%
EDL 2 189 94.7% 0 5.3%
TA 1 11 100% 0 0
TA2 7 100% 0 0
Table 3.7. Percentages of fast, slow and fast/slow hybrid myofibres in the products of soleus, 
EDL and TA single myofibre grafts into TA muscles.
Unexpectedly, the two myofibre grafts which generated the greatest proportions of 
slow myosin+ myofibres were those derived from EDL muscles (Table 3.7), 
suggesting that EDL satellite cells might have a greater degree of plasticity with 
regards to myosin isoform expression.
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Fig. 3.16. Expression of fast and slow myosin isoforms in muscle generated from 
grafts of single myofibres. Immunohistochemistry for dystrophin and slow myosin (A, 
C, E) and dystrophin and fast myosin (B, D, F). A and B are control sections of wild- 
type soleus muscle (different areas of sam e muscle). C-F are serial sections of 
mcfx-nude TA muscles engrafted with a single myofibre derived from a 3F-nLacZ-2E 
soleus (C-D) or EDL (E-F) muscle. All myofibres derived from single myofibre grafts 
expressed fast myosin (D, F); som e also co-expressed slow myosin (C, E). Original 
magnification x200.
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3.49 The myogenic potential of EDL single myofibres in long-term 
grafts
When examined at the 3 week timepoint, muscles engrafted with EDL single 
myofibres were found to contain numbers of donor-derived myofibres which had a 
very large range (Fig. 3.11). Hypothetically, the large range could be attributable to 
asynchrony of inter-graft satellite cell activation, whereby the smaller muscle colonies 
represent earlier stages of clonal expansion. The objective of this experiment was to 
test this hypothesis by analysing myofibre-engrafted muscles at a later timepoint.
Single myofibre grafts were inserted into 16 pre-irradiated TA muscles of mdx-nude 
host mice (2.53, 2.55). Engrafted TA muscles were removed after 12 weeks, and three 
serial 7 pm sections taken at 100 pm intervals throughout each entire muscle body 
(2.61, 2.62). In the first set of sections, X-gal staining was used to localise p-gal 
activity (2.77), and in the second set, dystrophin protein was detected 
immunohistochemically (2.76). For each engrafted muscle, counts were made of the 
maximum number of P-gal+ and dystrophin+ myofibres present in one section from 
the same level (Fig. 3.17).
9/16 (56%) of engrafted muscles contained both P-gal activity and dystrophin 
expression (Fig. 3.18).
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dystrophin
Fig. 3.17. Identification of donor-derived muscle formation in an irradiated mdx-nude 
TA muscle engrafted with a single EDL myofibre and harvested at the 12 week 
timepoint. Donor-derived muscle is identifiable by X-gal staining to localise p-gal 
activity (A) and in a serial section, fluorescence immunohistochemistry for dystrophin 
protein, counterstained with DAPI (B). Original magnification x100.
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Fig. 3.18. Histogram showing muscle formation by individual grafts of 3F-nLacZ-2E  EDL 
single myofibres 12 weeks post-grafting. Ranked in order of the num ber of dystrophin* 
myofibres. Counts were made of the maximum numbers of dystrophin+ and (B-gal+ myofibres 
in single serial sections of engrafted muscles. 9/16 (56%) of engrafted muscles contained 
both P-gal activity and dystrophin expression.
In total, an estimated 112 EDL satellite cells (based on 16 EDL single myofibres with 
an average of 7 associated satellite cells) were grafted in this experiment, generating a 
total of 104 p-gal+ myofibres and 406 dystrophin+ myofibres. Therefore the absolute 
efficiency of muscle formation was 0.93 p-gal+ myofibres and 3.63 dystrophin* 
myofibres per grafted satellite cell. If grafts that generated no donor-derived muscle 
are excluded from the calculation, the efficiency was 1.65 P-gal+ myofibres and 6.44 
dystrophin+ myofibres per satellite cell. Similarly, in the single graft that made the 
most muscle, the estimated efficiency was 6.43 p-gal+ myofibres and 16.43 
dystrophin+ myofibres per satellite cell.
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3 week timepoint 12 week timepoint
No. of grafts 34 16
Percentage of successfu l3 grafts 32% 56%
Mean p-gal+ myofibres formed by 
successfu l grafts
27.1 (±37.2) 11.6 (±13.0)
Mean dystrophin* myofibres 
formed by successfu l grafts
47.8 (±59.4) 46.3 (±31.7)
Overall efficiency0 2.21 3.63
a Grafts with >1 P-gaf nucleus. b Efficiency= the total donor-derived myofibres formed divided 
by the total myogenic cells grafted.
Table 3.8. Comparison of the quantities of muscle formed by grafts of single myofibres 
derived from the EDL muscles of 42 to 49-day-old 3F-nLacZ-2E mice, when harvested after 3 
weeks or 12 weeks.
In comparison with EDL myofibre grafts harvested at the 3 week timepoint, grafts 
harvested at the 12 week timepoint generated muscle more frequently, but in similar 
average quantity (Table 3.8). This implies that the increase in overall efficiency is 
attributable to an increase in the number of the number of successfully-engrafted 
muscles, rather than expansion of existing clusters. However, the comparative 
distributions of the numbers of donor-derived myofibres formed by individual grafts 
at the different timepoints argues against this. Only 4/34 (12%) of engrafted muscles 
harvested at the 3 week timepoint generated >30 dystrophin+ myofibres, whereas 6/16 
(38%) of engrafted muscles harvested at the 12 week timepoint contained >30 
dystrophin+ myofibres (Figs. 3.11 & 3.17). The single large outlier at the 3 week 
timepoint makes a very large contribution to the mean amount of muscle formed; in 
the absence of the outlier, there would also be an increase over time in the mean 
number of myofibres formed by successful grafts (Figs. 3.11 & 3.17).
Whilst at the 3 week timepoint, 57% of dystrophin+ myofibres contained p-gal 
activity, at the 12 week timepoint, only 25% of dystrophin+ myofibres contained P-gal 
activity (Table 3.8). This implies that expression of the nLacZ transgene declines 
over time. The 7/16 engrafted muscles that did not contain p-gal activity contained 
5.7 (±4.3) dystrophin+ myofibres, presumably revertants. The number of revertant 
myofibres was unexpectedly low for irradiated TA muscles in animals of this age (Q.
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Lu, personal communication). The effect of the nude background on revertant 
myofibre formation has not, however, been specifically studied, and speculatively 
could have been a determining factor.
The results of this experiment suggest that muscle formation by single myofibre grafts 
is spontaneously augmented over time.
3.5 Grafts of single myofibres derived from juvenile muscles
3.51 Aim
In previous experiments, single myofibre grafts were derived from the relatively 
mature muscles of young adult mice (3.4). The objective of this study was to 
investigate the myogenic potential of single myofibres derived from juvenile, growing 
muscles.
3.52 The myogenic potential of single myofibres derived from 
juvenile muscles
Single myofibres were isolated (2.21) from the EDL muscles of a 19-day-old male 
3F-nLacZ-2E mouse (2.13), and from the EDL and TA muscles of a 26-day-old male 
3F-nLacZ-2E mouse (2.13). Single myofibre grafts were inserted into 25 pre­
irradiated TA muscles of mdx-nudQ host mice (2.53, 2.55) (EDL myofibres from 19 d 
donor n=9; EDL myofibres from 26 d donor n=12; TA myofibres from 26 d donor 
n=4). Engrafted TA muscles were removed after 3 weeks, and three serial 7 pm 
sections taken at 100 pm intervals throughout each entire muscle body (2.61, 2.62). 
In the first set of sections X-gal staining was used to localise p-gal activity (2.77), and 
in the second set, dystrophin protein was detected immunohistochemically (2.76). For 
each engrafted muscle, counts were made of the maximum number of p-gal+ and 
dystrophin+ myofibres present in one section from the same level (Fig. 3.19). 4/9 
(44%) of muscles engrafted with EDL myofibres derived from the 19-day-old donor 
generated 26.0 (±32.7) P-gal+ myofibres and 28.0 (±35.3) dystrophin+ myofibres. 
10/12 (83%) of muscles engrafted with EDL myofibres derived from the 26-day-old 
donor generated 11.6 (±9.3) P-gal+ myofibres and 38.3 (±27.9) dystrophin+ myofibres 
(Fig 3.19 & Fig. 3.20, Table 3.9).
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d ys tro p h in
Fig. 3.19. Identification of donor-derived muscle formation in an irradiated mdx-nude 
TA muscle engrafted with a single myofibre isolated from the EDL muscle of a 26-day- 
old juvenile 3F-nLacZ-2E mouse. Donor-derived muscle is identifiable by X-gal 
staining to localise p-gal activity (A) and in a serial section, fluorescence 
immunohistochemistry for dystrophin protein, counterstained with DAPI (B). 3 week 
timepoint. Original magnification x200.
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Fig. 3.20. Histogram showing muscle formation by individual grafts of single myofibres 
derived from the EDL muscles of 19 to 26-day-old 3F-nLacZ-2E mice. Ranked in order of the 
num ber of dystrophin+ myofibres. 3 weeks after grafting, counts were made of the maximum 
numbers of dystrophin+ and P-gal+ myofibres in single serial sections of engrafted muscles. 
14/21 (67%) of engrafted muscles contained both p-gal activity and dystrophin expression. 
Engrafted muscles with no detectable p-gal activity were not stained for dystrophin. Pooled 
data from two experiments.
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Adult 42 to 49-day-old 
donors (n=4)
Juvenile 19 to 26-day- 
old donors (n=2)
No. of grafts 34 21
Percentage of successfu l9 grafts 32% 67%
Mean p-gal+ myofibres formed by 
successfu l grafts
27.1 (±37.2) 15.7 (±18.8)
Mean dystrophin* myofibres 
formed by successfu l grafts
47.8 (±59.4) 35.4 (±29.2)
Overall efficiency0 2.21 3.37
a Grafts with £1 P-gal* nucleus. b Efficiency= the total donor-derived myofibres formed divided 
by the total myogenic cells grafted.
Table 3.9. Comparison of the quantities of muscle formed by grafts of single myofibres 
derived from the EDL muscles of 42 to 49-day-old and 19 to 26-day-old 3F-nLacZ-2E mice.
Overall, grafts of EDL myofibres derived from juvenile donors generated muscle 
more than twice as frequently as grafts of myofibres derived from adult donors, 
although the mean quantity of muscle formed by each successful graft was slightly 
less. The overall increase in efficiency is therefore attributable to increased frequency 
of muscle formation rather than the generation of larger clusters of myofibres (Table 
3.9). 3/4 (75%) of muscles engrafted with TA myofibres derived from the 26-day-
old donor generated 9.7 (±7.4) p-gal+ myofibres and 34.7 (±22.4) dystrophin+ 
myofibres (Fig. 3.21). One individual graft generated 19 p-gal+ myofibres and 66 
dystrophin+ myofibres. Of 42 grafts derived from the TA muscles of adult mice no 
graft generated more that 11 P-gal+ myofibres (2.45).
The results of this study show that the discrete populations of satellite cells associated 
with single myofibres derived from juvenile muscles have greater myogenic potential 
than those with single myofibres derived from adult muscles.
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Fig. 3.21. Histogram showing muscle formation by individual grafts of single myofibres 
derived from  the TA muscles of a 26-day-old 3F-nLacZ-2E mouse. Ranked in order of the 
number of dystrophin* myofibres. 3 weeks after grafting, counts were made of the maximum 
numbers of dystrophin+ and (3-gal+ myofibres in single serial sections of engrafted muscles. 
3/4 (75%) of engrafted muscles contained both P-gal activity and dystrophin expression.
137
3.6 Investigation of the radiation-sensitivity of satellite cells
3.61 Aim
Skeletal muscle harbours a population of radiation-resistant stem cell-like cells which 
are the origin of efficient muscle regeneration after acute damage (Heslop et al. 2000). 
The results of experiments previously described in this chapter indicate that satellite 
cells have a stem cell-like myogenic potential. The objective of this study was to 
determine whether the stem cell-like satellite cells in single myofibre grafts are 
derived from the stem cell-like radiation-resistant population.
3.62 Cells emanating from irradiated single myofibres in culture
Two 44-day-old 3¥-nLacZ-2E mice (2.13) were anaesthetised (2.52) and the right 
hindlegs exposed to 18 Gy y-irradiation (2.53). The contralateral left hindlegs 
functioned as non-irradiated controls. 3 d post-irradiation, single myofibres were 
prepared from the EDL and soleus muscles (2.21) of irradiated and non-irradiated 
hindlegs. Myofibres from the two animals were pooled. Single myofibres from the 
same muscles were used for both tissue culture (3.62) and grafting (3.63) experiments. 
Since little is known about the timecourse of radiation effects on satellite cells, the 3 d 
timepoint was selected since it has been used successfully to ablate the satellite cell 
compartment of host mice prior to grafting (J. Morgan, personal communication, 
Gross et al. 1999)
The effect of irradiation on the proliferative competence of satellite cells was 
investigated. 24 single myofibres isolated from control non-irradiated EDL muscles 
and 24 single myofibres isolated from irradiated EDL muscles were plated in the 
separate wells of 24 well plates, and maintained as adherent cultures (2.21). After 72 
h, the number of cells emanating from each myofibre was counted. Non-irradiated 
control single myofibres (n=23) gave rise to 46.0 (±22.0) cells, and irradiated single 
myofibres (n=24) gave rise to 2.1 (±2.3) cells (Fig. 3.22), a statistically significant 
difference (Mann-Whitney, p=>0.05). The majority of wild-type single myofibre 
cultures give rise to myogenic satellite-derived cells only, but about 1/50 are 
contaminated by non-muscle cell types, probably fibroblasts (Rosenblatt et al. 1995, 
Bockhold et al. 1998). In this experiment, the myogenic lineage of emanating cells
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was confirmed by morphological observation only; non-myogenic cells might 
therefore have made a minor contribution to counts.
During the 72 h time-course, satellite cells in control cultures migrated away from 
myofibres and proliferated. In cultures derived from irradiated muscles, satellite cells 
migrated from myofibres, and sometimes appeared to undergo one cell division before 
detaching from the plate and presumably dying. These observations show that 18 Gy 
irradiation is sufficient to ablate the replication-competence of EDL muscle satellite 
cells when subsequently placed into tissue culture. This finding is supported by the 
results of another study which demonstrated a similar result using single myofibre 
explants derived from 18 Gy-irradiated TA muscles (Heslop et al. 2000).
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Fig. 3 .22. Bar graph showing the numbers of cells surrounding myofibres derived from control 
and 18 Gy irradiated EDL muscles. EDL muscles were obtained from two 3F-r?LacZ-2E mice 
where the right hindleg had been exposed to 18 Gy irradiation 3 days previously, and the left 
contralateral hindleg functioning as a non-irradiated control. Myofibres were maintained as 
adherent cultures and counts made 72 h after plating. These data show that whilst a few  cells 
emanate from myofibres derived from irradiated muscles, they do not have proliferative 
potential.
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3.63 The myogenic potential of irradiated EDL single myofibres
Single myofibres isolated from irradiated EDL (n=10) and soleus (n=10) 3F-nLacZ- 
2E muscles were grafted into the pre-irradiated TA muscles of anaesthetised mdx- 
nude mice (2.52, 2.53, 2.55). Engrafted muscles were removed after 3 weeks and 
processed for immunohistochemistry (2.61), 3 serial 7 pm sections were collected at 
100 pm intervals throughout the entire TA muscle body (2.62). Staining of the first 
set of sections in X-gal solution (2.77) failed to detect p-gal activity in any of the 20 
engrafted muscles (Table 3.10). These data demonstrate that similarly to the satellite 
cells which generate proliferation-competent progeny in tissue culture, the satellite 
cells responsible for the myogenic activity of single myofibre grafts in vivo are 
sensitive to 18 Gy irradiation.
Origin of single myofibre 
graft
No. of grafts Engrafted m uscles with >1 
p-gal+ nuclei
Irradiated 3F-nLacZ-2E EDL 
muscles
10 0
Irradiated 3F-n/_acZ-2E 
soleus muscles
10 0
Table 3.10. Absence of muscle formation in host TA muscles engrafted with myofibres 
derived from 18 Gy-irradiated 3F-nLacZ-2E  muscles.
3.64 The myogenic potential of irradiated and non-irradiated single 
myofibres in notexin-damaged sites
The myotoxic snake venom, notexin, causes necrosis of skeletal muscle tissue 
(reviewed, Harris 2003) and has been shown to augment the amount of muscle formed 
by grafted MPC (Kinoshita et al. 1994, Skuk et al. 1999, Pye et al. 2004). Heslop et 
al. (2000) describe a population of tissue-resident MPC that is only myogenic in 
response to notexin-induced damage. The purpose of this experiment was to 
determine whether single myofibre grafts derived from irradiated muscles retain 
myogenic potential in response to acute damage, or whether their entire myogenic 
potential is ablated.
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As previously, a 43-day-old male 3F-nLacZ-2E mouse was anesthetised (2.52) and the 
right hindleg exposed to 18 Gy y-irradiation (2.53). The contralateral left leg served 
the non-irradiated control. 3 days post-irradiation, single myofibres were isolated 
from irradiated and non-irradiated EDL muscles (2.21). The hindlegs of 6 mdjt-nude 
mice were irradiated (2.53) 3 d prior to grafting. 5 pi of notexin (10 pg/ml in PBS) 
was injected into each host TA muscle (2.56), and a single myofibre immediately 
grafted into the same site (2.55). Right TA muscles (n=6) received grafts of single 
myofibres isolated from the irradiated donor EDL muscle, and left TA muscles (n=6) 
received grafts of single myofibres isolated from the non-irradiated donor EDL 
muscle.
Engrafted muscles were removed after 3 weeks and processed for 
immunohistochemistry (2.61). 3 serial 7 pm sections were collected at 100 pm 
intervals throughout the entire TA muscle body (2.62). In the first set of sections X- 
gal staining was used to localise p-gal activity (2.77), and in the second set dystrophin 
expression was detected immunohistochemically (2.76). No P-gal expression was 
detected in any notexin-injected muscles engrafted with irradiated EDL myofibres. 
3/6 (50%) of notexin-injected muscles engrafted with non-irradiated EDL myofibres 
contained 14.0 (±17.4) P-gal+ myofibres and 30.3 (±13.7) dystrophin+ myofibres (Fig. 
3.23, Table 3.11).
Origin of single  
myofibre graft
Notexin damage 
to host graft site
No. of grafts Engrafted m uscles  
with £1 p-gal+ nuclei
Irradiated 3F-nLacZ- 
2E right EDL muscle
yes 6 (right host legs) 0
Contralateral non- 
irradiated 3F-nLacZ- 
2E left EDL muscle
yes 6 (contralateral left 
host legs)
3
Table 3.11. Muscle formation by myofibres isolated from non-irradiated and contralateral 
irradiated 3F-nLacZ-2E EDL muscles, and grafted into notexin-treated host muscles.
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Fig 3.23. Histogram showing muscle formation by individual grafts of single myofibres derived 
from the non-irradiated EDL muscle of a 42-day-old 3F-nLacZ-2E mouse, with notexin 
injected into the recipient muscle at the time of grafting. Ranked in order of the num ber of 
dystrophin+ myofibres. 3 weeks after grafting, counts were made of the maximum numbers of 
dystrophin+ and (B-gal+ myofibres in single serial sections of engrafted muscles. 3/6 (50%) of 
engrafted muscles contained both 3-gal activity and dystrophin expression. Engrafted 
muscles with no detectable 3-gal activity were not stained for dystrophin. 0/6 grafts derived 
from the contralateral irradiated EDL muscle of the same donor mouse generated 3-gal 
activity (data not shown here).
These data suggest that single myofibre grafts to not harbour radiation-resistant 
myogenic cells which can be activated in response to acute damage. In total, an 
estimated 110 irradiated EDL satellite cells (based on 16 single myofibres each with 
an average of 7 associated satellite cells), and 300 irradiated soleus satellite cells 
(based on 10 single myofibres each with an average of 30 associated satellite cells), 
were grafted in these experiments, of which appoximately 42 (6 EDL single 
myofibres) were grafted with notexin. None of these grafts resulted in muscle 
formation, demonstrating that a radiation-sensitive phenotype is responsible for the 
myogenic activity of single myofibre grafts. Since the products of grafts were only 
identifiable when cells had contributed to differentiated muscle, the absence of
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□ dystrophin
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proliferation by grafted satellite cells in vivo was implied, rather than unequivocally 
shown. However, since satellite cells derived from irradiated muscles do not 
proliferate in vitro (3.62), lack of proliferation is the most likely explanation for lack 
of myogenicity in vivo.
3.65 The myogenic potential of primary MPC isolated from 
irradiated muscles
Exposure to of muscles to 18 Gy irradiation ablates the proliferative and myogenic 
competence of subsequently isolated satellite cells both in vitro (Heslop et al. 2000, 
3.62) and in vivo (3.63, 3.64). However, 18 Gy irradiated muscles retain the ability to 
regenerate after severe injury (Heslop et al. 2000). Hypothetically, regeneration could 
be derived from radiation-resistant cells that are resident committed myogenic 
progenitors, or alternatively from cells of a non-myogenic lineage which are recruited 
into a myogenic program in response to damage. This experiment aimed to 
investigate the myogenic potential of cells isolated from muscles that had been 
exposed to 18 Gy irradiation, but not otherwise stimulated by damage.
The hindlegs of six 42-day-old 3F-nLacZ-2E mice (3 males and 3 females) were 
exposed to 18 Gy y-irradiation (2.53). Three days post-irradiation, mice were 
sacrificed and the EDL, soleus and TA muscles dissected. Pooled muscle groups 
were separately minced and enzymatically disaggregated to obtain cell suspensions. 
>95% of isolated cells were viable as defined by exclusion of Trypan blue dye (2.22). 
10 pi of each cell suspension was spotted onto a silane-coated slide and air-dried at 
RT. The remaining cells were preserved in aliquots under liquid nitrogen. The 
percentage of desmin+ cells in each isolate was determined by immunocytochemistry 
of air-dried cells (2.74). The numbers of desmin+ cells in preparations derived from 
the different irradiated muscle groups are shown in Table 3.12.
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EDL soleus TA
Number of m uscles 12 12 12
Mean weight (mg) 4.16 5.80 27.50
Viable cells per mg 
tissue
7.5 x 10y 1.44 x 104 8.45 x 10a
Desmin* cells  
(% of total)
10.27% 30.79% 56.16%
Desmin+ cells  per 
mg tissue
7.70 x 10* 4.43 x 10a 4.74 x 10a
Mean desm in+ cells 
per m uscle
3.2 x 10a 2.57 x 104 1.3 x 10s
Table 3.12. Isolation of putative myogenic cells from muscles of 42-day-old 3F-nLacZ-2E 
mice that had been exposed to 18 Gy y-irradiation 3 days previously.
In comparison to primary cell isolates derived from non-irradiated 3F-n/acZ-2E 
muscles (3.31), there were relatively small differences in numbers of viable desmin+ 
cells isolated from irradiated soleus and TA muscles (Tables 3.1 and 3.12). 
However, very few desmin+ cells were obtained from irradiated EDL muscles (Table 
3.12). The low yield may be attributable to the technical difficulty of dissagregating 
very small muscles, or may imply that the cell populations of the EDL muscle have an 
increased radiation-sensitivity over those of soleus and TA muscles.
The myogenic potential of cells derived from irradiated soleus and TA muscles was 
investigated by grafting. Immediately prior to grafting, cells were thawed, washed in 
growth medium and cell suspensions prepared such that 5 x 104 desmin+ cells were 
contained per 4 pi medium. Thus as previously (3.31), the total numbers of cells in 
each graft differed slightly between the two isolates, but the number of desmin+ cells 
remained constant. 4 pi aliquots of cell suspension were grafted into the pre­
irradiated TA muscles of four anaesthetised mdx-nude mice (2.52, 2.53, 2.55). Cells 
derived from irradiated soleus muscles were grafted into right host TA muscles and 
cells derived from irradiated TA muscles were grafted into contralateral left host TA 
muscles. Engrafted muscles were removed after 3 weeks and processed for 
immunohistochemistry (2.61). 3 serial sections were collected at 100 pm intervals
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throughout 2/3 of the TA muscle body (2.62). In the first set of sections, p-gal 
activity was localised using X-gal staining (2.77). No muscles engrafted with 
irradiated TA cells contained identifiable p-gal activity. Whilst 3/4 muscles engrafted 
with irradiated soleus cells contained no p-gal activity, one engrafted muscle 
contained a small group of 5 p-gal+ myofibres (Fig. 3.24, Table 3.13).
Origin of primary cell 
isolate
No. of grafts Engrafted m uscles with £1 
p-gal* nuclei
Irradiated 3F-nLacZ-2E  
soleus muscles
4 1
Irradiated 3F-nLacZ-2E TA 
muscles
4 0
Table 3.13. Infrequency of muscle formation in host TA muscles engrafted with primary cells 
derived from 18 Gy-irradiated 3F-nLacZ-2E muscles.
These data demonstrate that the myogenic activity of grafts of enzymatically- 
disaggregated muscle cells (3.32) is almost entirely localised to the radiation-sensitive 
compartment of MPC.
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Fig. 3.24. Identification of donor-derived muscle formed from a graft of 5 x 104 primary 
desmin+ cells isolated from 18 Gy-irradiated 3F-nLacZ-2E  soleus muscles. Section of 
engrafted TA muscle stained in X-gal to localise p-gal activity. The small cluster of 
p-gal+ myofibres shown here was the only donor-derived muscle identified in a total of 
8 muscles grafted with 5 x 104 desrnin* cells derived from irradiated soleus or TA 
muscles. 3 week timepoint. Original magnification x200.
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3.7 Comments on results
The quantity of muscle generated by grafts of clone SFIK immortalised myoblasts 
was proportional to the numbers of cells within the graft. However, the efficiency 
with which muscle was formed declined as the number of myoblasts increased, such 
that smaller numbers of myoblasts formed proportionately larger amounts of muscle. 
Grafts of 5 x 104 primary, non-cultured myogenic cells formed muscle with only 
slightly greater efficiency than grafts of 5 x 104 SFIK immortalised myoblasts. This 
finding could be interpreted as evidence that extensive in vitro expansion does not 
significantly impair myogenic potential, or alternatively indicate that only 
significantly-myogenic clones give rise to cell lines.
In grafts of primary muscle cells, the efficiency with which muscle was formed did 
not differ according to the muscle group (EDL, soleus or TA) from which cells were 
isolated, implying that the MPC populations of these muscles have similar 
regenerative potential (Fig. 3.7, Table 3.6). The low efficiency of muscle formation 
by all MPC grafts is in agreement with data generated by many previous studies 
which have failed to demonstrate donor-derived muscle formation greatly exceeding 
parity (reviewed, Partridge 2003). The number of desmin+ cells obtained per muscle 
in preparations of enzymatically disaggregated cells (Table 3.1) was unexpectedly 
high, exceeding the predicted maximum number of satellite cells present. For 
instance, the murine soleus muscle contains approximately 900 myofibres (personal 
communication, P. Zammit), each with an average of 22 satellite cells (3.42). 
Therefore the estimated total number of satellite cells per muscle is 1.98 x 104. 
However, a mean of 4.37 x 104 desmin+ cells were obtained per muscle. These data 
predict that uninjured adult skeletal muscles harbour substantial numbers of desmin+ 
(presumptively myogenic) cells that reside outside the satellite cell compartment.
Grafts of small discrete populations of satellite cells maintained in association with a 
viable parent myofibre were found, in some cases, to generate over 100 new 
myofibres within the 3 week timecourse. In comparison with primary myoblasts 
isolated from equivalent muscles and grafted into equivalent host environments, 
single myofibre grafts formed muscle with several thousand times greater efficiency 
(Table 3.6). This finding demonstrates that the considerable proliferative potential of
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at least a subset of satellite cells is critically dependent on their endogenous 
association with their parent myofibre. Importantly, single myofibres grafts inserted 
into notexin-treated sites still generated proportionately large amounts of muscle, 
despite the fact that the myofibre itself would have degraded within a few hours
(3.64). This implies the existence of an initial, myofibre-dependent activation event 
which generates highly proliferative myogenic progeny that are not functionally 
dependent on an interaction with the parent myofibre. Speculatively, this event could 
be the activation and division of a more primitive, myofibre-dependent stem cell, to 
generate a daughter cell whose non-myofibre-dependent progeny migrate away and 
proliferate to form a pool of MPC. The finding that muscle formation by EDL grafts 
is augmented over time (Table 3.8) shows that an MPC population persists beyond 
the 3 week timepoint, and further, the increased frequency of muscle formation at 12 
weeks over 3 weeks (Table 3.8) suggests that at least a proportion of MPC are 
generated by activation events that take place some time after grafting.
Whilst EDL and soleus satellite cells generated muscle with relatively similar overall 
efficiency (Table 3.6), though different frequency (Table 3.5), the efficiency of 
muscle formation by TA satellite cells was substantially and consistently less than 
satellite cells from the other two muscles. TA myofibres and EDL myofibres have 
similar numbers of associated satellite cells (Fig. 3.9) and were found to generate 
muscle with similar frequency (Table 3.5). Whilst many EDL myofibres generated 
only small amounts of muscle, a small subset generated large amounts (Figs. 3.10 & 
3.11). This highly-myogenic subset was apparently absent from adult-derived TA 
myofibre grafts (Figs. 3.14 & 3.15), though one individual juvenile-derived TA 
myofibre graft generated 19 P-gal+ myofibres (Fig 3.21). The small number of grafts 
of juvenile TA myofibres (n=4) cannot justify any firm conclusions; but speculatively, 
these data could be explained by an endogenous process whereby the proliferative/ 
myogenic potential of TA satellite cells becomes depleted by postnatal growth. The 
data do not exclude the possibility that adult TA satellite cells have similar myogenic 
potential to those of EDL and soleus muscles, but proliferate more slowly and 
consequently formed less muscle at the single timepoint analysed. The finding that 
TA satellite cells formed less muscle than EDL or soleus satellite cells, in a TA 
environment, directly contradicts the findings of other workers who have suggested 
that fibre-type compatibility is a positive determinant of myogenic potential (Qu &
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Huard 2000). These data show that satellite cells have qualities that are distinct to 
their muscle of origin, and that persist outside that environment.
Muscle formation by EDL myofibres isolated from the muscles of juvenile donors 
occurred with about twice the frequency, and with greater overall efficiency, of that 
by EDL myofibres from adult donors (Table 3.9). Since the numbers of satellite cells 
associated with myofibres from juvenile muscles were not quantified, this difference 
could be attributable to either greater numbers of cells, an increased proportion of 
endogenously-activated cells, or differences in proliferative rate. Nevertheless, these 
data suggest that the activation state of the donor muscle may be a factor which 
determines the efficiency of donor-derived muscle formation in the engrafted muscle.
Myofibres isolated from 18 Gy-irradiated donor muscles did not form any identifiable 
donor-derived products in engrafted muscles, either with or without notexin-induced 
damage (3.63, 3.64). Since the total number of grafted satellite cells was relatively 
small, the data do not absolutely exclude the possibility that radiation-resistant cells 
exist within the satellite cell compartment, but at a frequency too low to be detectable 
within the context of these experiments. Irradiated muscles were enzymatically 
disaggregated to obtain a larger sample of cells. However, grafts of 5 x 104 desmin+ 
cells derived from irradiated muscles generated a very small amount of muscle in only 
1/8 cases (Table 3.13, Fig. 3.24). Together, these data show that the cells which 
generate muscle after grafting are radiation sensitive both within single myofibre 
grafts and grafts of enzymatically disaggregated cells. Hypothetically, radiation- 
resistant cells might have been present in grafts of enzymatically-disaggregated cells
(3.65), but remained non-myogenic in the absence of acute damage. Alternatively, 
the cells responsible for endogenous regeneration in irradiated muscles (Heslop et al.
2000) could be recruited from the circulation or from other resident lineages during 
acute regenerative events.
In summary, the results of the experiments described in this chapter demonstrate the 
existence of a satellite cell population which has a stem cell-like myogenic potential, 
is radiation-sensitive and exhibits distinct inter-muscle variability.
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Chapter 4 
The potential of satellite cells to self-renew
4.1 Background and aim of study
4.11 Background to work
Whilst a progenitor cell may undergo extensive proliferation, it does not have the 
ability to generate another cell like itself, and once its progeny have differentiated, the 
complete regenerative potential of the original cell is fulfilled. The ability to self- 
renew is a defining quality of stem cells, and one which allows them to repeatedly 
generate progeny with the ability to form new differentiated tissue, thereby 
maintaining a sustainable regenerative source (Lajtha 1979, Moore 1979, Morrison et 
al. 1997, Anderson et al. 2001, Elwood 2004).
Satellite cell numbers are maintained throughout juvenile growth (Schultz 1996) and a 
limited number of adult regenerative events (Schultz 1984, Morlet et al. 1989, 
Reimann et al. 2000), but decline in both absolute numbers and proliferative 
competency with age (Gibson & Schultz 1983, Sadeh 1988, Bockhold et al. 1998, Di 
Donna et al. 2000, Kadi et al. 2004, Sajko et al. 2004). Whilst there is therefore 
strong evidence that the adult satellite cell pool has the potential for postnatal renewal, 
albeit finite, the origin of postnatally-renewed satellite cells has not been 
unequivocally established (Fig 1.2). Self-renewal has been postulated as the 
mechanism by which the satellite cell compartment is maintained (reviewed, Zammit 
& Beauchamp 2004). The results of in vitro experiments have shown that 
transformed C2C12 cells (Yoshida et al. 1998), primary human myoblasts (Barroffio 
et al. 1996) and mouse satellite cells (Zammit et al. 2004) generate undifferentiated 
reserve populations when the majority population differentiate, phenomena which 
predict an endogenous pattern of self-renewal.
In vivo, grafts of cloned immortalised myoblasts and primary neonatal myoblasts give 
rise to satellite cells that are proliferation-competent in vitro upon re-isolation in
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single myofibre preparations (Blaveri et al. 1998, Heslop et al. 2001, Cousins et al. 
2004). In addition, immortalised myoblasts can be serially passaged through several 
host animals with intervening periods of in vitro expansion (Morgan et al. 1994). 
However, graft-derived reserve cells have a somewhat limited ability to participate in 
damage-induced regeneration in vivo (Gross & Morgan 1999), suggesting that in vitro 
replicative competence does not necessarily predict proliferative and myogenic 
potential in vivo. Since all the above studies used grafts of large numbers (5 x 105) of 
cells, it was not possible to determine whether donor-derived satellite cells were 
generated stochastically from cells without significant in vivo myogenic potential, or 
whether they were the product of a clonogenic cell which originally generated both 
differentiation-committed and reserve progeny. In addition, it is not known whether 
donor-derived satellite cells express appropriate phenotypic markers. One study 
identified expression of Myf5-(3-gal fusion protein in satellite cells generated from 
grafts of primary neonatal myoblasts derived from the Myf5nlacZ/+ mouse (Heslop et al.
2001); however, since the transplanted population consisted of a mixture of different 
phenotypes, the precise cellular origin of the new satellite cells is ambiguous. In 
addition, the use of cells of neonatal origin could not exclude the possibility that new 
satellite cells were generated by a phenotype which does not persist into adulthood. 
In the absence of in vitro expansion, the ability of defined satellite cells to generate 
new defined satellite cells has not been formally demonstrated.
4.12 Aims of work
This experiments described in this chapter aimed to determine the potential of adult 
satellite cells to self-renew their own population by generating new anatomically- and 
phenotypically-defined satellite cells, and to investigate the frequency with which new 
satellite cell formation occurs.
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4.13 Note on genetic markers of graft-derived satellite cells
Expression of Myf5-p-gal fusion protein has been established as a marker of quiescent 
satellite cells in the Myf5nLacZ/+ mouse (Beauchamp et al. 2000, Heslop et al. 2001, 
Zammit et al. 2002) (Fig. 4.1). Myf5-p-gal fusion protein is expressed by the nuclei 
of immature myofibres during postnatal development, but in the adult, is lost in the 
nuclei of mature myofibres (Tajbakhsh et al. 1995) and retained only by satellite cells 
(Beauchamp et al. 2000). The Myf5nlacZ/+ mouse is therefore ideally suited as a 
genetically-marked donor strain for investigation of satellite cell formation after 
grafting.
Since Myf5-P-gal fusion protein is expressed by both replication-competent cells and 
newly-formed myotubes, in the absence of anatomical markers in vitro its expression 
does not discriminate between differentiated and undifferentiated nuclei. In tissue 
culture experiments, Pax7 was used as a marker of undifferentiated cells since in the 
mouse, its expression is lost after commitment to differentiation (Zammit et al. 
2004a).
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Fig. 4.1. Identification of satellite cells associated with single myofibres isolated from 
the EDL muscles of a Myf5nLacZ/+ mouse. Incubation in X-gal followed by DAPI 
staining (A-B) localises p-gal activity to a satellite cell nucleus (arrowed), which does  
not translocate to adjacent myonuclei identifiable only by DAPI staining. In a different 
myofibre (C-F) satellite cells are identified by immunocytochemistry for p-gal and Pax7. 
A satellite cell nucleus (arrowed) co-expresses Myf5- p-gal and Pax7 proteins. 
Myonuclei express neither of these markers, but are identified by DAPI staining. 
Original magnification x400.
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4.2 The ability of a satellite cell-derived clone to generate 
new satellite cells
4.21 Aim
The objective of this study was to investigate the ability of a conditionally- 
immortalised cell line to give rise to anatomically-defined satellite cells which express 
appropriate phenotypic markers.
4.22 Preparation of a Myf5nLacZ satellite cell-derived cell line
A cell line expressing Myf5nLacZ was generated. Single myofibres were isolated (2.21) 
from the EDL muscles of a 42-day-old male tsA58/ Myf5nLacZ/+ double
heterozygote mouse (2.16), and cultured individually in the wells of 24-well plates. 
After 24 h, myofibres were removed and remaining satellite-derived cells expanded 
under permissive conditions (2.23). Dilution cloning (2.23) was used to obtain six 
cell lines. Cells from each line were immunostained for expression of desmin and T 
antigen proteins (2.74) and nuclear P-gal activity localised by staining in X-solution 
(2.77), to respectively confirm myogenic lineage (Li et al. 1994), presence of the 
immortalising tsA58 antigen, and expression of Myf5-P-gal fusion protein. All cells 
in all clones were found to both express desmin and tsA58 and to exhibit p-gal 
activity (data not shown). Fusion assays (2.42) determined that clone Myf5E2 had the 
highest fusion index (73%). Fluorescence immunocytochemistry was used to survey 
expression of satellite cell marker proteins in clone Myf5E2 cells (2.74). In 
proliferating cells maintained under permissive conditions (2.23), nuclear expression 
of Pax7 and MyoD was almost universal. Immunocytochemistry using an anti-P-gal 
antibody resulted in a variable pattern of staining, with some cells showing very 
strong expression of Myf5-p-gal fusion protein, and others staining only weakly. This 
heterogeneity is consistent with the findings of previous studies which have shown 
that Myf5 expression is cell cycle regulated (Kitzmann et al. 1998). In differentiated 
cultures, nuclei within myotubes did not express Pax7, but sometimes expressed 
myogenin. Cells which remained mononucleate in differentiated cultures variously 
retained expression of Pax7, expressed myogenin, or were negative for both these 
markers. Pax7 and myogenin were not co-expressed (Fig. 4.2). These staining 
patterns suggest that conditional immortalisation does not significantly perturb normal 
patterns of MRF and Pax7 expression in Myf5E2 cells.
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Myf5-p-gal/ MyoD Pax71 MyoD Pax7/ myogenin
Fig. 4.2. Fluorescence immunocytochemistry of clone Myf5E2 satellite cell-derived 
myoblasts. Proliferating mononucleate cells stained for p-gal and MyoD (A-D) and 
Pax7 and MyoD (E-H). Almost all cells express Pax7, MyoD and, at varying levels, 
Myf5-p-gal. Differentiated culture stained for Pax7 and myogenin (l-L). Pax7 
expression is lost by nuclei that have become incorporated into a myotube (outlined), 
but is retained by many non-fused mononucleate cells (green arrows). Myogenin is 
expressed by som e cells (red arrows), but is not co-expressed with Pax7 (K). Som e 
DAPI+ mononucleate cells express neither marker (white arrows). Original 
magnification x400.
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4.23 The potential of immortalised satellite cell-derived Myf5nLacZ 
myoblasts to give rise to satellite cells
Clone Myf5E2 cells (4.21) were used to investigate the potential of a cloned cell line 
to generate anatomically and phenotypically-defined satellite cells. Myf5E2 cells 
were expanded in vitro, and immediately before grafting, trypsinised, washed in 
growth medium, and a viable cell count performed (2.22). Pellets of 5 x 105 cells 
were prepared. 3 mdx-nude host mice were anaesthetised (2.52) and 5 x 105 cells 
grafted into the pre-irradiated (2.53) TA muscle of each hindleg (2.54). Engrafted 
muscles were removed after 3 weeks. The left engrafted muscle of each mouse was 
processed for immunohistochemistry. Two serial sections were collected at 100 pm 
intervals throughout about 2/3 of the muscle body. In the first set, fluorescence 
immunohistochemistry was used to detect expression of dystrophin protein (2.76). 
3/3 engrafted muscles were found to contain 495 (±194) dystrophin+ myofibres (Fig. 
4.3).
The right engrafted muscle or each host mouse was disaggregated to obtain single 
myofibres (2.21). In contrast to preparations obtained for grafting (3.42), in this 
experiment myofibres with minor imperfections (i.e. small bends or branching) were 
not discarded, since it was thought that donor-derived satellite cells were most likely 
to be associated with recently-regenerated myofibres, which might be more sensitive 
to damage induced by the isolation process. However, myofibres with gross 
imperfections, such as areas of hypercontraction or adherent debris, were discarded. 
Single myofibres were either stained in X-gal solution to localise p-gal activity (2.77), 
or stained immunocytochemically for p-gal and Pax7 proteins (2.75) as described in 
Table 4.1. Single myofibres isolated from the EDL muscles of a Myf5nLacZ/+ mouse 
were used as positive controls (Fig. 4.1).
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Left engrafted TA Right engrafted TA
m ouse 1 Cryosectioning and dystrophin 
immunohistochemistry
Single myofibre isolation, 
immunocytochemistry for p-gal and 
Pax7
m ouse 2 Cryosectioning and dystrophin 
immunohistochemistry
Single myofibre isolation, 
immunocytochemistry for p-gal and 
Pax7
m ouse 3 Cryosectioning and dystrophin 
immunohistochemistry
Single myofibre isolation, 
X-gal and DAPI staining
Table 4.1. Analysis of muscles engrafted with 5 x 105 clone Myf5E2 conditionally-
immortalised myoblasts.
Staining of myofibres from mouse 3 in X-gal solution localised P-gal activity to 
numerous nuclei, p-gal” nuclei were strongly stained by DAPI, and p-gal+ nuclei 
were very weakly stained as a consequence of the quenching effect of the blue 
product of X-gal staining. In some newly-regenerated myofibres, chains of p-gal+ 
nuclei indicated that at least one myonucleus was of donor origin. Since myonuclear 
p-gal translocates to adjacent myonuclei contained within a common cytoplasm 
(Ralston & Hall 1989, Yang et al. 1997) it was not possible to distinguish donor- 
derived P-gal+ nuclei from closely-associated host myonuclei which had thus acquired 
p-gal expression. Conversely, some P~gal+ nuclei were identifiable as those of 
satellite cells by the absence of such translocation to adjacent DAPI+ myonuclei 
implying lack of cytoplasmic continuity with the parent myofibre (Heslop et al. 
2001). Satellite cells were identified on both large, mature myofibres and smaller, 
centrally-nucleated myofibres (Fig. 4.4). Where several p-gal+ nuclei were located in 
association with a single myofibre, it was not possible to determine whether they were 
within the cytoplasm of the myofibre or within satellite cells.
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dystrophin
Fig. 4.3. Donor derived muscle formation in an mdx-nude TA muscle engrafted with 
5 x 105 Myf5E2 satellite cell-derived myoblasts. Fluoresence immunocytochemistry for 
dystrophin protein, counterstained with DAPI. Original magnification x200.
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Fig. 4.4. Single myofibres isolated from an mdx-nude TA muscle engrafted with 5 x 105 
Myf5E2 satellite cell-derived myoblasts. X-gal staining was used to localise expression 
of Myf5-p-gal fusion protein in donor-derived nuclei (A, C, E). Other nuclei were stained 
with DAPI (B, D, F). p-gal+ satellite cells (arrows) can be distinguished from p-gal+ 
myonuclei by the lack of translocation to adjacent myonuclei. Donor-derived satellite 
cells were seen  on both mature myofibres (A-B) and relatively immature myofibres (C- 
D). Chains of fi-gal+ nuclei in som e immature myotubes indicated that one or more 
myonuclei were donor-derived (E- F). Original magnification x400 (A-D) or x200 (E-F).
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Satellite cells were also identified in single myofibre preparations stained 
immunocytochemically for expression of Pax7 and p-gal proteins. Pax7 is expressed 
by the majority of satellite cell nuclei, but not myonuclei (Seale et al. 2000, Zammit et 
al. 2004a). Donor-derived satellite cells were identifiable by their co-expression of 
Pax7 and Myf5-p-gal fusion proteins (Fig. 4.5). Pax7+ p-gal- satellite cells were 
presumed to be mainly host-derived. However, in the Myf5nLacZ/+ mouse, about 20% 
of anatomically-defined satellite cells do not express Myf5-P-gal fusion protein 
(Beauchamp et al. 2000), suggesting the possibility that in the present experiment, 
some Pax7+ P-gal- satellite cells could have been donor-derived. Occasionally, chains 
of Pax7- P-gal+ nuclei were seen in immature myofibres. Numbers of satellite cells 
were counted and are depicted in Table 4.2 and Fig. 4.6.
Treatment with 18 Gy irradiation has been reported to reduce the total number of 
satellite cells that migrate from single myofibres after 40-60 h in culture to about 20% 
of normal values (LaBarge & Blau 2002), and to completely ablate their proliferative 
ability (Heslop et al. 2000, 3.72). In a previous experiment, myofibres isolated from 
the non-irradiated (and non-dystrophic) TA muscles of 3F-nLacZ-2E TA mice were 
found to have a mean of 9.66 (±0.20) associated Pax7+ satellite cells (3.41). 
Myofibres isolated from irradiated mdjc-nude TA muscles in the present experiment 
had a mean of 1.81 (SE ±0.67) Pax7+ p-gal- satellite cells, 18.7% of the mean number 
associated with non-irradiated 3F-nLacZ-ZE myofibres (3.41). These data are 
therefore in accordance with the finding of LaBarge & Blau (2002).
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Fig. 4.5. Single myofibre isolated from an mdx-nude TA muscle engrafted with 5 x 105 
Myf5E2 satellite cell-derived myoblasts. Immunocytochemistry for p-gal (A) and Pax7 
(B) identifies a donor-derived satellite cell nucleus (arrowed) which co-expresses 
Myf5-p-gal fusion protein and Pax7 (D). Myonuclei are identifiable only by DAPI 
staining (C, D). Original magnification x400.
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m ouse 1 m ouse 2 total
Total myofibres 40 45 85
Total satellite cells 119 77 196
Pax7+ p-gal' 
satellite cells
91 60 151
Mean Pax7+ p-gal" 
satellite cells per 
myofibre
2.28 (±2.11) 1.33 (±1.62) 1.81 (SE ±0.67)
Pax7+ p-gal+ 
satellite cells
28 17 45
Mean Pax7+ p-gal+ 
satellite cells per 
myofibre
0.70 (±1.22) 0.38 (±0.86) 0.54 (SE ±0.23)
Percentage of 
myofibres with £1 
p-gal+ satellite cells
35.0% 28.6% 31.8%
Percentage of 
p-gal+ satellite cells  
in whole population
23.5% 22.1% 22.8%
Estimated total 
satellite cells  
formed per graft8
1.40 x 10a 0.76 x 10d 1.08x10*
a Based on an assumption of 2 x 103 total myofibres per engrafted muscle. The mean number 
of graft-derived satellite cells per sampled myofibre multiplied by the total myofibres in the 
engrafted muscle.
Table 4.2. Expression of and Pax7 and 3-gal proteins in satellite cells associated with 
myofibres isolated from two TA muscles engrafted with 5 x 105 Myf5E2 cells.
Assuming that each engrafted muscle contained about 2 x 103 total myofibres (typical 
for an irradiated mdx muscle at this timepoint, J. Morgan, personal communication), 
which had on average 0.54 donor-derived satellite cells per myofibre, Myf5E2 
myoblasts generated an estimated 1.08 x 103 new satellite cells per graft (Table 4.2). 
These data show that clonal populations of immortalised myoblasts can generate both 
differentiated muscle and anatomically-defined satellite cells which co-express the 
canonical satellite cell markers Pax7 and Myf5. However, since approximately 103
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satellite cells were formed from 5 x 1CT Myf5E2 cells in each engrafted muscle, the 
frequency o f satellite cell formation was only about 0.2% of the total grafted cells. 
M uscle formation from grafts of immortalised myoblasts is thought to originate from 
about 2% of grafted cells that survive and proliferate (Beauchamp et al. 1999). In the 
present study, muscle formation by the Myf5E2 clone was relatively efficient at 495 
(±194) dystrophin+ myofibres per graft, suggesting that the low efficiency of satellite 
cell formation was not due to inaccurate injections or poor myogenic potential of the 
cell line.
Fig. 4.6. Pie chart illustrating the contribution of Myf5E2 cell grafts to the satellite cell 
com partm ent of irradiated mdx-nude TA muscles (n=2). Alm ost all endogenous satellite cells 
express Pax7 (Zammit e t al. 2004a). Single myofibres isolated from engrafted muscles were 
im m unostained for Pax7 and (3-gal proteins. Donor-derived satellite cells were identified by 
co-expression of Pax7 and Myf5-(3-gal fusion protein.
The results of this experiment demonstrate that a clonal, conditionally-immortalised 
satellite cell-derived line is capable of both generating differentiated tissue and giving 
rise to satellite cells which express appropriate phenotypic markers.
□ Pax7(+) beta-gal (-) 
a  Pax7 (+) beta-gal (+)
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4.3 The ability of satellite cells to generate new satellite cells
4.31 Aim
The objective of these experiments was to investigate the potential of satellite cells to 
renew their own compartment by generating new satellite cells.
4.32 Generation of reserve populations from satellite cells in culture
Previous studies have demonstrated that in tissue culture, both primary human 
myoblasts (Baroffio et al. 1996) and the C2C12 murine myoblast cell line (Yoshida et 
al. 1998) are capable of maintaining a proliferation-competent reserve population 
during differentiation (Baroffio et al. 1996, Yoshida et al. 1998). In addition, a study 
on isolated myofibres in suspension culture has recently shown that associated 
satellite cells generate clonal progeny with divergent fates. Within a single (probably 
clonal) cluster of cells, some progeny commit to differentiation as shown by 
expression of myogenin protein, whilst others fail to express myogenin and maintain 
expression of Pax7, thus constituting an undifferentiated reserve population (Zammit 
et al. 2004). Though when maintained as adherent cultures, almost all single 
myofibres generate differentiation-competent progeny (Rosenblatt et al. 1995), it is 
not known whether they similarly all generate populations of reserve cells. Using 
adherent myofibre cultures, the present experiment aimed to investigate the fates of 
satellite cell progeny several days after differentiation of the majority population.
Single myofibres were isolated from the EDL muscles of an 84-day-old C57 Bl/10 
mouse and maintained as individual adherent cultures in the wells of chamber slides
(2.21). Single myofibres were cultured for 192 h, with 50% medium changes at 48 h, 
96 h and 144 h. Extensive proliferation occurred during the first 96 h after which 
satellite cell-derived myoblasts started to differentiate. By 192 h, the majority of 
mononucleate cells had fused into relatively large and mature myotubes. Cultures 
were fixed and fluorescence immunohistochemistry used to localise expression of 
myogenin and Pax7 proteins (2.74) (Fig. 4.7). The fusion index of each culture was 
calculated as previously described (2.43), except that nuclei were stained with DAPI 
instead of haematoxylin. Myogenin was expressed both in the nuclei of mononucleate 
cells and in some myonuclei. Pax7 expression was seen only in the nuclei of 
mononucleate cells. Counts were made in three random fields for each culture.
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Fig. 4.7. Immunocytochemical detection of Pax7+ (green arrows) and myogenin+ (red 
arrows) mononucleate cells in a differentiated single myofibre-derived culture. After 8 
days in culture, most satellite cell-derived myoblasts have fused into myotubes but 
some persist as a mononucleate undifferentiated reserve population. Co-expression of 
Pax7 and myogenin was not seen. Pax7~ myogenin* cells may have been either 
myogenic cells that expressed neither marker at the time of sampling, or non-muscle 
contaminants. Original magnification x100.
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No co-expression of myogenin and Pax7 was seen. Cultures (n=10) contained 76.5% 
(±16.1) nuclei within myotubes, 12.5% (±5.7) Pax7+ mononucleate cells and 4.7% 
(±3.0) myogenin+ mononucleate cells. The 6.3% (±14.0) of total nuclei within Pax7” 
myogenin” mononucleate cells were probably myogenic precursors which at the time 
of sampling did not express either of the markers examined, or less likely, non-muscle 
contaminants (Figs. 4.7 & 4.8). These data show that several days post­
differentiation, all (10/10) cultured single myofibres generated cells that persisted in a 
mononucleate and undifferentiated state. Pax7+ mononucleate cells may be analogous 
with satellite cells in vivo (Seale et a l 2000, Zammit et al. 2004). Myogenin+ cells 
may represent the differentiation-committed precursor population identified by 
Rantenan et al. (1995), or may be terminally differentiated myocytes which failed to 
fuse in the tissue culture environment.
In a previous study, satellite cells maintained in association with single myofibres 
were found to give rise to progeny that adopted divergent fates with a mechanism 
suggestive of self-renewal (Zammit et al. 2004a). Here, a Pax7+ satellite cell-like 
phenotype was generated from populations of cells which had exited their sub-laminal 
position and thus were not maintained in association with myofibres. These data 
therefore suggest that undifferentiated reserve cells might initially be formed by a 
myofibre-independent mechanism, and only later recruited into the sub-laminal 
satellite cell niche.
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□ nuclei within myotubes
El myogenin (+) mononucleate 
cells
□ Pax7 (+) mononucleate cells 
■ other mononucleate cells
Fig. 4.8. Pie chart showing the divergent fates of satellite cell-derived MPC in EDL single 
myofibre cultures 8 d after explant (n=10). The majority of cells fused into myotubes, however 
som e remained mononucleate and expressed either Pax7 or myogenin, but not both (Fig. 
4.7). Som e mononucleate cells were negative for both these markers. Pax7+ cells may be 
analogous with satellite cells in vivo (Seale etal. 2000, Zammit etaL  2004a). Myogenin+ cells 
may represent the differentiation-committed precursor population identified in vivo by 
Rantenan et al. (1995), or may be terminally differentiated cells which failed to fuse in the 
tissue culture environment. Unstained mononucleate cells are likely to be myogenic cells that 
at the time of sampling did not express either of the markers examined, but could alternatively 
be non-muscle contaminants.
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4.33 The potential of grafts of Myf5nLacZ/+ single myofibres to give rise 
to satellite cells
(a) Identification of satellite cells derived from grafts of EDL, soleus and TA 
myofibres
Grafts of myofibres derived from the muscles of Myf5nLacZ/+ mice were used to 
investigate the ability of satellite cells to generate new anatomically- and 
phenotypically-defined satellite cells in vivo. Single myofibres were isolated from the 
EDL, soleus and TA muscles of donor 42 to 49-day-old Myf5nLacZ/+ mice and prepared 
for grafting as previously described (2.21, 3.42). Myofibres were grafted into the pre­
irradiated TA muscles of mdx-nude mice (2.53, 2.55). After three weeks, engrafted 
muscles were removed and disaggregated into single myofibres (2.21), and X-gal 
staining used to localise p-gal activity (2.77). The undigested part of each engrafted 
TA muscle body was similarly fixed and stained in X-gal.
To maximise the chances of obtaining a positive result, in a preliminary experiment 
grafts of five, rather than single EDL myofibres were used. Of a total of 16 engrafted 
muscles, no isolated myofibres were stained by incubation in X-gal. However, 1 of 
16 muscle bodies contained nuclear-localised p-gal expression. Under a dissecting 
microscope, p-gal-expressing myofibres were dissected out of this muscle using fine 
forceps and pins. The fragility and small size of these myofibres (estimated at ~1 
mm) and made the process difficult; consequently, only four relatively-intact p-gal- 
expressing myofibres were obtained, a small sample of the total. Of these, two 
myofibres contained several p-gal+ nuclei which may have been either myonuclei, or 
within satellite cells. The other two myofibres contained one and two strongly p-gal+ 
nuclei respectively. These two myofibres were stained with DAPI to visualise all 
nuclei. The presence of several adjacent DAPI+ P-gal- nuclei showed that the p-gal 
activity was localised to the nuclei of satellite cells and not to myonuclei. It has been 
well-established that myonuclear P-gal translocates to adjacent myonuclei contained 
within the cytoplasm of the same myofibre (Ralston & Hall 1989, Yang et al. 1997). 
Satellite cells were therefore identifiable by the absence of such translocation 
implying lack of cytoplasmic continuity (Heslop et al. 2001). However, where 
several closely associated p-gal+ nuclei were seen in a single myofibre, it was not
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possible to determine whether they were within satellite cells, or alternatively were 
myonuclei.
In subsequent experiments grafts of single myofibres were used. A proportion of 
grafts contained p-gal+ nuclei in both myofibres isolated by collagenase digestion, and 
within the undigested part of the TA muscle body (Table 4.3). All successful grafts 
generated both unequivocally identifiable p-gal+ satellite cell nuclei, myonuclei, and 
many nuclei whose location was indeterminable. Donor-derived satellite cells were 
seen on both large, mature myofibres, and smaller, centrally-nucleated myofibres 
which were likely to have been recently regenerated. Chains of P-gal+ nuclei in small, 
immature myofibres indicated that one or more myonuclei were donor-derived (Fig. 
4.9). Only a proportion of myofibres containing p-gal+ nuclei were obtainable intact, 
and only a small number of probable satellite cell nuclei could be unequivocally 
characterised as such. However, subjectively, the number of donor-derived satellite 
cells appeared to greatly exceed the number originally present in the graft (see Fig. 
4.10A). P-gal+ nuclei appeared to be more numerous and distributed over a larger 
area when derived from EDL or soleus myofibre grafts than when derived from TA 
myofibre grafts. Since at this timepoint, successful EDL and soleus myofibre grafts 
generate larger numbers of donor-derived myofibres than TA myofibre grafts (3.4), 
this suggests that donor-derived satellite cells may have been formed with a frequency 
proportional to the amount of new muscle generated.
Graft derived from M yf& Lacn+ 
m uscle
No. of grafts Grafts generating p-gal+ 
satellite cells
5 x EDL myofibres 16 1 (6.3%)
EDL single myofibre 10 2 (20%)
so leu s single myofibre 6 2 (33.3%)
TA single myofibre 10 5 (50%)
Table 4.3. Frequency of satellite cell formation by grafts of Myf&'LacZ/+ myofibres. p-gal activity 
was localised by incubation in X-gal.
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Fig. 4.9. Single myofibres isolated from mdx-nude TA muscles engrafted with a single 
Myf5niacZ/+ EDL myofibre. X-gal staining localises Myf5-p-gal fusion protein to donor- 
derived nuclei (A,C, E). Other nuclei are stained with DAPI (B, D, F). p-gal+ satellite 
cells (arrows) are distinguished from p-gal+ myonuclei by the lack of translocation to 
adjacent myonuclei. Donor-derived satellite cells were seen  on both mature myofibres 
(A-B) and immature myofibres (C-D). Chains of fi-gal+ nuclei in som e immature 
myotubes indicated that one or more myonuclei were donor-derived (E- F). A-D were 
originally isolated as viable single myofibres. E-F was dissected from the fixed and 
stained muscle body. Original magnification x400.
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Fig. 4.10. Can grafted satellite cells contribute to muscle spindle regeneration? Most 
Myf5nLacZ/+ myofibre-engrafted muscles exhibited a pattern of X-gal staining similar to 
that shown in (A). In one muscle engrafted with a soleus single myofibre, however, a 
group of myofibres exhibited an unusual pattern of staining after incubation in X-gal 
(C, D). The staining was reminiscent of that seen  in muscle spindles isolated from 
Myf5P'acZ/+ muscles (B), suggesting the possibility that satellite cells may have the 
potential to contribute to spindle regeneration. Original magnification x200 (A, C) or 
x100 (B, D).
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Grafts of five myofibres generated satellite cells less frequently than grafts of one 
single myofibre (Table 4.3). Although five myofibres could be drawn into a glass 
needle relatively easily, when expelled they were likely to have become tangled and 
damaged, perhaps hypercontracting. The decreased viability of myofibres may have 
affected the viability or potential of their associated satellite cells.
In one soleus myofibre-engrafted muscle, after incubation in X-gal a pattern of P-gal 
expression similar to that of Myf5nLacZ/+ muscle spindles (Zammit et al. 2004) was 
seen. In the absence of staining for specific markers such as spindle-specific MyHC 
isoforms (Soukup & Thomell 1997), it could not be determined unequivocally 
whether this staining indicated a contribution to spindle regeneration (Fig. 4.10), 
however, this could be a possibility.
(b) Quantification of Pax7+ satellite cells derived from grafts of soleus single 
myofibres
Single myofibres were isolated from the soleus and TA muscles of a donor 43-day-old 
Myf5nLacZ/+ mouse (2.21, 3.42) and one myofibre grafted into each of the bilateral pre­
irradiated TA muscles of three mdx-nude mice (2.53, 2.55). After three weeks, 
engrafted muscles were removed and disaggregated into single myofibres (2.21). 
Isolated myofibres were stained immunocytochemically for Pax7 and P-gal proteins 
(2.74) (Fig. 4.11). The undigested part of the engrafted TA muscle body was stained 
in X-gal solution (2.77).
After incubation in X-gal, 2/6 muscle bodies were found to have nuclear-localised P- 
gal activity (Fig. 4.10A). 4/6 single myofibre preparations were found to contain 
Pax7+ p-gal+ satellite cells, counts of which are shown in Table 4.4 and Fig. 4.12. 
Overall, 5/6 (83%) of engrafted muscles contained donor-derived cells identifiable 
either by X-gal staining of the undigested body, immunocytochemistry of isolated 
myofibres, or both (Table 4.4).
Counts of satellite cells for individual engrafted muscles were likely to have been 
subject to either positive or negative sample bias. Where satellite cells were formed 
on single myofibres located in the centre of the muscle, they were unlikely to have 
been isolated in single myofibre preparations. Conversely, where satellite cells were
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formed close to the periphery of the muscle, they were very likely to have been 
included in the sample. Of the six engrafted muscles, only one contained satellite 
cells identifiable by both X-gal staining of the muscle body and
immunocytochemistry of single myofibres. One muscle contained cells only 
identified by X-gal staining of the muscle body, and three contained satellite cells 
only identified by immunocytochemistry of isolated myofibres (Fig. 4.11). Although 
counts derived from individual muscles could therefore potentially be either over- or 
underestimates, data pooled from the total counts derived from all six muscles are 
likely to be representative of the overall trend (Table 4.4).
An estimated 0.47 x 103 Pax7+ P-gal+ satellite cells were formed per graft of 22 (3.42) 
soleus satellite cells (Table 4.4) (Fig. 4.12). The estimated frequency of satellite cell 
formation was therefore about 2000% of the original number of grafted cells. In 
contrast, grafts of Myf5E2 cells had an estimated frequency of satellite cell formation 
which was about 0.2% of the total grafted cells (4.23). In Chapter 3, it was shown 
that satellite cells in single myofibre grafts generate new muscle more efficiently than 
grafts of immortalised myoblasts (Table 3.6). Similarly, the results of the present 
experiment demonstrate that satellite cells in single myofibre grafts generate new 
satellite cells with much greater efficiency than immortalised myoblasts.
In previous experiments, 75% of soleus myofibre grafts were found to give rise to 
differentiated muscle (3.45), and the results of the present experiment demonstrate 
that 83% of grafts give rise to satellite cells by the same timepoint. This indicates that 
most grafts generate both differentiated muscle and satellite cells. Pax7+ p-gal+ 
satellite cells were observed on both large, mature myofibres, and more frequently, on 
small, centrally-nucleated myofibres that were probably still being augmented at the 
time of sampling (Fig. 4.11). Together, the empirical data and morphological 
observations strongly suggest that the cohort of satellite cells associated with each 
grafted single myofibre give rise to both new differentiated myofibres and new 
satellite cells concomitantly during the same regenerative event.
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Fig. 4.11. Single myofibres isolated from mdx-nude TA muscles engrafted with a 
single Myf5f'lacZJJt soleus myofibre. Immunocytochemistry for p-gal (A, D) and Pax7 (B, 
F) identifies donor-derived satellite cells (arrowed) which co-express Myf5-p-gal fusion 
protein and Pax7 (D, H). Myonuclei are identifiable by DAPI staining (C, G). Original 
magnification x400.
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m ouse 
1 (RL)
m ouse
1(LL)
m ouse 
2 (RL)
m ouse  
2 (LL)
m ouse  
3 (RL)
m ouse  
3 (LL)
total
X-gal staining of 
undigested m uscle 
body
no yes yes no no no 2/6
Total isolated  
myofibres
27 40 31 34 25 29 186
Total satellite cells 31 55 ND ND 50 70 ND
Pax7+ p-gal" 
satellite cells
26 35 ND ND 49 50 ND
Mean Pax7+ p-gal" 
satellite cells per 
myofibre
0.96
(±1.68)
0.88
(±1.24)
ND ND 1.96
(±1.97)
1.72
(±2.49)
ND
Pax7+ p-gal+ 
satellite cells
5 20 0 0 1 20 46
Mean Pax7+ p-gal+ 
satellite cells per 
myofibre
0.19
(±0.40)
0.50
(±1.30)
0 0 0.04
(±0.20)
0.69
(±1.23)
0.24 (SE 
±0.29)
Percentage of 
myofibres with £1 
p-gal+ satellite cells
18.5% 22.5% 0 0 4.0% 34.5% 13.3%
Percentage of 
p-gal* satellite cells  
in whole 
population
16.1% 36.4% 0 0 2.0% 28.6% 13.8%
Estimated total 
satellite cells  
formed per graft3
0.38 x 
103
1.00 x 
103
0D 0 0.08 x 
103
1.38 x 
103
0.47 x 
103
a Based on an assumption of 2 x 103 total myofibres per engrafted muscle. The mean number 
of graft-derived satellite cells per sampled myofibre multiplied by the total myofibres in the 
engrafted muscle. b No Pax7+ (3-gal+ satellite cells were identified in the isolated myofibre 
preparation, but the presence of (3-gal activity in the undigested part of the muscle strongly 
suggests that som e satellite cells had been formed.
Table 4.4. Expression of and Pax7 and (3-gal proteins in satellite cells associated with 
myofibres isolated from TA muscles engrafted with a single Myf&lLacZ/+ soleus myofibre. 
RL= right engrafted muscles. LL= contralateral left engrafted muscles. ND= not done.
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14%
□  Pax7(+) beta-gal (-) 
0  Pax7(+) beta-gal (+)
Fig. 4.12. Pie chart illustrating the contribution Myf{?iacZ+ soleus single myofibre grafts to the 
satellite cell compartm ent of irradiated mdx-nude TA muscles (n=6). Single myofibres 
isolated from engrafted muscles were immunostained for Pax7 and (3-gal proteins. Donor- 
derived satellite cells were identified by co-expression of Pax7 and Myf5-(3-gal fusion protein.
The results of these experiments demonstrate that the proliferative progeny of satellite 
cells in single myofibre grafts adopt divergent fates, such that a subset of cells form a 
reserve population which returns to the satellite cell niche, and thereby renews the 
compartment. The spontaneous formation of satellite cell-like Pax7+ reserve cells in 
post-differentiated cultures further suggests that satellite cells are generated in a pre­
programmed manner rather than solely in response to active recruitment by 
myofibres.
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4.4 Formation of MPC by single myofibre grafts
4.41 Aim
In previous experiments, adult EDL myofibre grafts were found to form muscle (3.43) 
and satellite cells (4.32) infrequently. This low frequency was thought to result, at 
least partly, from a physiological rather than technical factor, since grafts of soleus 
myofibres formed muscle with much higher frequency (3.44). The apparent 
proportional relationship between the number of satellite cells present in the graft and 
the frequency of muscle formation (the proportion of grafts which generated P-gal+ 
nuclei) implies that donor-derived muscle may have been of clonal or oligoclonal 
origin (Table 3.5). However, the data did not exclude the possibility that donor- 
derived products were generated as a result of the synchronous activation and 
expansion of entire myofibre-associated satellite cell populations.
The clonality of muscle regeneration and satellite cell formation from grafts of 
conditionally-immortalised H-21?-tsA58 MPC has previously been studied by 
labelling cultured cells with unique retroviral inserts (Cousins et al. 2004). However, 
since retroviruses are only incorporated by actively mitotic cells, this approach was 
hampered by the fact that less than 100% of cells in primary cultures were labelled 
(personal communication, J. Morgan). Since the most significantly-myogenic MPC 
are those which do not incorporate 3H-thymidine prior to grafting (Beauchamp et al. 
1999), this is a potentially significant limiting factor. In addition, the numerous 
unique insertion sites generated by infection of primary cultures were found to be 
difficult to resolve (Cousins et al. 2004). However, even with these caveats, the data 
generated by Couisins et al. (2004) demonstrated that muscle formation by grafted 
primary myoblasts was oligoclonal, rather than toticlonal. The original aim of the 
present experiment was to investigate the clonality of MPC formation by satellite cells 
in single myofibre grafts.
4.42 Experiment plan
The original plan was to infect the quiescent satellite cells in single myofibre 
preparations with a lentiviral vector containing a GFP gene (GFP lentivirus) (2.34), 
thereby labelling each satellite cell with a unique pattern of viral insertion sites. 
Labelled single myofibres would then be grafted into mouse muscles according to the
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usual protocol. MPC derived from the graft would subsequently be isolated by 
enzymatic disaggregation and expanded in tissue culture. The clonality of these 
graft-derived cells would be analysed by identifying the number of unique viral 
insertion sites using linear amplification-mediated PCR (LAM-PCR). If cultures 
contained more than one insertion site, further analysis of the population would be 
carried out by generating several subclones. The single myofibre grafts would be 
derived from the H-2¥^~tsA58 immortomouse (2.16) to facilitate expansion of graft- 
derived cells after subsequent in vitro conditional immortalisation. The experimental 
plan is shown in Fig 4.13.
Problems were encountered which prevented the whole of the experimental plan from 
being carried out. The LAM-PCR protocol was developed by Schmidt et al. (2002) 
for clonal analysis of retrovirally-labelled HSC engraftment in primates, where it was 
found to be a highly-sensitive technique which allowed identification of up to 80 
clones within a population. Briefly, the technique involves linear amplification of 
target DNA with solid-phase second-strand synthesis, followed by ligation of an 
oligonucleotide cassette and then nested exponential PCR. Other workers within the 
laboratory were involved in a project which aimed to develop the LAM-PCR 
technique such that it could be used to analyse the clonality of cells derived from 
grafts of GFP lentivirus-infected myoblasts. Unfortunately, the project found that 
LAM-PCR produces inconsistent and unreliable results when applied to this type of 
experiment. Consequently, in the present experiment LAM-PCR could not be used to 
perform clonal analysis as was originally planned. However, without clonal analysis, 
the preliminary data were found to present some interesting features.
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H-2Kb-tsA58 donor
lG i hii
i
H LAM-PCR to
► identify unique 
insertion sites
Fig. 4.13. Strategy for investigating the clonality of MPC formation by grafted satellite 
cells. Single myofibres isolated from EDL muscles of H-2Kb-tsA58 donor mouse (A). 
Lentiviral infection of freshly-isolated myofibres (B). Culture of infected single 
myofibres (C) and expansion of satellite-derived cells under permissive conditions (D) 
Grafting of infected single myofibres into host TA muscles (E). Isolation of cells from 
engrafted muscles (F) and expansion and selection under permissive conditions (G). 
Use of LAM-PCR to identify number of unique insertion sites in in vivo and in vitro 
selected cells (H).
4.43 Grafts of GFP lentivirus-labelled H -21^-tsA58 single myofibres
Single myofibres were prepared from the EDL muscles of a male 112-day-old 
tsA58 mouse (2.21) and labelled with GFP lentivirus (2.33, 2.34). A single labelled 
myofibre was grafted into each of the pre-irradiated TA muscles of seven mdbc-nude 
mice (2.53,2.55).
In addition, labelled myofibres from the same population were either fixed 
immediately after isolation, or maintained as suspension cultures in plating medium 
for 48 h, and then fixed. Immunocytochemistry of these myofibres for Pax7 and GFP 
showed that whilst at T:0 there was, as expected, no GFP expression, by T:48 both 
the myofibre and associated proliferating satellite cells contained cytoplasmic GFP 
protein (Fig. 4.14). This showed that the lentivirus had successfully integrated into at 
least a proportion of myonuclei and most satellite cell nuclei.
Some labelled myofibres were also maintained as adherent cultures (2.21). After 
three days, microscopic examination of cultures showed that satellite cells had 
emanated from myofibres and started to proliferate. Both the single myofibres and 
satellite cell progeny expressed cytoplasmic GFP. Single myofibres were removed 
from cultures. Cells were transferred to conditions permissive for tsA58 expression to 
induce conditional immortalisation (2.23). Six single myofibre-derived cultures were 
expanded, and aliquots preserved under liquid nitrogen. These populations were 
intended as controls to allow the numbers of clones generated by in vitro expansion to 
be compared with the numbers of clones generated by in vivo followed by in vitro 
expansion.
Single myofibre-engrafted muscles were removed after three weeks. Each muscle 
was individually disaggregated to obtain cell suspensions as previously described
(2.22). To maximise the chances of obtaining graft-derived cells, the protocol was
modified such that all three fractions were pooled and the suspension was not sieved.
— — • 1The cells derived from each muscle were cultured separately in small (75 cm ) flasks.
By 72 h, some cells had adhered to the matrigel substrate, though no obvious
proliferation had occurred. Cultures were then transferred to conditions permissible
for tsA58 antigen expression, thereby inducing conditional immortalisation of graft-
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derived cells (2.23). Cells were cultured for a further two weeks with medium changes 
at 72 h intervals. During this period, most cells appeared to die and detach from the 
substrate. This was as expected since most cells derived from the host would be 
rendered replication-incompetent after irradiation. However, after the first few days, 
clones of cells arose which had a healthy appearance and proliferated steadily. 
Aliquots of cells were seeded in chamber slides and cultured overnight before fixation 
and separate immunocytochemical stains desmin and T antigen (2.74). The numbers 
of cells found to express desmin and T antigen are shown in Table 4.5.
10/14 (71.4%) of cultures derived from engrafted muscles contained significant 
numbers (50-100%) of cells that expressed tsA58 antigen, a marker of donor origin 
(Fig. 4.15). Most cells in these cultures also expressed desmin (Table 4.5, Fig. 4.15).
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Fig. 4.14. Single myofibres infected with GFP lentivirus at T:0 (A-D) and T:48 (E-H) 
timepoints. Immunocytochemistry for Pax7 and GFP. At T:0, a the nucleus of a satellite 
cell is identifiable by Pax7 expression (arrows) but GFP is not expressed. By T:48, GFP 
is expressed in both the myofibre and clusters of proliferating Pax7+ satellite cells 
(arrows). Original magnification x400.
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Fig. 4.15. Immunocytochemical detection of tsA58 antigen, a marker of donor origin 
(A-C), desmin, a marker of the myogenic lineage (D-F), and cytoplasmic GFP, a 
marker of successful lentiviral integration (G-l) in cells obtained by enzymatic 
disaggregation of muscles engrafted with a single H-2Kb-tsA58 EDL myofibre infected 
with GFP lentivirus. Original magnification x400 (A-C, G-l) or x200 (D-F).
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Primary culture from 
engrafted m uscle
tsA58 antigen+ (% of cells) Desm in+ (% of ce lls)
1A 89.3 100
1B ND ND
2A 87.3 79.8
2B 100 96.3
3A 90.1 97.0
3B 2.1 50 .0
4A 95.6 100
4B 87.8 90.9
5A 0 9 7
SB 0 92.1
6A 90.8 89.9
6B 50.0 66.7
7A 69.0 98.9
7B 85.2 92.6
Table 4.5. Expression of desmin and tsA58 antigen in primary cultures derived from  muscles 
engrafted with H-2K?-tsA58 EDL myofibres infected with GFP-lentivirus. Fluorescence 
imm unocytochem istry for each antigen was carried out on separate aliquots of P1 cells. 
Cultures in grey italics were discarded as they contained few or no donor-derived (tsA58 
antigen+) cells. ND= not done, due to absence of surviving cells.
Some cultures contained a relatively high frequency of desmin+ cells but no T antigen 
expression (Table 4.5). These cells were presumptively derived from host radiation- 
resistant cells (Heslop et al. 2000). Aliquots of cells from some cultures (at P2) were 
subsequently stained with an antibody against GFP. GFP protein was detected in 
most cells (Fig 4.15), showing that the foreign gene was expressed by cells that were 
proliferation-competent and had been expanded in vitro.
The presence of tsA58+ satellite cell-derived myoblasts in 10/14 (71.43%) cultures 
demonstrated that all of the corresponding single myofibre grafts had generated 
proliferation-competent progeny in engrafted muscles. This is surprising in light of 
the results of previous experiments in which only 20% of EDL myofibre grafts 
generated satellite cells (4.33) and 32% of grafts generated differentiated muscle 
(3.43). The extent to which proliferation occurred in vivo was not known, but it is
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unlikely that the enzymatic disaggregation protocol would have been efficient enough 
to yield viable graft-derived cells if no proliferation had occurred.
The difference in frequency could be explained by the fact that in this experiment, 
single myofibres were incubated in lentiviral medium (containing 10% HS and 0.5% 
CEE) for 2 h prior to grafting. In a preliminary experiment, it was found that 
lentiviral integration did not occur in the absence of serum (data not shown). In all 
other experiments single myofibres were not exposed to serum and were grafted 
immediately after isolation. Exposure to serum may have activated previously 
quiescent satellite cells (Zammit et al. 2002), thereby causing them to enter an active 
myogenic program before insertion into the host muscle. Alternatively, some single 
myofibre grafts may generate proliferative progeny which do not differentiate into 
muscle and do not enter the satellite cell compartment. This suggests that in 
previously-described experiments (3.43, 4.43) some engrafted muscles either 
contained persistently quiescent graft-derived satellite cells, or alternatively, graft- 
derived proliferative phenotypes which were not identifiable by expression of Myf5- 
p-gal fusion protein.
The results of this experiment showed that the majority of EDL single myofibre grafts 
harbour satellite cells capable of generating significant numbers of MPC which are 
capable of extensive proliferation after subsequent re-isolation and conditional 
immortalisation in vitro. In addition, the finding that within single myofibre 
preparations, satellite cells can be isolated, infected at high frequency with a foreign 
gene, be grafted into a new muscle within a few hours of isolation, and subsequently 
both express the foreign gene and remain proliferation-competent, suggests that an 
efficient ex vivo gene therapy protocol could be designed around the single myofibre 
grafting technique.
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4.5 The contribution of Pax3-GFP+ cells to satellite cells
4.51 Aim
This experiment formed part of a larger collaborative study carried out by Dr. D. 
Montarras and Dr. J.E. Morgan.
The paired box transcription factor Pax3 is a critical regulator of embryonic muscle 
development (Williams & Ordahl 1994, Tajbakhsh et al. 1997). In adult mice, Pax3 
expression is retained by a subset of satellite cells which occur frequently in the 
gracilis, diaphragm and certain forelimb muscles, but infrequently elsewhere 
(personal communication, D. Montarras). In the Pax3GFP/+ mouse (2.15), cytoplasmic 
GFP expression reports expression of the Pax3 gene. Recent work carried out by Dr. 
D. Montarras and Dr. J.E. Morgan has shown that GFP+ cells sorted from Pax3GFP/+ 
diaphragms are highly myogenic in vivo. Grafts of 2 x 104 freshly-isolated cells were 
found to generate 587 (±330) dystrophin+ myofibres in irradiated radjc-nude TA 
muscles (personal communication, J. Morgan). Pax3-GFP+ cells retain their 
phenotype after proliferation in vitro, suggesting that they may represent a distinct 
lineage of muscle precursors (personal communication, D. Montarass).
The objective of the present experiment was to investigate the ability of Pax3-GFP- 
sorted cells to both generate satellite cells and retain the Pax3-GFP+ phenotype.
4.52 Identification of satellite cells derived from grafts of Pax3+ cells
All cell isolation and sorting was carried out by Dr. D. Montarras on the day of 
grafting. 2 x 104 Pax3-GFP+ diaphragm-derived cells were grafted into the right pre­
irradiated TA muscles of two mdx-nude host mice (2.53, 2.54). Relatively small 
numbers of cells were used because of the difficulty in obtaining larger numbers. 
After three weeks, engrafted muscles were removed and enzymatically disaggregated 
to obtain single myofibres (2.21). Fluorescence immunohistochemistry using 
antibodies against GFP and Pax7 was carried out on isolated myofibres (2.75). 
Localisation of nuclear Pax7 protein marked satellite cells of both host and donor 
origin. Localisation of cytoplasmic GFP marked expression of nuclear Pax3 protein
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in donor-derived satellite cells (Fig. 4.16). The numbers of satellite cells expressing 
Pax7 and/ or GFP were counted and are shown in Table 4.6 and Fig. 4.17.
0.92 (SE ±0.09) Pax3-GFP+ satellite cells were counted per myofibre. Assuming that 
the engrafted muscle contained 2 x 103 total myofibres, a mean of 1.79 x 103 satellite 
cells were therefore derived from each graft of 2 x 104 cells, a frequency of 9.0% 
(Table 4.6). The majority (94.4%) of the total 107 donor-derived satellite cells co­
expressed Pax7 (Table 4.6, Figs. 4.16 & 4.17). The robust expression of GFP by the 
donor-derived satellite cells identified in this study (Fig. 4.16) shows that the Pax3+ 
phenotype can be retained in a host environment where endogenous Pax3+ cells are 
infrequent, and that it is not dependent on component of the niche from which the 
cells were isolated. Since it was not known whether GFP expression persisted in all 
donor-derived satellite cells, or just a subset, GFP' Pax7+ satellite cells may have been 
of either host or donor origin. The number of Pax7+ satellite cells which did not 
express a marker of donor origin was, at 3.84 (SE ±2.07) per myofibre, at least double 
that seen in previous comparable experiments (4.22, 4.33), and was greater than 
would be expected if 18 Gy irradiation reduced numbers to 20% of their normal value, 
as has been previously reported (LaBarge & Blau 2002).
This finding suggests the possibility that in the present experiment, the number of 
Pax7+ satellite cells was additionally augmented by donor-derived cells which did not 
express Pax3-GFP. However, it has been demonstrated that GFP-Pax3 cells retain 
their phenotype throughout prolonged tissue culture and until commitment to 
differentiation, strongly implying that Pax3+ Pax7+ MPC are lineage-distinct from 
Pax3' Pax7+ MPC (personal communication, D. Montarras). In addition, the large 
count of Pax3‘ Pax7+ satellite cells is mainly attributable to data derived from only 
one of the host animals, mouse 2 (Table 4.6). Therefore, although data generated by 
the present experiment do not exclude the possibility that Pax3+ Pax7+ cells are the 
earlier precursors of Pax3' Pax7+ satellite cells, inter-animal variability is a more 
likely explanation for the discrepancy.
187
Fig. 4.16. Single myofibres isolated from an mdx-nude TA muscle engrafted with 2 x 
104 Pax3-GFP+ cells sorted from the diaphragms of Pax3PFP/+ mice. Donor-derived 
satellite cells (arrowed) identified by expression of cytoplasmic GFP (A, D) and nuclear 
Pax7 (B, F). Counterstained with DAPI (C, G). Original magnification x100 (A-D) or 
x400 (E-H).
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m ouse 1 m ouse 2 total
Total myofibres 57 63 120
Total satellite cells 188 381 569
Pax7+ GFP' 
satellite cells
133 329 462
Mean Pax7+ GFP' 
satellite cells per myofibre
2.38 (±3.19) 5.31 (±5.21) 3.84 (SE ±2.07)
Pax7+ GFP+ 
satellite cells
53 48 101
Pax7' GFP+ 
satellite cells
2 4 6
Total GFP+ 
satellite cells
55 52 107
Mean GFP+
satellite cells per myofibre
0.98 (±3.70) 0.86 (±2.30) 0.92 (SE ±0.09)
Percentage of myofibres with >1 
GFP+ satellite cells
14.0% 27.0% 20.5%
Percentage of GFP+ satellite cells 
in whole population
29.3% 13.7% 18.8%
Estimated total satellite cells 
formed per graft8
1.93 x 10a 1.65 x 10a 1.79 x 1 0 a
a Based on an assumption of 2 x 103 total myofibres per engrafted muscle. The mean number 
of graft-derived satellite cells per sampled myofibre multiplied by the total myofibres in the 
engrafted muscle.
Table 4.6. Expression of cytoplasmic GFP and nuclear Pax7 proteins in satellite cells 
associated with myofibres isolated from two TA muscles engrafted with GFP-Pax3+ cells.
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1%
□ Pax7 (+) GFP(-) 
m Pax7(+) GFP(+) 
■  Pax7(-) GFP(+)
Fig. 4.17. Pie chart illustrating the contribution Pax3-GFP+ cell grafts to the satellite cell 
com partm ent of irradiated mdx-nude TA muscles (n=2). Alm ost all endogenous satellite cells 
express Pax7 (Zammit e t al. 2004a). Single myofibres isolated from muscles engrafted with 
GFP-sorted cells were immunostained for Pax7 and GFP proteins. Pax7+ GFP' cells could 
have been entirely host-derived, or may have included donor-derived cells which had ceased 
to express Pax3-GFP protein. GFP+ satellite cells are unequivocally donor-derived; most co­
expressed Pax7 protein but a small subset did not.
The results of this experiment demonstrate that firstly, Pax3+ cells are capable of 
generating satellite cells, and secondly, that the Pax3-GFP+ phenotype is retained by 
cells that have acquired the satellite cell position. This suggests that Pax3+ myogenic 
cells form a separate lineage that is capable of maintaining its own population in a 
stem cell-like manner.
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4.6 Comments on results
The experiments described in the chapter demonstrate that a conditionally- 
immortalised clonal cell line (4.2), primary isolated myoblasts (4.5) and myofibre- 
associated satellite cells (4.3) can generate new anatomically- and phenotypically- 
defined satellite cells after grafting. The data suggest that the ability to enter the 
satellite cell compartment and maintain or acquire expression of appropriate marker 
proteins is a quality common to myogenic phenotypes.
A previous study showed that the percentage of cells which survive in both 
conditionally-immortalised and primary myoblast grafts is about 2% (Beauchamp et 
al. 1999). Whilst Myf5E2 cells formed muscle reasonably efficiently (for an H-2j£- 
tsA58 cell line), at 495 (±194) dystrophin+ myofibres per graft, the absolute number 
of donor-derived satellite cells generated in contralateral engrafted muscles was 
equivalent to no more than 0.2% of the total grafted population (4.22). These data 
therefore imply that the number of subclones which generate satellite cells is smaller 
than the number of subclones that generate differentiated muscle. The very large 
numbers of cells in the original graft made it impossible to determine whether the 
subclones which generated satellite cells had previously undergone proliferation and 
also generated muscle. A study which employed retroviral labelling as a means of 
studying the clonality of regeneration derived from myoblast grafts failed to find a 
correlation between clones that were significantly myogenic and those which 
generated satellite cells (Cousins et al. 2004). This presents the possibility that in 
grafts of Myf5E2 cells, satellite cells may have been formed from subclones which 
were stochastically recruited into a sub-laminal position, irrespective of their in vivo 
proliferative or myogenic potential. Hence though these data demonstrate that a 
satellite cell can generate a cell line capable of giving rise to anatomically- and 
phenotypically-defined satellite cells (Fig. 4.5), the formation of satellite cells under 
the experimental conditions described was not considered to be an unequivocal 
demonstration of self-renewal.
It has been shown previously that in vitro, Pax3-GFP expression is maintained by 
proliferating cells until commitment to differentiation, a finding which implies that 
Pax3+ cells are a distinct lineage rather than a transitory phenotype, or the more
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primitive precursor of Pax3* Pax7+ satellite cells (personal communication, D. 
Montarras). The data described in this thesis further show that proliferating Pax3+ 
cells can withdraw from the cycle without committing to differentiation and without 
adopting the more frequent Pax3' Pax7+ satellite cell phenotype.
Grafts of 2 x 104 Pax3-GFP+ cells form comparable amounts of muscle to grafts of 5 x 
105 Myf5E2 cells, and therefore do so with much greater efficiency. Whereas the 
absolute number of satellite cells generated from grafts of Myf5E2 cells was 
equivalent to only about 0.2% of the original population (4.22), grafts of Pax3-GFP+ 
cells were found to generate absolute numbers of satellite cells equivalent to 9.0% of 
the original population (4.52). Since only about 2% of cells are thought to survive 
grafting (Beauchamp et al. 1999), these data imply that at least a proportion of the 
clones which generated satellite cells had previously undergone proliferation, and 
probably participated in myogenesis. It is conceivable that the unusually high 
myogenic potential of Pax3-GFP cells+ (personal communication, J. Morgan) could 
be traced to improved survival in comparison to the cells examined by other studies 
(Beauchamp et al. 1999, Cousins et al. 2004). However, even if 100% survival is 
assumed, the number of nuclei required to generate several hundred myofibres and 
numerous satellite cells greatly exceeds the number of nuclei originally present in the 
graft, making proliferation a necessity. The results of this experiment therefore 
strongly imply that satellite cells were generated as part of a mechanism whereby a 
reserve population was actively maintained.
The derivation of Pax3-GFP+ cells from minced tissue prevented their origin from 
being defined unequivocally. Using a different gene-targeted mouse with a LacZ 
reporter, Pax3+ cells have been identified in the satellite cell position (Buckingham et 
al. 2003). However, it is not known whether the satellite cell compartment harbours 
the entire adult component of Pax3+ cells, or whether others exist outside the basal 
lamina. Therefore these data cannot be considered as a demonstration of satellite cell 
self-renewal. Notwithstanding, they strongly suggest that Pax3+ muscle-derived cells 
are a separate lineage which is capable of maintaining its own population during 
regenerative events.
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Grafts of isolated single myofibres were used to examine the potential of defined 
satellite cells to generate new defined satellite cells (4.3). A proportion of grafts 
derived from EDL, soleus and TA muscles generated satellite cells identifiable by 
their discrete nuclear expression of Myf5-P-gal fusion protein. In addition, satellite 
cells derived from soleus myofibre were identified by immunocytochemistry for Pax7 
and p-gal proteins. The progeny of grafts were also found to also contribute to newly­
regenerated Myf5-P-gal+ myonuclei (Fig. 4.9). Satellite cells therefore became 
activated, proliferated to generate a larger pool of cells, and subsequently adopted 
divergent fates, either committing to differentiation or remaining mononucleate and 
becoming recruited into the satellite cell compartment. This finding formally 
demonstrates firstly, that the adult satellite cell compartment actively maintains itself 
by self-renewal, and secondly, that the satellite cells associated with one myofibre can 
generate progeny which contribute to the satellite cell populations of other myofibres, 
sometimes large numbers of other myofibres.
In vitro, all EDL single myofibres gave rise to progeny that were capable of both 
generating differentiated myotubes and maintaining a reserve population of 
undifferentiated satellite cell-like progeny (4.31). In principle, this implies that all 
EDL single myofibres should have the ability to generate satellite cells after grafting; 
in practice, only 20% (2/10) were found to do so. On exposure to serum-rich 
medium, the vast majority of satellite cells rapidly become activated (Zammit et al. 
2002, 2003a) and in adherent myofibre cultures, many (or perhaps all) satellite cells 
subsequently proliferate (Rosenblatt et al. 1995, Zammit et al. 2002). This factor may 
explain the observed difference between the proportion of single myofibre grafts 
which generated MPC after exposure to serum (71.4%) (4.4) and the proportion of 
single myofibre grafts which generated satellite cells without exposure to serum 
(20%) (4.31).
In differentiated cultures, Pax7+ mononucleate cells formed 12.5% of the total nuclei 
(Fig. 4.8). Satellite cells form 2.79% of the total myofibre nuclei in single myofibre 
preparations (Zammit et al. 2002), less than a fifth of this value. The large counts of 
Pax7+ cells could either have been a tissue culture artefact, or could suggest that in 
vivo, not all reserve cells are destined to enter the satellite cell compartment. In a 
previously described experiment, the numbers of desmin+ cells obtained by enzymatic
193
disaggregation of EDL and soleus muscles was greater than the maximum number of 
satellite cells that could have been present in the preparation (Table 3.1). 
Speculatively, satellite cells may generate both new satellite cells, and other MPC 
which are outside the compartment at any given timepoint. The ability of satellite 
cell-like Pax7+ reserve cells to form outside the satellite cell niche in differentiating 
cultures suggests that reserve MPC may be actively generated prior to satellite cell 
formation, thus constituting the earlier precursors of anatomically-defined satellite 
cells. Alternatively, trafficking between satellite cells and non-satellite cell MPC 
might occur, whereby the two populations exist in a state of dynamic equilibrium.
In summary, the results of the experiments described in this chapter demonstrate that 
the adult satellite cell compartment maintains itself by a physiological process of self­
renewal, whereby proliferative satellite cell progeny actively generate a reserve 
population of which some cells subsequently return to the satellite cell niche.
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Chapter 5 
The response of satellite cells to damage
5.1 Background and aim of study
5.11 Background to work
The function of stem cells is dependent on their characteristic ability to respond to the 
increased demands induced by damage, by upregulating proliferative activity and 
giving rise to differentiation-committed progeny that subsequently restore tissue 
integrity. When HSC are introduced into the circulatory system of a lethally- 
irradiated mouse, they respond by undergoing rapid clonal expansion to generate 
sufficient progeny to reconstitute the lymphohaematopoietic system and thus maintain 
viability (Till & McCulloch 1961, Smith et al. 1991, Osawa et ah 1996). After 
skeletal muscle tissue is severely injured by mincing (Studitsky 1964, Carlson 1970) 
or injection of myotoxins (Sadeh et al. 1985, Schultz & Jaryszak 1985, Heslop et al. 
2000, Luz et al. 2002, reviewed Harris 2003), it rapidly regenerates. Histological 
analysis of myotoxin-damaged whole muscles has suggested that proliferative 
myoblasts rapidly congregate at the focus of injury, strongly implicating them as the 
subsequent regenerative source (Klein-Ogus & Harris 1983). However, isolated 
myoblasts have only a limited ability to contribute to myotoxin-induced regeneration, 
after grafting into a new host muscle (Gross & Morgan 1999). Similarly, though 
grafted bone marrow-derived cells can regenerate skeletal muscle following myotoxin 
injury, their contribution is very low, and regenerated myofibres are distributed 
diffusely in the host muscle (Camargo et al. 2003, Corbel et al. 2003), providing little 
evidence of organised clonal expansion. Therefore although the regenerative 
behaviour of whole muscles strongly suggests the existence of a stem cell-like 
phenotype, the implied functional potential has not been localised to any adult cell 
isolate of either muscle or non-muscle origin.
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5.12 Aims of work
Previous observations (see Chapter 4) showed that a proportion of single myofibre 
grafts give rise to satellite cells, and, under different experimental conditions, the 
majority of EDL myofibres grafts give rise to MPC that are subsequently 
proliferation-competent in vitro. The work described in this chapter aimed to 
investigate the response of such graft-derived cells to subsequent muscle damage. A 
notexin-induced injury model was used to investigate the ability of satellite cells and 
their progeny to respond to severe acute damage of the irradiated or non-irradiated 
graft site. In vitro experiments were used to investigate the response of satellite cells 
to damage in the absence of other components of the regenerative milieu.
5.13 Note on identification of regenerate graft products
To investigate the response of satellite cells to damage, myofibre grafts were derived 
from the muscles of Myf5nLacZ/+ mice, which express Myf5-p-gal fusion protein in the 
nuclei of satellite cells and newly-regenerated myofibres (Tajbakhsh et al. 1996a, 
Beauchamp et al. 2000) (2,14). Single myofibre-engrafted muscles were damaged by 
injection of the potent myotoxin, notexin (reviewed, Harris 2003). Newly-regenerated 
myofibres were identified both morphologically, by their small size and central 
nucleation (Coulton et al. 1988, Gross & Morgan 1999), and phenotypically, by the 
expression of neonatal myosin (Gross & Morgan 1999, Heslop et al. 2000) and 
myonuclear Myf5-P-gal fusion protein (Tajbakhsh et al. 1996a, Beauchamp et al. 
2000, Zammit et al. 2004b).
In wild-type mice, neonatal myosin is expressed by a large proportion of myofibres in 
soleus, EDL, and gastrocnemius muscles during the early neonatal period of muscle 
maturation, but is lost by 21 days of age (Agbulut et al. 2003). Whilst neonatal 
myosin is not present in the TA muscles of wild-type mice between aged 35-168 days, 
mdx TA muscles have been found to contain some neonatal myosin+ myofibres when 
examined at 42 days of age or 49 days of age, even after previous exposure to 18 Gy 
irradiation (Heslop et al. 2000). Expression of neonatal myosin in adult muscle is 
induced by experimental manipulations such as injection of myotoxic agents (Gross & 
Morgan 1999, Heslop et al. 2000) or whole muscle grafting (Yoshimura et al. 1998b 
and remains strong for at least 7-10 days after injury (Gross & Morgan 1999).
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Neonatal myosin is also found in mature myofibres that are inadequately innervated 
(Yoshimura et al. 1998a, 1998b). Similarly, Myf5-P~gal fusion protein is re­
expressed by fast-fibre myonuclei in response to denervation both in vivo (Zammit et 
a l  2004b) and in vitro in isolated single myofibres (Zammit et al. 2002). However, 
newly-regenerated myofibres are distinguishable from mature non-innervated (or 
developmentally aberrant) myofibres by their small size and central nucleation (Gross 
& Morgan 1999).
5.2 The response of grafted satellite cells to damage
5.21 Aim
The objective of these experiments was to investigate whether cells derived from 
single myofibre grafts have the ability to upregulate myogenic activity in response to 
subsequent severe acute damage of the engrafted muscle.
5.22 The effect of notexin on control Myf5nLacZ/+ muscles
As a control experiment, the effect of notexin on adult Myf5nLacZ/+ muscles was 
examined.
Both TA muscles of two 90-day-old male Myf5nLacZ/+ mice were damaged by injection 
of notexin (2.56). One mouse was sacrificed 24 h post-injection and the second 
mouse 7 d post-injection, and the damaged muscles harvested. The TA muscles of a 
third mouse functioned as non-damaged controls. Muscles were processed for 
immunohistochemistry (2.61) and four 7 pm serial sections collected at 100 pm 
intervals at four levels in each muscle (2.62). The first set of sections was stained in 
X-gal, (2.77), in the second set, fluorescence immunohistochemistry was used to 
detect expression of membrane-localised dystrophin and cytoplasmic neonatal myosin 
proteins (2.76), and the third set was stained with H & E (2.78). In non-damaged 
control muscles (Fig 5.1), only occasional nuclei expressing Myf5-P-gal fusion 
protein were seen, which were presumably those of satellite cells. As expected, all 
myofibres expressed dystrophin protein. Some myofibres were weakly stained by the 
neonatal myosin antibody. This may have been an artefact attributable to myofibre- 
specific endogenous autofluoresence (Jackson et al. 2004), or could have been due to
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the recognised weak cross-reactivity of the BF34 antibody (Table 2.1) with slow 
myosin (Borrione et al. 1988). H & E stained control sections contained large, 
peripherally-nucleated myofibres. 24 h after notexin injection (Fig. 5.1), increased 
numbers of p-gal+ nuclei were observed in sections, probably due to myonuclear re­
activation of Myf5-p-gal fusion protein (Zammit et al. 2002, 2004b). Dystrophin 
expression was weak or absent, as expected since structural proteins are reportedly 
degraded with 9 h of exposure to notexin (Harris et al. 2003). Some damaged 
myofibres appeared to stain positively for neonatal myosin, but the high potential for 
background in these acutely necrotic and disorganised muscles makes this observation 
unreliable. In H & E stained sections, the disorganisation of muscle tissue 24 h post- 
notexin injection was particularly apparent. Most myofibres had completely 
disintegrated, whilst others had become swollen, suggesting a lack of membrane 
integrity. An area of about 1/5 of the muscle appeared to escape injury in each case. 
In muscles removed 7 d after notexin injection (Fig. 5.1), the tissue had regenerated 
efficiently after injury. Some myofibres at the edge of muscles had escaped notexin 
damage, and were identifiable by their large size, peripheral nucleation and lack of 
expression of neonatal myosin or Myf5-P~gal fusion protein. Newly-regenerated 
myofibres were identifiable by their small size, central nucleation, and robust 
expression of neonatal myosin and Myf5-p-gal fusion protein. 7 d post-notexin 
injury, dystrophin expression was also restored, in agreement with the findings of a 
previous study (Gross & Morgan 1999).
In mdx-nude TA muscles engrafted with Myf5nLacZ/+ single myofibres and 
subsequently damaged, there were two potential phenotypic markers of donor origin, 
P-gal and dystrophin. Within areas of grafted-derived muscle, recently regenerated 
myofibres could be identified by expression of myonuclear P-gal and cytoplasmic 
neonatal myosin proteins, and also by their small size and central nucleation.
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Fig. 5.1. Regeneration of Myf5niacZ/+ TA muscles following notexin-induced injury. 
Serial sections: stained with X-gal (A, D, G), fluorescence immunohistochemistry for 
dystrophin and neonatal myosin (B, E, H), and stained with H & E (C, F ,l). In a control 
muscle (A-C) Myf5-p-gal fusion protein is restricted to satellite cells (A), dystrophin 
expression is strong and neonatal myosin expression weak (B) and myofibres are 
large and peripherally nucleated (C). 24 h post-injury (D-F) p-gal+ nuclei are more 
frequent (D), the tissue has becom e necrotic and disorganised (E, F) and dystrophin 
protein has been degraded (E). Apparent expression of neonatal myosin (E) may be 
artefactual. 7 d post-injury (G-l) efficient regeneration has occurred, and dystrophin 
protein is restored (H). Myofibres which survived injury are identifiable by their lack of 
p-gal activity (G) or neonatal myosin (H), and by their large size and peripheral 
nucleation (I). Newly-regenerated myofibres are identifiable by their expression of 
neonatal myosin (H) myonuclear Myf5-p-gal fusion protein (G) and by their small size  
and central nucleation (I). Original magnification x100.
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5.23 The effect of notexin on Myf5nLacZ/+ EDL single myofibre grafts
Single myofibres were isolated from the EDL muscles of a 42-day-old Myf5nLacZ/+ 
mouse and prepared for grafting as previously described (2.21, 3.42). Grafts were 
inserted (2.55, 3.42) into the pre-irradiated (2.53) TA muscles (n=34) of 17 radx-nude 
host mice. Four weeks after grafting, 12/17 mice were re-anaesthetised (2.51) and 
muscle damage induced to bilateral engrafted TA muscles by injection of 10 pi 
notexin (2.56). The 10 engrafted muscles of the remaining 5/17 mice served as non­
damaged controls. Engrafted TA muscles were removed 5 weeks after grafting and 1 
week after notexin damage, and processed for immunohistochemistry (2.61). Four 
serial sections were collected at 100 pm intervals throughout the entire muscle body 
(2.62). The first set of slides were stained in X-gal (2.77). In muscles with detectable 
P-gal activity, in the second set of slides fluorescence immunohistochemistry was 
used to detect expression of dystrophin and neonatal myosin proteins (2.76), and the 
third set stained with H & E (2.78). The maximum numbers of total dystrophin+ 
myofibres, dystrophin+ neonatal myosin+ myofibres, and p-gal+ nuclei were counted 
in single serial sections for each muscle. In these experiments, counts were made of 
the total numbers of p-gal+ nuclei, rather than the total numbers of myofibres 
containing P-gal+ nuclei. Counts of P-gal+ nuclei therefore included both myonuclei, 
and presumptive satellite cells and MPC outside myofibres.
18/24 (75%) of engrafted muscles damaged with notexin, and 4/10 (40%) of 
undamaged engrafted control muscles contained both p-gal activity and dystrophin 
expression.
In the 4 successfully-engrafted undamaged control muscles, there were 114.0 (±57.1) 
dystrophin+ myofibres of which 2.3 (±2.2) co-expressed neonatal myosin, and 5.0 
(±4.7) nuclei expressing Myf5-P-gal fusion protein, positioned on the periphery of 
dystrophin+ myofibres. Their location and low frequency, combined with the lack of 
neonatal myosin expression and morphological markers of regeneration, suggests that 
these cells may have been satellite cells (Figs. 5.2 & 5.3).
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Fig. 5.2. Regeneration of mdx-nude TA muscles 5 weeks after engraftment with a 
single Myf5PLacZ/+ EDL myofibre, and 1 week after notexin-induced damage. Serial 
sections: stained with X-gal (A, D), immunohistochemistry for dystrophin and 
neonatal myosin (B, H), and stained with H & E (C, F). In an undamaged control 
muscle (A-C), only a few, peripheral p-gal+ (possibly satellite cell) nuclei are localised 
(A) (arrows). Dystrophin+ myofibres are neonatal myosin- (B) and central nucleation is 
not pronounced. In notexin-damaged muscles (D-F), recently-regenerated myofibres 
of donor origin are identifiable by co-expression of myonuclear p-gal (D) and 
dystrophin and neonatal myosin (E), and by their small size and central nucleation (F). 
Original magnification x100.
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Fig. 5.3. H istogram showing muscle formation by individual M yf&LacZ/+ EDL single myofibres 5 
weeks after grafting. Ranked in order of the number of dystrophin+ myofibres. 4/10 (40%) of 
engrafted muscles contained p-gal activity and dystrophin* myofibres. Very few  dystrophin+ 
m yofibres co-expressed neonatal myosin, a m arker of recent regeneration. Associated with 
each group of dystrophin+ myofibres were occasional peripheral nuclei expressing Myf5-P-gal 
fusion protein. Their small numbers, the low level of neonatal myosin expression and the lack 
of morphological markers of recent regeneration (Fig. 5.2) suggest that these nuclei may 
have been those of satellite cells. Engrafted muscles with no detectable p-gal activity were 
not stained for dystrophin or neonatal myosin.
In the 18 successfully-engrafted notexin-damaged muscles, there were 70.0 (±40.0) 
dystrophin+ myofibres of which 60.3 (±40.1) strongly co-expressed neonatal myosin, 
and 30.0 (±21.7) P-gal nuclei, many of them located in the centre of dystrophin+ 
myofibres. Myofibres expressing phenotypic markers of regeneration were usually 
morphologically small, and always centrally nucleated. Donor-derived myofibres 
with phenotypic and morphological markers of recent regeneration were located in 
single compact clusters, or infrequently in two or three clusters, suggesting that they 
had been formed by rapid clonal or oligoclonal expansion in the seven days following 
injury (Fig. 5.2 & 5.4). Although in most cases, more than 75% of each engrafted 
muscle appeared to have been severely damaged by the notexin treatment, diffuse 
distribution of donor-derived products was not seen.
□  total dystrophin
□  dystrophin + neonatal myosin 
■  beta-gal (nuclei)
202
M ost engrafted notexin-damaged muscles also contained numerous myofibres that 
expressed neonatal myosin and morphological markers of recent regeneration, but 
contained no donor products (Fig. 5.2). These myofibres were presumed to be 
derived from endogenous radiation-resistant muscle stem cells, which have been 
shown previously to be myogenic in response to notexin injury (Heslop et al. 2000).
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Fig. 5.4. Histogram showing newly-regenerated muscle derived from individual M yf^ Lac2:/+ 
EDL single myofibre grafts in response to severe damage. Ranked in order of the num ber of 
dystrophin+ myofibres. 4 weeks after grafting, muscles were injured by injection of the 
myotoxin, notexin, and then removed for analysis 1 week later. 18/24 (75%) of engrafted 
muscles contained (3-gal activity and dystrophin+ myofibres. In most grafts, the m ajority of 
dystrophin* myofibres co-expressed neonatal myosin, and many also contained nuclei 
expressing Myf5-(3-gal fusion protein, markers of recent regeneration. Counts of nuclei 
expressing Myf5-(3-gal fusion protein include both myonuclei, and m ononucleate MPC present 
outside myofibres. In comparison, grafts derived from the same animal, but not challenged 
with notexin, formed muscle in 40% of host sites and only expressed markers of regeneration 
in a few myofibres (Figs. 5.2 and 5.3). Engrafted muscles with no detectable (3-gal activity 
were not examined for other markers.
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There was no statistically significant difference (Mann-Whitney, p=>0.05) between 
the total numbers of dystrophin+ myofibres in undamaged and notexin-damaged 
engrafted muscles. Damaged muscles contained significantly higher numbers of 
dystrophin+ neonatal myosin+ myofibres (Mann-Whitney, p=0.0023) and p-gal+ nuclei 
(Mann-Whitney, p=0.0053) than undamaged muscles.
5.24 The effect of notexin on Myf5nLac/+ soleus single myofibre grafts
Single myofibres were isolated from the soleus muscles of a 42-day-old Myf5nLacZ/+ 
mouse and a 49-day-old Myf5nLacZ/+ mouse and prepared for grafting as previously 
described (2.21, 3.42). Grafts were inserted (2.55, 3.42) into the pre-irradiated (2.53) 
TA muscles (n=14) of 7 mdx-nude host mice, split between two small experiments. 
Four weeks after grafting, mice were re-anaesthetised and notexin injected into the 
right engrafted TA muscles. The contralateral left engrafted TA muscles functioned 
as non-damaged controls. Engrafted TA muscles were removed 5 weeks after 
grafting and 1 week after notexin damage, and processed for immunohistochemistry 
(2.61). Four serial sections were collected at 100 pm intervals throughout the entire 
muscle body (2.62). The first set of slides was stained in X-gal (2.77). The second 
set was stained for dystrophin and neonatal myosin proteins (2.76) and the third with 
H & E (2.78), as previously. The maximum numbers of total dystrophin+ myofibres, 
dystrophin+ neonatal myosin+ myofibres, and P~gal+ nuclei were counted in single 
serial sections for each muscle.
7/7 (100%) of notexin-damaged engrafted muscles and 7/7 (100%) of undamaged 
contralateral engrafted muscles contained both P-gal activity and dystrophin 
expression.
In undamaged muscles, there were 75.3 (±56.8) dystrophin+ myofibres of which 31.0
(33.1) co-expressed neonatal myosin, and 3.3 (±2.8) p-gal+ nuclei, most of which 
were located on the periphery of myofibres. In some control engrafted muscles, a 
large proportion of dystrophin+ myofibres co-expressed neonatal myosin and were 
centrally nucleated (Figs 5.5 & 5.6). This implies that muscle formation had 
continued to be augmented up until the five week timepoint.
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Fig. 5.5. Regeneration of mcfx-nude TA muscles 5 weeks after engraftment with a 
single Myf5nLacZ/+ soleus myofibre, and 1 week after notexin-induced damage. Serial 
sections: stained with X-gal (A, D), immunohistochemistry for dystrophin and neonatal 
myosin (B, H), and stained with H & E (C, F). In an undamaged control muscle (A-C), 
several peripheral p-gal+ nuclei are localised, (A) (arrows). Some dystrophin+ 
myofibres express neonatal myosin (B) but central nucleation is not pronounced. In a 
contralateral notexin-damaged muscle (D-F), recently-regenerated myofibres of donor 
origin are identifiable by co-expression of myonuclear p-gal (D) and dystrophin and 
neonatal myosin (E), and by their small size and central nucleation (F). Original 
magnification x100.
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In damaged muscles, there were 94.7 (±74.3) dystrophin+ myofibres of which 93.1
(75.2) strongly co-expressed neonatal myosin, and 44.4 (±50.1) (3-gal+ nuclei, many in 
the centre of dystrophin+ myofibres. As previously, most myofibres expressing 
phenotypic regenerative markers were morphologically small and centrally-nucleated, 
and formed compact clusters (Figs. 5.5 & 5.7).
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Fig. 5.6. Histogram showing muscle formation by individual grafts of Myf5TLacZ/+ soleus single 
myofibres 5 weeks after grafting. Ranked in order of the the num ber of dystrophin+ myofibres. 
The left engrafted TA muscle of each mouse (data shown here), was left undamaged, whilst 
the right contralateral leg was damaged with notexin (Fig. 5.7). Here, w ithout damage, 100% 
(7/7) of engrafted muscles contained p-gal activity and dystrophin expression. In several 
engrafted muscles, although only a few myonuclei expressed Myf5-p-gal fusion protein, many 
dystrophin+ myofibres co-expressed neonatal myosin, a m arker of recent regeneration, and 
were centrally nucleated (Fig. 5.5). Pooled data from two experiments.
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Fig. 5.7. H istogram showing newly-regenerated muscle derived from individual MyfZ?iacZJ+ 
soleus single myofibre grafts in response to severe damage. Ranked in order of the the 
num ber of dystrophin+ myofibres. The left engrafted TA muscle of each mouse was left 
undamaged, (Fig. 5.6), whilst the right contralateral leg was damaged by injection of notexin 1 
week before removal (data shown here). 100% (7/7) of engrafted muscles contained (3-gal 
activity and dystrophin expression. Most dystrophin+ myofibres co-expressed neonatal 
myosin, and many also contained myonuclei that expressed Myf5-@-gal fusion protein, 
m arkers of recent regeneration. Counts of nuclei expressing Myf5-(3-gal fusion protein include 
both myonuclei, and mononucleate MPC present outside myofibres. Pooled data from  two 
experiments.
There was no statistically-significant difference (Mann-Whitney, p=>0.05) between 
the total numbers of dystrophin+ myofibres in undamaged and notexin-damaged 
engrafted muscles. Damaged muscles contained significantly higher numbers of 
dystrophin+ neonatal myosin+ myofibres (p=0.0262) and p-gal+ nuclei (p=0.0070) 
than undamaged muscles.
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5.25 The effect of notexin on Myf5nLac/+ TA single myofibre grafts
Single myofibres were isolated from the TA muscles of a 42-day-old Myf5nLacZ/+ 
mouse and a 49-day-old Myf5nlacZ/+ mouse and prepared for grafting as previously 
described (2.21,3.42). The two donor mice were the same animals used for the soleus 
myofibre grafts (5.23). Grafts were inserted (2.55, 3.42) into the pre-irradiated (2.53) 
TA muscles (n=16) of 8 mdx-nude host mice, split between two small experiments. 
Four weeks after grafting, mice were re-anaesthetised and notexin injected into the 
right engrafted TA muscles, with the contralateral muscles functioning as controls. 
Engrafted TA muscles were removed 5 weeks after grafting and 1 week after notexin 
damage, and processed for immunohistochemistry (2.61). Four serial sections were 
collected at 100 pm intervals throughout the entire muscle body (2.62). The first set 
of slides was stained in X-gal (2.77), the second set was stained for dystrophin and 
neonatal myosin proteins (2.76) and the third with H & E (2.78), as previously. The 
maximum numbers of total dystrophin+ myofibres, dystrophin+ neonatal myosin+ 
myofibres, and p-gal+ nuclei were counted in single serial sections for each muscle.
8/8 (100%) of notexin-damaged engrafted muscles and 5/8 (63%) of contralateral 
undamaged engrafted muscles contained both p-gal activity and dystrophin 
expression.
In successfully-grafted undamaged muscles (5/8), there were 85.6 (±89.1) dystrophin+ 
myofibres of which 73.2 (±89.4) co-expressed neonatal myosin, and 2.8 (±1.8) p-gal+ 
nuclei, most of which were located on the periphery of myofibres (Figs 5.8 & 5.10). 
Two grafts (nos. 7 and 8 on graph, Fig. 5.10) formed more than 150 dystrophin+ 
myofibres, most of which co-expressed neonatal myosin, suggesting that they had 
been formed shortly before the five week timepoint. This was unexpected, since in 
previously described experiments, grafts of 3F-nLacZ-2E myofibres harvested at the 
three week timepoint usually formed no more than 11 donor-derived myofibres (3.4).
In damaged muscles, there were 37.1 (±25.9) dystrophin+ myofibres of which 35.4 
(±27.4) co-expressed neonatal myosin, and 15.2 (±11.2) p-gal+ nuclei, mostly in the 
centre of dystrophin+ myofibres (Figs. 5.8 & 5.9). There was no statistically- 
significant difference (Mann-Whitney, p=>0.05) between the total numbers of
208
dystrophin+ myofibres in control and notexin-damaged engrafted muscles. In contrast 
to equivalent experiments using grafts of EDL or soleus myofibres (5.23, 5.24), the 
difference between the number of dystrophin+ neonatal myosin+ myofibres in 
undamaged and damaged TA myofibre-engrafted muscles was not significant (Mann- 
Whitney, p=>0.05). This was due to the high numbers of dystrophin+ neonatal 
myosin+ myofibres that were present in the absence of damage. However, damaged 
muscles did contain significantly higher numbers of p-gal+ myofibres than undamaged 
muscles.
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Fig. 5.8. Regeneration of mdx-nude TA muscles 5 weeks after engraftment with a 
single Myf5PLacZJJr TA myofibre, and 1 week after notexin-induced damage. Serial 
sections: stained with X-gal (A, D), fluorescence immunohistochemistry for dystrophin 
and neonatal myosin (B, H), and stained with H & E (C, F). In an undamaged control 
muscle (A-C), a few, peripheral p-gal+ nuclei are localised (A) (arrows). Many 
dystrophin+ myofibres co-express neonatal myosin (B) and central nucleation is frequent. 
In notexin-damaged muscle (D-F), recently-regenerated myofibres of donor origin are 
identifiable by co-expression of myonuclear p-gal (D) and dystrophin and neonatal 
myosin (E), and by their small size and pronounced central nucleation (F). Original 
magnification x100.
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Fig. 5.9. H istogram showing muscle formation by individual grafts of M yf$liacZ/+ TA single 
myofibres 5 weeks after grafting. Ranked in order of the the number of dystrophin+ myofibres. 
The left engrafted TA muscle of each mouse (data shown here), was left undamaged, whilst 
the right contralateral leg was damaged with notexin (Fig. 5.10). Here, w ithout damage, 63% 
(5/8) of engrafted muscles contained 3-gal activity and dystrophin expression. In 4/5 
successfully engrafted muscles, although only a few myonuclei expressed M yf5-3-gal fusion 
protein, most dystrophin+ myofibres co-expressed neonatal myosin and were centrally 
nucleated (Fig. 5.8), suggesting that they had formed recently, in the absence of 
experim entally-induced damage. Pooled data from two experiments.
211
□  total dystrophin
□  dystrophin + neonatal myosin 
■  beta-gal (nuclei)
Fig. 5.10. H istogram showing newly-regenerated muscle derived from individual Myf&lLacZ/+ 
TA single myofibre grafts in response to severe damage. Ranked in order of the the num ber 
of dystrophin+ myofibres. The left engrafted TA muscle of each mouse was left undamaged, 
(Fig. 5.9), whilst the right contralateral leg was damaged by injection of notexin 1 week before 
removal (data shown here). 100% (8/8) of engrafted muscles contained (3-gal activity and 
dystrophin expression. Most dystrophin* myofibres co-expressed neonatal myosin, and many 
also contained myonuclei that expressed Myf5-(3-gai fusion protein, markers of recent 
regeneration. Counts of nuclei expressing Myf5-(3-gal fusion protein include both myonuclei, 
and m ononucleate MPC present outside myofibres. Pooled data from two experiments.
5.26 The response of graft-derived cells to repeated bouts of damage
75% of grafted EDL myofibres and 100% of grafted soleus and TA myofibres were 
found to generate at least one cell capable of undergoing rapid clonal expansion in 
response to notexin damage (5.22, 5.23, 5.24). Since there are several putatively 
myogenic satellite cells associated with each myofibre (3.41), it was not clear from 
these experiments whether muscle was formed exclusively from cells that had 
previously never been activated, or whether it was derived from newly-formed donor- 
derived satellite cells that had been generated during an initial myogenic event. The 
aim of this experiment was to investigate whether graft-derived satellite cells were 
capable of regenerating tissue after a second round of acute damage, and therefore of 
maintaining their own population after the first regenerative event.
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Single myofibres were isolated from the EDL muscles of a 43-day-old Myf5nLacZ/+ 
mouse and prepared for grafting as previously described (2.21, 3.42). Grafts were 
inserted (2.55, 3.42) into the pre-irradiated (2.53) TA muscles (n=16) of 8 metc-nude 
host mice. Four weeks after grafting, mice were re-anaesthetised (2.51) and muscle 
damage induced to bilateral engrafted TA muscles by injection of notexin (2.56). 
Muscles were left to regenerate for three weeks, after which mice were again re­
anaesthetised (2.51) and notexin injected into the right engrafted TA muscles. (2.56). 
The contralateral left TA muscles were not damaged a second time. Muscles were 
removed eight weeks after grafting, four weeks after the first round of notexin damage 
and one week after the second round of notexin damage, and processed for 
immunohistochemistry (2.61). Four serial sections were collected at 100 pm intervals 
throughout the entire muscle body (2.62). The first set of slides were stained in X-gal 
(2.77), in the second set of slides, fluorescence immunohistochemistry was used to 
detect expression of dystrophin and neonatal myosin proteins (2.76), and the third set 
stained with H & E (2.78). Unfortunately, two of the left engrafted muscles 
(subjected to one round of damage only) had to be discarded. The maximum numbers 
of total dystrophin+ myofibres, dystrophin+ neonatal myosin+ myofibres, and P-gal+ 
nuclei were counted in single serial sections for each muscle.
5/8 (63%) of twice-damaged muscles and 3/6 (50%) of once-damaged muscles 
contained both p-gal activity and dystrophin expression. In the 5/8 successfully- 
grafted twice-damaged muscles, there were 45.8 (±31.5) dystrophin+ myofibres of 
which 45.2 (±32.1) co-expressed neonatal myosin, and 31.0 (±28.1) p-gal+ nuclei, 
mainly within dystrophin+ myofibres. Donor-derived myofibres formed small, 
centrally-nucleated clusters (Figs. 5.11 & 5.12). After two bouts of notexin damage, 
the host regenerative response appeared to be less efficient than after one bout of 
damage; however, host-derived regenerating myofibres were not quantified. Clusters 
of donor-derived myofibres were less compact than those generated after a single bout 
of damage, but nonetheless, diffuse distribution was not observed. As in previous 
experiments, it is therefore likely that muscle was generated from closely associated 
cells, or possibly from a single cell.
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In the 3/6 successfully-grafted once-damaged contralateral host TA muscles, there 
were 135.7 (±153.8) dystrophin* myofibres of which 105.0 (±180.8) co-expressed 
neonatal myosin, and 45.3 (±64.7) P-gal+ nuclei. Two grafts formed small amounts of 
muscle with little expression of regenerative markers, whereas one graft formed an 
exceptionally large amount of muscle (313 dystrophin+ myofibres), with high co­
expression of molecular markers of regeneration, and frequent central nucleation (Fig. 
5.13). These data suggest that in at least some grafts, the regenerative response can 
persist until at least 4 weeks post-notexin damage.
214
Fig. 5.11. Regeneration of an mdx-nude TA muscle 8 weeks after engraftment with a 
single Myf5nLacZ/+ EDL myofibre, and 1 week after two serial rounds of notexin-induced 
damage at 4 weeks and 7 weeks after grafting. Serial sections: stained in X-gal (A), 
fluorescence immunohistochemistry for dystrophin and neonatal myosin (B), and 
stained with H & E (C). Newly-regenerated donor-derived myofibres are identifiable by 
co-expression of Myf5-p-gal fusion protein (A) and dystrophin and neonatal myosin (B) 
and by their small size and central nucleation (C). Original magnification x100.
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Fig. 5.12. Histogram showing newly-regenerated muscle derived from individual MyfE?LacZJ+ 
EDL single myofibre grafts after two rounds of severe damage. Ranked in order of the 
num ber of dystrophin+ myofibres. 4 weeks after grafting, both the left and right engrafted TA 
muscles were injured by injection of the myotoxin, notexin. After a further 3 weeks, right 
engrafted muscles were further injured with a second notexin injection (shown here). 
Contralateral left engrafted TA muscles were not re-injured (Fig. 5.13). Here, engrafted 
muscles were removed 8 weeks after grafting, 4 weeks after the first notexin injection and 1 
week after the second notexin injection. Counts of nuclei expressing Myf5-(3-gal fusion protein 
include both myonuclei, and mononucleate MPC present outside myofibres. In all successful 
grafts, most dystrophin* myofibres co-expressed neonatal myosin and many co-expressed 
Myf5-|3-gal fusion protein, showing that grafted satellite cells retained the ability to respond to 
a second round of damage (Fig. 5.11).
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Fig. 5.13. H istogram showing newly-regenerated muscle derived from individual Myf&'iacZ/+ 
EDL single myofibre grafts 4 weeks after severe damage. Ranked in order of the num ber of 
dystrophin+ myofibres. 4 weeks after grafting, both the left and right engrafted TA muscles 
were injured by injection of notexin. After a further 3 weeks, right engrafted muscles were 
further injured with a second notexin injection (Fig. 5.12). Contralateral left engrafted TA 
muscles were not re-injured (shown here). These muscles were removed 8 weeks after 
grafting and 4 weeks after the single notexin injection. 3/6 (50%) of engrafted muscles 
contained p-gal activity and dystrophin+ myofibres. Counts of nuclei expressing Myf5-p-gal 
fusion protein include both myonuclei, and mononucleate MPC present outside myofibres. 1 
successfully-engrafted muscles contained 313 dystrophin+ neonatal myosin+ m yofibres and 
120 p-gaP nuclei, showing that the regenerative response had persisted up to 4 weeks post­
damage.
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EDL myofibre soleus myofibre TA myofibre
No. satellite cells per graft T 22a 10a
Treatment undamaged notexin 2na notexin undamaged notexin undamaged notexin
No. of grafts 10 24 8 7 7 8 8
Percentage of successful grafts0 40% 75% 62.5% 100% 100% 62.5% 100%
Total dys* myofibres formed by all grafts 456 1259 229 527 663 453 297
Total dys* nm+ myofibres formed by all grafts 9 984 226 217 652 366 283
Total p-gal* nuclei formed by all grafts 20 547 155 23 311 14 124
Overall efficiency of all grafts0 6.51 7.49 4.09 3.42 4.31 5.66 3.71
Max. dys* myofibres from a single graft 192 140 89 178 258 189 66
Max. dys* nm* myofibres from a single graft 5 137 89 72 258 172 66
Max. p-gal* nuclei from a single graft 10 79 71 9 150 5 38
Max. efficiency of a single graft0 27.42 20.00 12.70 8.09 11.72 18.90 6.60
a Mean Pax7+ satellite cells per single myofibre (3.41). b Grafts which generated £1 p-gal* nuclei. c Efficiency= the total dystrophin* myofibres formed divided 
by the total myogenic cells grafted. dys= dystrophin. nm= neonatal myosin.
Table. 5.1. Comparison of the efficiency of muscle regeneration derived from single myofibre grafts 1 week after notexin-induced damage.
5.27 Summary: comparison of the response of single myofibre grafts 
to damage
(a) Comparison of regeneration in control engrafted muscles harvested at the 5 
week timepoint
The Kruskal-Wallis test was used to compare expression of dystrophin and of 
regenerative markers between muscle formed by grafts of EDL, soleus and TA 
myofibres harvested at the 5 week timepoint without notexin-induced damage (Table 
5.2). There was no statistically significant difference between the numbers of total 
dystrophin+ myofibres formed from grafts derived from the three different muscles 
(p=>0.05). However, the difference between the number of myofibres co-expressing 
dystrophin and neonatal myosin was significant between the three muscles 
(p=0.0171). In addition, the difference between the numbers of p-gal+ nuclei was 
very significant (p=0.0022). The efficiency of muscle formation by control grafts was 
6.51 for EDL myofibres, 3.42 for soleus myofibres, and 5.66 for TA myofibres 
(Table 5.1).
When in previous experiments, engrafted muscles were analysed at the 3 week 
timepoint, single myofibres formed muscle with lower frequency, and lower 
efficiency than at the 5 week timepoint, and the difference between the numbers of 
myofibres formed by grafts derived from the three different muscles was extremely 
significant (3.46, Table 3.6). Most notably, at the 3 week timepoint the efficiency of 
muscle formation by TA myofibre grafts was more than ten times less that of EDL or 
soleus myofibre grafts (Table 3.6), but by the 5 week timepoint, efficiency of muscle 
formation by TA myofibre grafts was comparable to that of EDL myofibre grafts and 
greater to that of soleus myofibre grafts (Table 5.1). These differences are too 
substantial to be exclusively explained by potential inter-animal variability of donors, 
and strongly suggest that muscle formation had spontaneously augmented up until the 
5 week timepoint.
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EDL single  
myofibre
so leus single 
myofibre
TA single  
myofibre
Satellite cells per graft3 7 22 10
No. of grafts 10 7 8
Percentage of successfu l0 
grafts
40.0% 100% 62.5%
Mean dystrophin4 
myofibres formed by 
successfu l grafts
114.0 (±57.1) 75.29 (±56.8) 85.60(±89.1)
Mean dystrophin4 neonatal 
myosin4 myofibres formed 
by successfu l grafts
2.3 (±2.2) 31.0 (±33.1) 73.20 (±89.4)
Mean p-gal4 nuclei formed 
by successfu l grafts
5.00 (±4.7) 3.29 (±2.8) 2.80 (±1.8)
3 Mean Pax7+ satellite cells per single myofibre (3.41). b Grafts with p-gal4 nuclei.
Table 5.2. Comparison of the quantities of muscle formed by control grafts of Myf!?LacZ/+ 
single myofibres harvested at the 5 week timepoint.
(b) Comparison of regeneration in engrafted muscles 1 week after notexin 
damage
The results of the experiments described in 5.22, 5.23 and 5.24 showed that satellite 
cells derived from the EDL, soleus and TA muscles of young adult mice have the 
ability to undergo rapid clonal expansion in response to damage. The Kruskal-Wallis 
test was used to compare notexin-induced regeneration generated by myofibres 
derived from EDL, soleus and TA muscles (Table 5.3). There were no statistically 
significant differences between the numbers of dystrophin+ myofibres, or between the 
numbers of dystrophin+ neonatal myosin+ myofibres formed by single myofibre grafts 
derived from the three different muscles (p=>0.05). The lack statistical significance 
may have been due to small sample number. However, there was a statistically 
significant difference (p=<0.05) between the numbers of P-gal+ nuclei formed by 
myofibre grafts derived from different muscles.
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The efficiencies with which grafted single myofibres regenerated new myofibres after 
damage differed according to their muscle of origin (Tables 5.1 and 5.2). Soleus 
(5.23) and TA (5.24) single myofibre grafts were isolated from the muscles of the 
same two donor Myf5nLacZ/+ mice, allowing the regenerative potential of the satellite 
cell populations of the two muscles to be compared in the absence of artefacts 
generated by inter-animal variability. In response to notexin-induced damage, the 
mean number of dystrophin+ myofibres formed by TA myofibre grafts was only 40% 
of the mean number formed by soleus myofibre grafts derived from the same donor 
animals (5.23). However, the overall efficiencies of muscle formation were quite 
similar, at 4.31 for soleus myofibre grafts and 3.71 for TA myofibre grafts (Table 
5.1). At 7.49, the overall efficiency of damage-induced regeneration generated from 
EDL myofibre grafts (derived from a different donor) (5.21) was higher than that of 
either soleus or TA myofibre grafts. In response to a second bout of damage (5.25) 
new myofibres were regenerated by EDL myofibre grafts with a reduced efficiency of 
4.09. This difference, however, is probably not great enough to exclude the 
possibility that it is partly attributable inter-animal variability of donors. After two 
bouts of damage (5.25) EDL satellite cells generated new muscle with comparable 
efficiency to single myofibres derived from soleus or TA muscles after one bout of 
damage (Table 5.1).
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EDL single 
myofibre
EDL single  
myofibre, 
2nd round
soleus single  
myofibre
TA single  
myofibre
Satellite cells per 
graft3
7 7 22 10
No. of grafts 24 8 7 8
Percentage of 
su c c e s s fu l grafts
75.0% 62.5% 100% 100%
Mean dystrophin* 
myofibres formed 
by successfu l 
grafts
70.0 (±40.0) 45.80 (±31.5) 94.71 (±74.3) 37.12 (±25.9)
Mean dystrophin* 
neonatal myosin* 
myofibres formed 
by successfu l 
grafts
63.0 (±40.1) 45.20 (±32.1) 93.14 (±75.2) 35.38 (±27.4)
Mean p-gal* nuclei 
formed by 
successfu l grafts
30.0 (±21.7) 31.00 (±28.1) 44.43 (±50.1) 15.50 (±11.2)
3 Mean Pax7+ satellite cells per single myofibre (3.41). b Grafts with P-gal* nuclei.
Table 5.3. Comparison of the quantities of muscle formed by grafts of Myf&,LacZ/+ single 
myofibres 1 week after notexin-induced damage.
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5.3 The effect of notexin on single myofibre cultures
5.31 Aim
The results of the experiments previously described in this chapter showed that 
satellite cells are the origin of efficient muscle regeneration after notexin damage 
(Table 5.1). In principle, myogenic activity could have been stimulated either by the 
damage induced by notexin, or by the notexin itself. The objective of this experiment 
was to use single myofibre cultures to investigate the effects of notexin on myofibre 
viability and satellite cell proliferation in vitro, outside the regenerative milieu of 
damaged muscle.
5.32 Exposure of single myofibre cultures to notexin
Single myofibres were isolated from the soleus muscles of a 43-day-old male C57 
Bl/10 mouse, and cultured individually in the wells of 24-well-plates (2.21). After 48 
h in vitro, counts were made of the number of cells surrounding each myofibre. 
Notexin (1 ng/ml, 10 ng/ml, lOOng/ml, 1 fig/ml or 10 pg/ml) was added to the plating 
medium of each culture, and left overnight. Ten replicates of each concentration were 
carried out, and in addition, ten control cultures without notexin. After 12 h, notexin 
was removed, cultures were gently washed with warmed PBS, and fresh warmed 
plating medium added. Cells were cultured for a further 72 h and the number of cells 
surrounding each myofibre counted at 24 h intervals. 120 h after plating and 72 h 
after notexin exposure, cultures were fixed (2.71) and desmin immunocytochemistry 
(2.74) used to verify the myogenic lineage of emanating cells (Bockhold et al. 1998). 
2 of a total of 60 cultures contained small numbers of desmin” cells.
Notexin concentrations in the range 100 ng/ml to 10 pg/ml caused 100% of myofibres 
to hypercontract (Fig. 5.14). Only 1 myofibre survived exposure to 10 ng/ml notexin. 
All myofibres exposed to 1 ng/ml and all controls survived. Therefore, despite the 
fact that myofibres were isolated from the soleus muscle and had presumably 
heterogeneous fibre-type profiles, the toxic effects of notexin did not appear to be 
differential as has been reported previously (reviewed, Harris 2003). The mean 
numbers of cells surrounding myofibres exposed to the different concentrations of 
notexin are shown in Fig. 5.15. At the highest concentrations (10 pg/ml and 1 pg/ml), 
cells took on a granular appearance, and some appeared to die and detach from the
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substrate. The numbers of desmin+ cells surrounding single myofibres after 120 h in 
culture was compared using the Kruskal-Wallis test. The differences between the six 
treatment groups were found to be extremely significant (p=<0.0001). Dunn’s 
multiple comparisons test was used to compare the control individually with each of 
the five different treatment groups. The difference between the control and notexin 
10 pg/ml was found to be very significant (p=<0.001). The difference between the 
control and notexin 1 jig/ml was found to be significant (p=<0.05). Differences 
between the control and the other three treatment groups were not significant 
(p=>0.05). These data show that in vitro, notexin does not stimulate proliferation but 
is toxic to proliferating satellite cell-derived myoblasts in a dose-dependent manner.
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Fig. 5.14. Effect of notexin on soleus single myofibre cultures. In a control culture (A) 
the adherent myofibre is intact and is surrounded by proliferating satellite cell-derived 
myoblasts. In a culture exposed to notexin (10 fig/ml) 24 h previously (B) the 
myofibre has hypercontracted, and many of the surrounding myoblasts appear sick, 
and subsequently detached from the substrate. Image capture of live cells. Original 
magnification x50.
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Fig. 5.15. Bar graph showing the effect of notexin on satellite-derived cell proliferation in 
soleus single myofibre cultures. After 48 h in culture, cells were exposed overnight to various 
concentrations of notexin, and then gently washed and returned to normal culture conditions 
for a further 72 h. In other in vivo experiments notexin was injected at 10 pg/ml. Here in vitro, 
at notexin concentrations from 0.01-10 pg/ml all myofibres hypercontracted, excepting 1 
single myofibre that survived exposure to 0.01 pg/ml. Control myofibre cultures and those 
exposed to 0.001 pg/ml notexin all survived for the duration of the experim ent (Fig. 5.14). 
Error bars represent SD.
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5.4 Investigation of the effect of myofibre damage on 
myoblast proliferation
5.41 Aim
Exposure of single myofibre cultures to notexin was found to have toxic effects on 
both the parent myofibre and its associated satellite cell-derived myoblasts, and did 
not enhance myoblast proliferation (5.3). In vivo, satellite cell proliferation is 
stimulated by muscle tissue damage (reviewed, Bischoff 1994); however, it is not 
known whether this effect is significantly mediated by direct signalling from damaged 
myofibres, or via signalling from other (e.g. inflammatory) phenotypes present within 
the regenerative milieu. The objective of this study was to use single myofibre 
cultures to investigate whether the proliferation of satellite cell-derived myoblasts was 
altered after the parent myofibre had been subjected to physical damage.
5.42 Effect of myofibre damage on the proliferation of satellite cell- 
derived myoblasts in single myofibre cultures
Single myofibres were isolated from the EDL and soleus muscles of one 28-day-old 
C57 Bl/10 mouse and from the EDL muscles of a second 42-day-old C57 Bl/10 
mouse and cultured individually in the wells of 24-well-plates (2.21). After 48 h, 
examination of cultures showed that satellite cells had migrated away from parent 
myofibres and started to proliferate. At this stage, 50% of the medium in cultures was 
removed and replaced with fresh warmed plating medium, added gently down the side 
of each well to avoid disturbing myofibre. In some cultures (24/48 soleus myofibres, 
45/89 total EDL myofibres), focal damage was caused to adherent myofibres by 
crushing a central segment with a heat-polished Pasteur pipette, taking care not to 
touch surrounding mononucleate cells. This treatment resulted in part or all of the 
myofibre hypercontracting, and in some cases, detaching from the substrate. 
Remaining cultures served as undamaged controls. Cultures were maintained for a 
further 72 h post-damage and then fixed and immunostained for desmin protein to 
confirm the myogenic lineage of emanating cells (Bockhold et al. 1998) (2.74) (Fig. 
5.16). The numbers of desmin+ and desmin cells surrounding each myofibre were 
counted (Figs. 5.17 & 5.18). 2/23 (8.7%) of control soleus myofibre cultures
respectively had 1.1% and 1.5% desmin' cells. 1/24 (4.2%) of damaged soleus
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myofibre cultures had 1.7% desmin- cells. 1/44 (2.3%) of control EDL myofibre 
cultures had 19.6% desmin cells. 1/45 (2.2%) of damaged EDL myofibre cultures had 
15.3% desmin- cells. In all other cultures, all cells surrounding parent myofibres 
expressed desmin protein.
The Kolgomorov-Smimov test (see Appendix) was used to compare the distribution 
of counts of desmin+ cells emanating from control and damaged myofibres. There was 
no statistically significant difference between the numbers of desmin+ cells 
surrounding intact or damaged EDL or soleus parent myofibres (p=>0.05). These 
data suggest that in vitro, damaged myofibres to not release substances that either 
augment or retard the proliferation of satellite cell-derived myoblasts.
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desmin
Fig. 5.16. Effect of myofibre damage in single myofibre cultures. Single myofibres (arrows) 
isolated from the EDL (A, C) or soleus (B, D) muscles of wild-type mice were maintained as 
adherent cultures for 120 h, and immunostained for expression of desmin protein (peroxidase 
detection protocol). Control cultures (A, B) and cultures in which the parent myofibre was 
physically damaged after 48 h in culture (C, D), 72 h before fixation and staining. There was 
no statistically significant difference between the numbers of desmin+ cells surrounding 
control and myofibre-damaged cultures (Kolgomorov-Smirnov p=>0.05). Original 
magnification x50 (A-B) or x100 (C-D).
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Fig. 5.17. Cumulative plot of data from individual cultured EDL myofibres, ranked according to 
the num ber of desm in+ cells surrounding each explant. To normalise the data fo r sample 
size, the individual ranks are expressed as a percentage of the total rank for each group. 
After 48 h in culture, adherent myofibres in the ‘dam age’ group were focally damaged by 
crushing a central segment with a heat-polished Pasteur pipette, w ithout disturbing cells that 
had previously emanated from the explant. This caused part or all of the myofibre to 
hypercontract, and in some cases to detach from the substrate (5.16). Cultures were 
maintained for a further 72 h before fixation and desmin immunocytochem istry. Pooled data 
from two experiments.
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------1-------------------- j-------------------- 1---------------------1
200 400 600 800
Desmin (+) cells surrounding each myofibre
—•— control 
damage
231
5.5 The myogenic potential of satellite cells in non-irradiated 
graft sites
5.51 Aim
Previous unpublished attempts to graft EDL single myofibres into non-irradiated host 
sites failed to generate donor-derived muscle formation. However, engrafted muscles 
were analysed at only the three week timepoint, and were not challenged with damage 
(L. Heslop, PhD Thesis 2001). Hypothetically, the lack of muscle formation could 
have been due to either death of the grafted cells, or non-proliferation of surviving 
cells in a sub-optimal environment. Another previous study showed that grafted 
C2C12 cells survived in non-irradiated environments but formed less muscle than in 
irradiated environments (Morgan et al. 2002). The objective of the present 
experiment was to determine whether satellite cells persist in non-irradiated graft sites 
and can be stimulated to enter an active myogenic program after severe damage, or 
whether the the myogenic potential of grafted satellite cells is entirely absent in non- 
irradiated environments.
5.52 Grafts of single myofibres into non-irradiated host sites
Single myofibres were isolated from The EDL muscles of a 43-day-old Myf5nLacZ/+ 
mouse and prepared for grafting as previously described (2.21, 3.42). The donor 
mouse used was the same as that used in 5.25. Single myofibre grafts were inserted 
into the non-irradiated TA muscles (n=20) of ten mdjt-nude host mice (2.55, 3.42). 
Four weeks post-grafting, mice were anaesthetised and the right engrafted TA muscle 
of each animal damaged by injection of notexin (2.56). The contralateral engrafted 
TA muscles served as non-damaged controls. Muscles were removed five weeks after 
grafting and one week after notexin damage, and processed for immunohistochemistry 
(2.61). Four serial sections were collected at 100 pm intervals throughout entire 
muscle bodies (2.62). The first set of sections was stained in X-gal solution (2.77). P- 
gal activity could not be identified in any sections of any engrafted muscles, either 
those with, or without notexin damage (Fig. 5.19, Table 5.4).
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Origin of graft No. of 
grafts
Pre-irradiation 
of graft site
Notexin damage 
to engrafted 
muscle
Engrafted 
m uscles with >1 
p-gal+ nucleus
M yf& Lac“ + EDL 10 (right 
host TA 
muscles)
no yes 0/10
M yf& Lac“ + EDL 10 (left host 
TA
muscles)
no no 0/10
Table 5.4. Absence of muscle formation by grafts of Myff?iacZ/+ EDL single myofibres inserted 
into non-irradiated host TA muscles. Muscles were removed 5 weeks after grafting. Notexin 
was injected into the right engrafted muscle of each mouse 1 week before removal. The 
contralateral left engrafted muscle served as the non-damaged control.
This result shows that single myofibre grafts do not generate any MPC capable of 
forming muscle in non-irradiated sites. The data could represent a failure of cell 
survival, or alternatively an absence of myogenic potential in the presence of the 
normal complement of host satellite cells.
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Fig. 5.19. Absence of donor-derived muscle formation in non-irradiated mdx-nude TA 
muscles engrafted with a single Myf5niacZy+ EDL myofibre, either with (D-F) or without 
(A-C) subsequent notexin-induced damage. Serial sections: stained in X-gal (A, D), 
immunohistochemistry for dystrophin and neonatal myosin (B, E), and stained with 
H & E (C, F). 1 week after notexin injury (D-F), non-irradiated muscles contain 
numerous small, centrally nucleated myofibres (F) that express neonatal myosin (E). 
However, the lack of expression of p-gal (A, D) and dystrophin (B, E) in both 
undamaged (A-C) and damaged (D-F) engrafted muscles shows that there is no donor 
contribution. A single weakly dystrophin+, presumably revertant, myofibre is arrowed 
(E). Original magnification x100.
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5.6 Comments on results
The data derived from experiments in this chapter demonstrate that all soleus and TA 
single myofibre grafts (5,23, 5.24) and the majority of EDL myofibre grafts (5.22) 
generate at least one cell capable of undergoing rapid clonal expansion in response to 
severe damage. In all cases, donor-derived regenerate muscle formation was localised 
to either a single compact cluster, or less frequently, two or three discrete foci. These 
clusters could either have been of clonal origin, or have originated from several 
closely-associated progenitors. Since notexin caused severe damage to more than 
75% of the area of injected muscles, it is unlikely that clusters were generated from 
more widely-distributed precursors that migrated towards a single focus.
In muscles engrafted with EDL (5.22) or TA (5.24) myofibres the frequency of 
muscle formation was increased in notexin-damaged muscles compared to non­
damaged controls (Table 5.1). In soleus myofibre grafts (5.23), whilst the grafting 
efficiency was 100% in both notexin-damaged and non-damaged engrafted muscles, 
the quantity of muscle formed 1 week after notexin injection was greater than the 
quantity of muscle formed in the absence of notexin damage. Soleus myofibres have 
more satellite cells than either EDL or TA myofibres (3.41) and in these experiments, 
their regenerative potential was found to be greater than myofibres isolated from 
either of the other muscles. Taken together, these data suggest that notexin damage 
recruited previously inactive (possibly quiescent) precursors into an active myogenic 
program, instead of, or as well as, upregulating the proliferative activity of already- 
active precursors. However, the data do not distinguish whether the notexin-activated 
cells were the originally-grafted satellite cells which had hitherto remained 
persistently quiescent, or newly-formed satellite cells generated during a previous 
myogenic event, or other donor-derived progeny located outside the satellite cell 
compartment.
Without the stimulus of notexin-damage, both the frequency and overall efficiency 
(Table 5.1) of muscle formation was greater at the five week timepoint than that 
observed in previous experiments analysed at the three week timepoint (3.4). This 
implies that satellite cell recruitment into active myogenesis also occurs in the 
absence of additional experimental pressure, either in response to local bouts of
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degeneration and regeneration which are characteristic of the host mdx muscles, or 
spontaneously as a result of pre-programmed cell cycle re-entry determined by cell- 
intrinsic factors. Most strikingly, the efficiency of muscle formation by TA myofibre 
grafts at the five week timepoint greatly exceeded that at the 3 week timepoint, both 
in absolute terms and relative to muscle formation by EDL and soleus myofibres. 
These data suggest that TA satellite cells have similar myogenic potential to EDL and 
soleus satellite cells, but that their progeny proliferate (or possibly differentiate) at a 
slower rate.
The finding that myogenic cells derived from a proportion of EDL myofibre grafts are 
capable of responding to at least two bouts of severe damage (2.25) demonstrates that 
satellite cells can maintain their own population in terms of retaining functional 
potential in addition to generating new anatomically- and phenotypically-defined 
satellite cells, as was shown in Chapter 4. Since in the majority of cases each graft 
presumptively contained several satellite cells, it is possible, albeit improbable, that 
after the second bout of damage muscle regeneration was derived from a cell which 
had resisted activation during the first bout.
Though notexin-induced damage elicits a robust regenerative response from satellite 
cells in vivo (5.2), in the tissue culture environment exposure to notexin retards the 
proliferation of satellite cell-derived myoblasts (5.3). This disparity may reflect 
differences in the concentrations to which satellite cells were exposed to. In vivo, the 
injected concentration (10 pg/ml) is likely to be considerably higher than the 
concentration to which the majority of satellite cells are exposed after dispersal of the 
injected fluid throughout the muscle body. At lower concentrations, the in vitro 
toxicity of notexin was much less marked (Fig. 5.15), probably a closer representation 
of its actual effects in vivo. Alternatively, the in vivoI in vitro disparity may be 
attributable to factors related directly to the tissue culture environment itself. 
Oxidative myofibres are reportedly more sensitive to myotoxic agents than glycolytic 
myofibres (1.6). Cells are likely to be subject to greater oxidative stress in a tissue 
culture environment with 21% O2 than in vivo with 6% O2, a possible consequence of 
which could be greater sensitivity to myotoxins such as notexin. In addition, it is 
possible that quiescent satellite cells are less sensitive to notexin than the actively- 
proliferating satellite cell-derived myoblasts examined in this study. It would be
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difficult to test the effects of notexin on anatomically-defined quiescent satellite cells 
in vitro, firstly because satellite cells rapidly activate on exposure to the tissue culture 
environment (Zammit et al. 2002), and secondly because notexin exposure causes 
myofibres to hypercontract, preventing them from adhering in culture and making 
them too optically dense for fluorescence immunocytochemistry. Consequently, it is 
difficult to determine whether the toxic effects of notexin on proliferating myoblasts 
in vitro are really representative of its effects on quiescent satellite cells in vivo. 
Notwithstanding, the data strongly suggest that satellite cell proliferation is stimulated 
by the tissue damage caused by notexin, rather than by a direct effect of notexin itself.
Grafts of single myofibres into non-irradiated sites failed to generate a single donor- 
derived nucleus that could be identified as such by expression of Myf5-P~gal fusion 
protein, either after or without notexin-induced damage (Table 5.4, Fig. 5.19). 
Although it might be predicted that the presence of proliferation-competent host 
satellite cells would reduce the graft-derived regeneration through direct competition, 
it is notable that the donor contribution was completely absent. In contrast to this 
finding, both primary neonatal myoblasts (Partridge et al. 1989) and immortalised 
C2C12 myoblasts (Morgan et al. 2002) form muscle in non-irradiated environments. 
This difference suggests that the mechanism of muscle formation by satellite cells in 
single myofibre grafts may differ from the mechanism of muscle formation by grafted 
myoblasts which are outside the basal lamina.
In summary, the results of the experiments described in this chapter demonstrate that 
satellite cells respond to damage by undergoing rapid and sustained proliferation to 
both regenerate large areas of new muscle and maintain a reserve population capable 
of participating in subsequent regenerative events. The behaviour of satellite cells in 
single myofibre grafts recapitulates the endogenous process of regeneration in whole 
muscles and suggests that satellite cells constitute the basal origin of adult muscle 
regeneration.
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Chapter 6 
General Discussion
This thesis has aimed to analyse the stem cell potential of satellite cells by formally 
investigating their contribution to skeletal muscle regeneration. In this chapter, 
results are consolidated, placed in the context of current knowledge of muscle 
regeneration and satellite cell biology, and their contribution to the field discussed.
6.1 Stem cell activity of satellite cells in myofibre grafts
Skeletal muscle has a remarkable ability to regenerate functional tissue within a few 
days of severe injury (Studitsky 1964, reviewed, Carlson 1986). Though the ability of 
satellite cells to contribute to adult myogenesis is beyond doubt both in vivo (Moss & 
Leblond 1971, Snow 1978) and in vitro (Rosenblatt et al. 1995), the rapidity with 
which regeneration proceeds (reviewed, Carlson 1986), has prompted some workers 
to predict that this relatively minor population is not the only significant source of 
myonuclei in regenerating muscles (Reznik 1970, Seale et al. 2001, LaBarge & Blau 
2002). Others have disputed this, demonstrating that in vitro, the satellite cells 
associated with each single myofibre have sufficient proliferative potential to 
completely replace the number of nuclei in the parent myofibre within four days 
(Zammit et al. 2002).
Following muscle injury, inflammatory cells rapidly infiltrate the regenerative milieu 
(reviewed, Partridge 1982). Whilst it has been demonstrated that cells derived from 
the circulatory system can contribute at low frequency to myofibres (Ferrari et al. 
1998, Camargo et al. 2003, Torrente et al. 2004), the severe growth deficit generated 
by local irradiation of juvenile muscles (Wakeford et al. 1991, Quinlan et al. 1995) 
implies that the most significantly myogenic cells are both located within the tissue, 
and sensitive to radiation. It has been shown that cell types which are phenotypically 
distinct from satellite cells, but believed to be tissue-resident, can be recruited into a 
myogenic program in response to injury (Polesskaya et al. 2003). However, in vivo,
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these non-satellite cell phenotypes have not yet been unequivocally linked with 
significant myogenic activity.
This thesis has demonstrated that in vivo, the satellite cells associated with a single 
grafted myofibre have the potential to not only regenerate the nuclei of their parent 
myofibre (Zammit et al. 2002), but to make a significant contribution to the nuclei of 
more than a hundred other myofibres. This is the first time that such substantial 
myogenic activity has been formally localised to a defined phenotype. The data 
predict that satellite cells have sufficient proliferative, myogenic, and self-renewal 
potential to form the major, or possibly only, cellular source in the rapid and robust 
regenerative process previously described by other workers (Studitsky 1964, Carlson 
1968, 1970, Luz et al. 2002). Although most quiescent satellite cells express certain 
muscle-specific proteins such as Myf5 (Beauchamp et al. 2000), M-cadherin 
(Irintchev et al. 1994, Kuschel et al. 1999) and probably desmin (personal 
communication, P. Zammit), this thesis demonstrates that they are not merely 
committed precursors held in a temporary differentiation block, but have the 
endogenous potential to function as tissue-specific stem cells.
6.2 Evidence for a myofibre-dependent activation event
In Chapter 3, it has been shown that in similar host environments, single myofibres 
form muscle with greatly increased efficiency compared to primary myoblasts derived 
from equivalent muscles, despite the fact that many (or perhaps most) primary 
myoblasts are likely to have been derived from the satellite cell position. These data 
demonstrate the existence of a phenotype which does not retain its full myogenic 
potential in conventional preparations of myoblasts. The mitotic quiescence of 
satellite cells may give them a survival advantage over proliferating cells. Single 
myofibres may represent highly-purified populations of the most potent myogenic 
precursors which in heterogeneous populations are greatly diluted. Alternatively, the 
data may describe a phenotype whose myogenic potential is non-autonomous, but is 
dependent on a component of the satellite cell niche.
The number of cells that survive in grafts of immortalised or primary myoblasts is 
only about 2% of the total population (Beauchamp et al. 1999). In this thesis, this
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figure equates to approximately 104 cells surviving in grafts of 5 x 105 immortalised 
myoblasts and 103 desmin+ cells surviving in grafts of 5 x 104 primary myoblasts. 
Even in the largest possible outliers, the maximum number of satellite cells surviving 
in single myofibre grafts was necessarily always less than 50, and in EDL single 
myofibre grafts usually less than 10. Whilst the 10 cells that would be predicted to 
survive in grafts of 500 immortalised myoblasts formed a maximum of 12 new 
myofibres, the less than 10 satellite cells associated with an EDL myofibre formed a 
maximum of 189 myofibres at the 3 week timepoint. Thus the increased myogenicity 
of myofibre grafts cannot be wholly attributed to purification of a myogenic stem cell 
which forms a small subset of other myoblast preparations. It has been shown that the 
2% of myoblasts which survive grafting are those which, in tissue culture, are slow- 
cycling and do not incorporate 3H-thymidine in the immediate period before 
transplantation (Beauchamp et al. 1999). Hypothetically, the mitotic quiescence of 
adult satellite cells (Schultz et al. 1978) might enhance their survival in myofibre 
grafts, but equally, primary myoblasts which have never been maintained in tissue 
culture might be expected to have a survival advantage for the same reason.
Purity of the myogenic population and potentially enhanced frequency of survival 
cannot fully account for the very high efficiency of muscle formation by grafted 
single myofibres. It is therefore strongly implied that the satellite cell niche has a role 
in maintaining stem cell potential. The stem cell potential of many phenotypes, 
including intestinal epithelial stem cells (Kaeffer 2002), skin epithelial stem cells 
(Blanpain et al. 2004) and neural stem cells (Song et al. 2002b, Shen et al. 2004), is 
critically controlled by a component of their endogenous niche, and therefore non- 
autonomous. The high frequency of single HSC engraftment demonstrates that these 
stem cells have an excellent ability to home to the appropriate niche (Matsuzaki et al. 
2004).
Whilst the association of satellite cells with their parent myofibre appears to be an 
important factor determining myogenic potential, the large amounts of muscle formed 
by single myofibre grafts are evidence that satellite cell progeny do not remain 
associated with their parent myofibre for an extended period. Experiments described 
in Chapter 3 demonstrated that though enzymatically-disaggregated myoblasts formed 
muscle relatively inefficiently, grafts of single myofibres generated muscle very
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efficiently, even when the graft was inserted into a notexin-treated site in which the 
myofibre could not have remained viable for long. In addition, in vitro experiments 
described in Chapter 5 showed that the proliferation of satellite cell-derived myoblasts 
was not increased when damage was caused to the parent myofibre. These data 
predict a mechanism whereby an initial myofibre-associated activation event is 
dependent on a component of the satellite cell niche, but the subsequent proliferation 
of satellite cell progeny is myofibre-independent.
Though terminally differentiated, myonuclei retain the ability to alter their expression 
profiles in response to changing workloads or after damage. Myofibres can switch 
expression of MyHC isoforms in response to changes in the electrical activity of their 
attendant nerve (reviewed, Hughes & Salinas 1999, Pette & Staron 2000). The 
myonuclei of isolated EDL and TA myofibres re-activate the Myf5 locus in response 
to denervation and serum stimulation, though the myonuclei of soleus myofibres do 
not (Zammit et al. 2002). Since myonuclei are postmitotic, upregulation of 
myonuclear Myf5 expression (Zammit et al. 2002) does not precede mitotic activity as 
it does in satellite cells (Comelison & Wold 1997), but speculatively may be 
indicative of some form of signalling mechanism between myofibre and satellite cell. 
This thesis did not attempt to determine the period for which grafted myofibres 
remained viable after insertion into the host muscle. It would be difficult to do so, 
since the extremely delicate nature of single myofibres means that labelling with any 
form of dye could itself have a negative effect on viability. It is probable that outside 
the tissue culture environment, and in the absence of nerves and vasculature, 
myofibres do not persist for long. However, since in vitro, most satellite cells become 
activated at the protein level within six hours of isolation (Zammit et al. 2002), a 
hypothetical myonuclear signalling event would not necessarily require persistence of 
grafted myofibres for long.
Minced muscle grafts regenerate functional tissue with remarkable efficiency 
(reviewed, Carlson 1986), despite the fact that the original myonuclei rapidly become 
pyknotic (Snow 1977a, 1977b), and cannot be supposed to have a persistent signalling 
role. Satellite cells remain viable beneath the relatively intact basal laminae (Snow 
1977a, 1977b). The basal lamina also survives after other forms of severe damage, 
such as barium chloride treatment, and acts as a scaffold for subsequent regeneration
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(Caldwell et al. 1990). It could, therefore, be involved in determining satellite cell 
fate. Proliferation and quiescence of arterial smooth muscle cells have been shown to 
be controlled by integrin signalling, mediated by extracellular matrix proteins (Hedin 
et al. 1999), and proliferation and quiescence of skin stem cells are similarly thought 
to be mediated through basal lamina signalling (Blanpain et al. 2004). This suggests 
the possibility that the basal lamina of myofibres could play an equivalent role in 
mediating the activation status of satellite cells.
The increase in frequency of muscle formation over time and in response to severe 
damage, shown in Chapter 5, demonstrates that some grafted satellite cells remained 
inactive in engrafted muscles, and retained latent stem cell potential after the original 
parent myofibre had, in all probability, been degraded. In the irradiated graft site, 
donor satellite cells could have been recruited or homed to the satellite cell-depleted 
niches of host myofibres, and thereby acquired a position in which they were 
amenable to appropriate signalling mechanisms. It has been proposed that the ability 
to home to a niche appropriate for their survival and proliferation should be one of the 
qualities by which stem cells are defined (Matsuzaki et al. 2004). The high frequency 
of satellite cell engraftment demonstrated by this thesis suggests that satellite cells 
satisfy this criterion, albeit, similarly to HSC (Smith et al. 1991, Osawa et al. 1996, 
Matsuzaki et al. 2004), in irradiated graft sites. It has been shown in Chapter 5 that 
single myofibre grafts do not generate muscle or new satellite cells in non-irradiated 
graft sites. Isolated myoblasts, however, have previously been shown to form muscle 
in non-irradiated graft sites (Partridge et al. 1989, Morgan et al. 2002), though with 
lower efficiency than in irradiated sites (Morgan et al. 2002). This difference was 
found to be attributable to reduced proliferation rather than reduced survival 
(Beauchamp et al. 1999, Morgan et al. 2002). Hodgetts & Grounds (2003) showed 
that in the immunocompetent host, the improved efficiency of muscle formation in 
irradiated sites is linked to a reduction in numbers of host immune cells. However, 
the experiments described in this thesis (and also those of Morgan et al.) were carried 
out in mdx-nude hosts, which lack thymi and are highly immunotolerant of mouse 
allografts (personal communication, T. Partridge). It is therefore likely that the 
observed differences between the behaviour of grafted satellite cells in irradiated and 
non-irradiated environments resulted from a factor independent of host immune 
response. Speculatively, the absence of muscle formation in non-irradiated sites could
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be due to the inability of donor satellite cells to home to a suitable niche in the 
presence of the intact population of host satellite cells. The sustained absence of 
muscle formation five weeks after grafting, and moreover after severe myotoxin- 
induced damage, implies that satellite cells do not remain viable (or at least lose their 
functional attributes) if they are prevented from homing to this niche within a certain 
period of grafting. This hypothesis could be tested further using grafts into host 
muscles that are depleted of satellite cells for reasons other than exposure to 
irradiation, for instance into the muscles of adult PaxTA animals (Seale et al. 2000, 
Oustanina et al. 2004).
6.3 Self-renewal of the adult satellite cell compartment
It was Moss and Leblond (1971) who originally proposed that the adult satellite cell 
compartment could be maintained by self-renewal. More recent studies have shown 
that satellite cells can be derived from transplanted populations of myoblasts (Blaveri 
et al. 1999, Heslop et al. 2001, Cousins et al. 2004) and that in vitro, isolated 
myoblasts (Baroffio et al. 1996, Yoshida et al. 1998) and myofibre-adherent satellite 
cells (Zammit et al. 2004a) generate reserve populations that remain proliferation- 
competent when the majority population commits to differentiation. In experiments 
described in Chapter 4, this thesis has demonstrated that defined satellite cells can 
generate new defined satellite cells during the course of a regenerative event, and that 
the satellite cell compartment is therefore capable of renewing its own population. 
The satellite cells associated with a single grafted myofibre were found to contribute 
new satellite cells to the populations associated with numerous other myofibres, 
thereby both expanding the original number of satellite cells as well as contributing 
differentiated myonuclei. The presence of satellite cells on very immature, centrally 
nucleated myofibres implies that satellite cells and myonuclei were generated within a 
similar timescale, rather than by temporally separable events. This ability to activate 
and generate proliferation-competent progeny of which a subset return to an inactive 
or quiescent state has been recently demonstrated using single myofibres in 
suspension culture (Zammit et al. 2004a). However, satellite cells were found to have 
a very limited proliferative capacity, undergoing only a few divisions before the 
majority population committed to differentiation (Zammit et al. 2004a). This thesis 
has demonstrated that in vivo, satellite cell progeny can undergo very extensive
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proliferation to generate large numbers of myofibres and new satellite cells. 
Hypothetically, this process could involve sequential small discrete regenerative 
events, whereby an activated cell both generates a small number of differentiation- 
committed progeny and replaces' itself with a proliferation-competent cell that 
subsequently derives the next cohort after its sibling population have differentiated. 
Alternatively, all progeny may exit the cell cycle relatively synchronously after a 
single prolonged episode of proliferation. Evidence derived from previous studies 
(Barroffio et al. 1996, Zammit et al. 2004a) suggests that the former possibility is 
most probable.
Stem cells are thought to self-renew by the asymmetric division of a founder cell to 
generate two daughter cells, of which only one gives rise to differentiation-committed 
progeny (reviewed, Hall & Watt 1989, Potten & Loeffer 1990, Morrison et al. 1997, 
Weissman et al. 2000). However, there is evidence that under some circumstances, 
stem cells can be renewed via alternative mechanisms. Intestinal crypts contain both 
self-renewing stem cells, and their progeny, transit amplifying cells, which are 
programmed to terminally differentiate after a few rounds of division, and do not 
normally self-renew. However, if the stem cell population is ablated, transit 
amplifying cells can revert to a stem cell phenotype and regenerate the entire crypt, 
including the primitive stem cell population (reviewed, Marshman et al. 2002, Potten 
2004). Most quiescent satellite cells do not contain MyoD protein (Zammit et al. 
2002) or MyoD mRNA (Comelison & Wold 1997), and though Myf5 protein is 
present (Beauchamp et al. 2000), Myf5 mRNA is not detectable (Comelison & Wold 
1997). Satellite cell activation is characterised by the almost ubiquitous upregulation 
of Myf5 and MyoD mRNA and protein expression (Comelison & Wold 1997, Cooper 
et al. 1999, Zammit et al. 2002, 2004a), which is retained by the proliferative progeny 
(Zammit et al. 2002). This thesis has demonstrated that the progeny of satellite cells 
can undergo extensive in vivo or in vitro proliferation before returning to the satellite 
cell niche. This implies the existence of a renewal mechanism analogous to the stem 
cell-reversion of intestinal crypt transit amplifying cells (reviewed, Marshman et al. 
2002, Potten 2004), whereby satellite cell progeny enter an active myogenic program 
from which a subset subsequently withdraw, maintaining the precursor population by 
reverting to a quiescent state. Perhaps similarly, HSC have been shown to exist in a 
state of reversible mitotic quiescence whereby at least 75% of the population is
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quiescent at any one timepoint, but almost the entire population is recruited into the 
cell cycle during a thirty day period (Bradford et al. 1997, Cheshier et al. 1999). 
However, there is no evidence that the progeny of HSC can express markers of 
commitment to a particular myeloid lineage and subsequently return to mitotic 
quiescence, a respect in which they may differ from the progeny of satellite cells.
Previously, it has been demonstrated that satellite cells associated with single 
myofibres in suspension culture generate reserve progeny with a mechanism 
suggestive of self-renewal (Zammit et al. 2004a). In Chapter 4 it was shown that the 
satellite cells associated with one grafted myofibre can generate progeny which form 
new satellite cells on many other myofibres, demonstrating that satellite cells can be 
formed outside of the original parental niche. In addition, a Pax7+ satellite cell-like 
phenotype was generated as a reserve population in differentiated single myofibre 
cultures (Chapter 4), from cells unequivocally outside the satellite cell niche. 
Therefore although it is possible, and perhaps highly probable, that the satellite cell 
niche has a role in maintaining the undifferentiated and quiescent state of satellite 
cells, these findings predict that cells committed to becoming satellite cells are 
originally generated outside of the niche into which they are subsequently recruited.
Skeletal muscles maintain the ability to regenerate throughout several bouts of 
damage (Luz et al. 2002). This thesis has shown that the satellite cells associated 
with a single grafted myofibre generate progeny which can both participate in 
regeneration induced by the chronic mdx myopathy, and in at least two acute 
regenerative episodes induced by application of myotoxin. This demonstrates that 
satellite cells can maintain a functional myogenic population not only throughout the 
relatively moderate demands of postnatal growth and focal myopathic damage, but 
whilst undergoing rapid clonal expansion within the disorganised regenerative milieu 
of notexin-damaged muscle. These data predict that the satellite cell compartment 
constitutes a self-sufficient regenerative source, and is not dependent on a 
contribution from other cells either derived from other niches within the tissue, or 
from the circulation. Though anatomically-defined satellite cells which express 
appropriate phenotypic markers can be derived from grafts of bone marrow cells 
(LaBarge & Blau 2002, Dreyfus et al. 2004), data linking these cells to any significant 
myogenic activity is lacking. Furthermore, previous studies have shown that local
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exposure of mouse muscles to 18 Gy irradiation results in a long-term growth deficit 
(Wakeford et al. 1991, Quinlan et al. 1995), and sustained depletion of satellite cells 
that can give rise to replicative progeny in tissue culture (Heslop et al. 2000). This 
thesis has demonstrated that the myogenic activity of single myofibre grafts originates 
from satellite cells which lose their myogenic potential after exposure to 18 Gy 
irradiation, thereby further implicating radiation-sensitive satellite cells as the 
phenotype whose absence prevents generation of functional MPC in irradiated 
muscles.
6.4 Evidence for MPC outside the satellite cell compartment
The numbers of desmin+ cells obtained from enzymatically-disaggregated muscles 
exceeded the number of satellite cells likely to have been present in each muscle 
(Chapter 3). This suggests that uninjured adult muscles contain MPC both within 
and outside of the satellite cell niche. In vitro, single myofibres were found to 
generate a greater proportion of satellite cell-like reserve progeny than satellite cells 
exist in vivo. Speculatively, satellite cells may generate both new satellite cells and 
MPC outside the niche. That non-satellite cell MPC are probably present in uninjured 
adult muscles suggests that they are not a transitory population which exists only 
during regenerative events, but form a permanent compartment.
The myogenic satellite cells in single myofibre grafts were found to be sensitive to 
radiation (Chapter 3). The results of a previous study showed that muscle also 
contains a radiation-resistant population of myogenic cells (Heslop et al. 2000). In 
Chapter 4, proilferative cells cultured from irradiated but otherwise undamaged adult 
muscles were found to be desmin+, but did not express donor markers, and were 
therefore likely to have been derived from the host tissue. This supports the view that 
radiation-resistant MPC are committed and resident within the tissue, rather than 
derived from the myogenic recruitment of endogenous or exogenous non-muscle 
phenotypes in response to acute damage. Radiation-resistant MPC can give rise to 
satellite cells (Heslop et al. 2000), but this thesis has demonstrated that grafts of 
radiation-sensitive satellite cells also efficiently generate new satellite cells. 
Speculatively, trafficking may occur between satellite cells and radiation-resistant 
cells such that the cells of what is essentially a single population acquire different
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functional attributes according to their residency within two alternative niches. 
Whilst the ability of radiation resistant MPC to give rise to satellite cells has been 
established, the potential of radiation-sensitive satellite cells to conversely generate 
radiation-resistant MPC is not known. The implied existence of two closely-related, 
yet separable, subsets is analogous with the stem cell system of the adult skin 
epidermis, whereby two functionally similar subpopulations of stem cells exhibit 
behavioural and phenotypic heterogeneity that is linked to differences in anatomical 
location (Blanpain et al. 2004).
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6.5 A proposed model for the role of satellite cells in adult muscle 
regeneration
A: Quiescent satellite cells in 
undamaged adult muscle.
B: After damage, signaling 
from the parent myofibre 
causes a satellite cell to 
become activated and divide.
A daughter cell migrates out 
from beneath the basal 
lamina.
C: The daughter cell 
proliferates extensively to 
generate numerous progeny.
D: The progeny adopt 
alternative fates and either 
commit to differentiation (blue) 
or remain undifferentiated 
(yellow).
E: Differentiation-committed 
cells fuse and contribute to 
new myonuclei.
F: Undifferentiated progenitors 
either continue proliferating to 
derive the next cohort of 
myoblasts, or stop 
proliferating and alternatively 
remain outside the satellite 
cell niche, or are captured 
beneath the basal lamina of 
newly-formed myofibres and 
thus generate new satellite 
cells.
G: New myofibres gradually 
mature, retaining their 
associated populations of 
satellite cells.
H: The new generation of 
satellite cells are fully 
competent to participate in 
subsequent bouts of 
regeneration.
D t t t t
H
t t t
♦ * t
Fig. 6.1. A proposed model for the mechanism by which satellite cells constitute a 
self-sufficient source of myonuclei in adult muscles.
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6.6 Satellite cell heterogeneity between different muscles
In Chapter 3, whilst the amounts of muscle generated from grafts of primary isolated 
myoblasts did not differ according to whether the cells were prepared from pooled 
EDL, soleus or TA muscles, muscle formation from grafted single myofibres 
exhibited striking inter-muscle heterogeneity. At the three week timepoint, soleus 
myofibres (with 22 satellite cells) formed muscle in 75% of graft sites, whereas EDL 
and TA myofibres, (with 7 and 10 satellite cells respectively), formed muscle in 32% 
and 33% of graft sites. These differences appear to correlate directly with differences 
the numbers of satellite cells typically present in each graft.
The large differences between the amounts of muscle formed by myofibres of 
different origin were unexpected, and cannot be explained fully by differences in 
numbers of satellite cells. At the three week timepoint, whereas a proportion of EDL 
and soleus myofibre grafts contributed to more than 100 new myofibres, no TA 
myofibre graft contributed to more than 11 new myofibres. This difference was found 
to be extremely significant. However, in experiments described in Chapter 5, where 
muscles were harvested at the five week timepoint, some muscles engrafted with TA 
myofibres contained more than 150 donor-derived myofibres. At this later timepoint, 
there was no statistically-significant difference between the total numbers of 
dystrophin+ myofibres formed by grafts derived from different muscles. However, 
when the numbers of newly-regenerated (dystrophin+ neonatal myosin+) myofibres 
were compared, there were significantly more newly-regenerated myofibres in TA 
myofibre-engrafted muscles than in EDL or soleus myofibre-engrafted muscles. 
Together, the data described in this thesis suggest that firstly, muscle formation is 
spontaneously augmented over time, and secondly, that the progeny of TA satellite 
cells chiefly differ from the progeny of EDL and soleus satellite cells in terms of their 
rate of proliferation (or possibly rate of differentiation), rather than in terms of 
absolute myogenic potential. One week after notexin treatment, TA single myofibre 
grafts generated smaller numbers of new myofibres than EDL or soleus single 
myofibre grafts, a difference which might also have resulted from a slower 
proliferative rate.
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In vitro, the progeny of EDL and soleus satellite cells proliferate at similar rates, 
though the larger numbers of satellite cells associated with individual soleus 
myofibres accordingly generate larger absolute numbers of progeny (Zammit et al. 
2002). There is no corresponding data available for TA satellite cells. However, 
since exposure to serum mitogens synchronously activates 98% of satellite cells 
within 24 h of myofibre isolation (Zammit et al. 2002), the tissue culture environment 
may not be the ideal means of modelling the in vivo, phenomenon where inter- or 
intra-graft asynchrony of activation could be an important factor.
Other workers have reported that the efficiency of muscle formation is increased 
where donor myoblasts and host muscle are matched for fibre type compatibility 
(Peterson & Huard 2000, Qu & Huard 2000). The data described in Chapter 3 
directly contradict this finding, in that TA satellite cells grafted into TA muscles 
formed muscle with initially lower efficiency than EDL or soleus satellite cells 
grafted into TA muscles. In addition, though it has previously been reported that a 
subset of soleus satellite cells preferentially differentiate into slow myofibres 
(Rosenblatt et al. 1996), this thesis has shown that after grafting into irradiated TA 
muscles, soleus satellite cells do not generate slow myofibres de novo but 
predominantly generate fast fibre-types, many of which moreover express the 3F- 
nLacZ-2E transgene. This finding suggests that any endogenous commitment is 
overridden by signals from the host tissue.
The different murine skeletal muscles are of oligoclonal embryonic origin (Eloy- 
Trinquet & Nicolas 2002, reviewed, Buckingham et al. 2003). It has been 
demonstrated that transplanted myoblasts can migrate between different muscles 
(Watt et al. 1987, Jockusch & Voigt 2003) and that satellite cells can be derived from 
bone marrow grafts (LaBarge & Blau 2002, Dreyfus et al. 2004). This thesis has 
shown that adult satellite cells have distinct muscle-specific qualities which are 
retained after transplantation into a different muscle. Whilst the TA and EDL muscles 
are anatomically adjacent (see Fig. 2.1), their satellite cell populations appear to be 
discrete. This finding suggests that firstly, functional satellite cells are not frequently
r-
derived from outside the tissue, and secondly, that inter-muscle trafficking of satellite 
cells is also infrequent.
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Pax3+ Pax7+ cells are thought to represent a separate lineage to Pax3' Pax7+ myogenic 
cells in adult skeletal muscle (personal communication, D. Montarras). It Chapter 4, 
it has been shown that Pax3-GFP+ cells can give rise to satellite cells which retain 
robust expression of Pax3-GFP protein. Since Pax3-GFP+ cells are frequent in the 
donor diaphragm muscle but infrequent in the host TA muscle, this is further evidence 
that the MPC populations of different adult muscles have distinct qualities which are 
retained independently of their external environment, and speculatively could reflect 
different embryonic origins.
6.7 Evidence for functionally-distinct subsets of satellite cells
In some of the experiments described in Chapter 5, 100% of single myofibre grafts 
were found to give rise to donor-derived products after regeneration of engrafted 
muscles was stimulated by notexin damage. This suggests that technical failure was 
not a major contributory factor in other experiments where only a proportion of grafts 
generated muscle. Local environmental differences in the myopathic host graft site 
(Tanabe et al. 1986, Coulton et al. 1988, reviewed, Partridge 1997) are likely to have 
been a partial determinant of myogenic recruitment, but there is no obvious reason 
why this factor should generate the evident variability between grafts derived from 
different muscles.
In contrast to soleus and TA myofibres, grafts of EDL myofibres were never found to 
generate donor-derived products in 100% of engrafted muscles. The highest 
frequency occurred after notexin treatment, and was 75%. Only EDL myofibre- 
engrafted muscles were examined at the extended twelve week timepoint; even under 
these conditions the frequency was only 56%. All EDL myofibres (n=77 examined) 
were found to have at least one Pax7+ associated satellite cell (Chapter 3). The lack of 
muscle formation by some EDL myofibres therefore implies that not all satellite cells 
form muscle after grafting. Since EDL myofibres have 7 associated satellite cells, 
soleus myofibres have 22 satellite cells and TA myofibres have 10 satellite cells, the 
maximum observed frequencies of muscle formation (100% for soleus and TA 
myofibre grafts, 75% for EDL myofibre grafts) could be accounted for by a 
hypothetical subset which forms only 10% of the compartment, and is therefore 
absent from some EDL myofibres whilst being present on the vast majority of soleus
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and TA myofibres. This subset could either differ with regards to its ability to 
survive grafting, or differ in terms of its innate myogenic potential.
Functional heterogeneity of satellite cells has previously been identified by other 
workers (Rantenan et al. 1995, Schultz 1996, Rouger et al. 2004). Rantenan et al. 
(1995) showed that though proliferation does not commence until about 24 h after 
injury, some myoblasts upregulate expression of MyoD and myogenin within 8 h. 
This was taken as evidence for two separate subsets of satellite cells: one population 
which rapidly commits to differentiation and has only limited subsequent proliferative 
ability, and another more stem cell-like population that has the ability to undergo 
more extensive proliferation (Rantenan et al. 1995). Rouger et al. (2004) carried out 
clonal analysis of myoblasts derived from turkey muscles. It was found that about 8% 
of clones formed a highly-proliferative subset which preferentially fused into mature 
myofibres (Rouger et al. 2004). The proliferative subset described in these two 
studies (Rantenan et al. 1995, Rouger et al. 2004) could be analogous to the highly- 
proliferative satellite cells described in this thesis.
Schultz (1996) administered BrdU to juvenile rats. He found that whilst the majority 
population of satellite cells incorporated BrdU within a five day period, about 20% 
formed a slow-cycling subset which were labelled more slowly, and were postulated 
as the source of renewal of the majority population (Schultz 1996). Similarly, Rouger 
et al. (2004) found that about 50% of turkey myoblast clones cycled more slowly than 
the rest of the population, and had lower fusion indices. Slow-cycling clones were 
thought to generate satellite cells more frequently than other clones (though the lack 
of phenotypic markers in this study renders the observation slightly equivocal) 
(Rouger et al. 2004). The single myofibre grafts employed in this thesis each 
contained multiple satellite cells. Therefore hypothetically, satellite cells and muscle 
could have been generated separately by different clones. Nevertheless, the ability to 
participate in two or more regenerative events is evidence that the graft-derived 
satellite cells or MPC had latent myogenic potential.
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6.8 Therapeutic implications
The data presented in thesis predict that in the mouse, satellite cells are the main 
source of new myonuclei in regenerating adult muscles. The extent to which these 
findings extrapolate to human skeletal muscle could be assessed using xenografts of 
human single myofibres (Bonavaud et al. 2002) into highly-immunodeficient host 
mouse strains such as the RAG2(‘/‘)/y-chain(‘/‘) (Cooper et al. 2001) which are tolerant 
of human cells.
Historically, the apparent efficacy of MTT in mouse models (Partridge et al. 1989, 
Morgan et al. 1990) was not recapitulated by human clinical trials (Gussoni et al. 
1992, Karpati et al. 1993, Tremblay et al. 1993, Mendell et al. 1995, Miller et al. 
1997). It was found that though viable cells derived from the graft had persisted in 
patient muscles several months after transplantation, they had apparently failed to 
differentiate (Gussoni et al. 1997). In mouse models, myoblasts form muscle with 
greater efficiency in irradiated than in non-irradiated graft sites (Morgan et al. 1990, 
Kinoshita et al. 1994, Gross et al. 1999), and this thesis has demonstrated that single 
myofibres harbour a phenotype which is completely non-myogenic in non-irradiated 
graft sites. Irradiation was not used in human trials; perhaps the presence of the 
patients’ own satellite cells inhibited the donor cells from homing to the niche 
required for them to initiate an active myogenic program.
Single myofibre grafts could represent a refinement over grafts of cultured myoblasts 
in future clinical trials of MTT. However, there are a number of practical problems 
which would need to be overcome. Whereas human myoblasts can be isolated from 
needle biopsies, isolation of viable single myofibres would probably require a more 
invasive surgical procedure. In addition, it would not be feasible to treat patient 
muscles with 18 Gy irradiation, though speculatively, the minimum dose required 
might be lower than this.
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6.9 Future work
The single myofibre graft technique is a model system for investigating the behaviour 
of satellite cells during muscle regeneration. The most precise way of investigating 
the potential of stem cells is to use single cell transplantation (Osawa et al. 1996, 
Matsuzaki et al. 2004). The myofibres of the murine FDB muscle typically have only 
one satellite cell (personal communication, P. Gailly), and could therefore be used to 
perform grafts of single defined satellite cells. Single satellite cell transplantation 
would be a simple and robust method of clonal analysis, and would avoid the 
problems associated with viral labelling strategies described in Chapter 4.
A very robust method of demonstrating self-renewal is to carry out serial 
transplantations, whereby donor cells are re-isolated from a first host, and their 
continued potential examined in a second host. This might be achieved using a donor 
mouse strain in which satellite cells are marked by GIT expression, and would 
therefore be identifiable in living myofibres isolated from the first host. More refined 
experiments such as these could be used to analyse satellite cell behaviour with more 
precision and in greater detail.
The single myofibre graft technique could be used to investigate the contribution of 
satellite cells to other lineages, either using a donor strain with a ubiquitously- 
expressed genetic marker, or strains with genetic markers of specific lineages. 
Likewise, the technique could be employed to investigate the relationship of satellite 
cells with other putative stem cells within muscle tissue, such as muscle SP (Asakura 
et al. 2002) and the radiation-resistant population (Heslop et al. 2000).
6.10 Concluding remarks
This thesis has demonstrated that anatomically-defined satellite cells exhibit several 
stem cell-like qualities, including the ability to generate large numbers of 
differentiation-competent progeny, the potential to self-renew their own compartment, 
and the capacity to respond to damage by undergoing rapid clonal expansion and 
efficiently regenerating new muscle tissue. These findings show that the satellite cell 
niche is an important determinant of stem cell potential, and predict that satellite cells 
are the basal origin of new myonuclei in regenerating adult muscles.
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Appendix 
Notes on statistical techniques
Statistical analyses were carried out using the computer program INSTAT.
Mann-Whitney test
The parametric t-test is correctly used to compare pairs of treatment populations that 
have a normal distribution and similar variability, but does not reliably compare 
populations that are not normally distributed or have unequal SDs. Since the data sets 
described in this thesis are not normally distributed and in many cases have dissimilar 
SDs, the Mann-Whitney test was used as a non-parametric (distribution-free) 
alternative to the t-test. This test requires that the sample populations have similar, 
but not necessarily normal, distributions i.e. they may be either positively or 
negatively skewed, but to a similar degree in each population. It can be used to 
compare two populations of different sizes. Mann-Whitney tests whether there is a 
difference between two population medians. The total data points from the two 
populations are ranked together in order of size. If two data points are tied, the 
average rank is given to each. The sum of ranks for each population forms the test 
statistic (W)- The p value is adjusted to account for tied values. A p value of >0.05 
indicates that the two populations are significantly different from each other (Watt 
1997).
Kruskal-Wallis test
Kruskal-Wallis is a non-parametric ANOVA test that is used to compare multiple 
populations. It differs from standard parametric ANOVA in that whilst it is a less 
sensitive test, it can be used to compare populations that are not normally distributed, 
but are either positively or negatively skewed. However, the different populations 
are required to have similarly-shaped distributions. The total data points derived from 
all the treatment populations are ranked together, and the mean rank of each treatment 
population calculated. The test compares the mean rank of each treatment population 
with the mean rank of the total population, generating a *z value’ for each treatment
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population. A p value of <0.05 indicates that at least one population is significantly 
different from the other populations (Fisher & van Belle 1993, Watt 1997).
Where p was <0.05, Dunn’s multiple comparisons test was used to resolve the origin 
of the significant difference. Dunn’s test compares individual pairs of treatments 
within the data set and generates a p value for each pair. Where p=<0.05, the two 
paired populations are significantly different from one another.
Kolgomorov-Smirnov two sample test
The Kolmogorov-Smimov non-parametric test is used to compare the distributions of 
two populations one or both of which does not follow the normal distribution. Data 
within each population are ranked as empirical culmulative distributions such that the 
distributions of two unequally sized populations can be compared. The value of the 
Kolgomorov-Smirnov test statistic (KS) is derived from the maximum absolute 
difference between the two empirical cumulative distribution functions. The test 
statistic is not efficient where the t-test applies. Where p=<0.05, the distributions of 
the two populations are significantly different from one another. The test is most 
reliable in the absence of tied data points (Fisher & van Belle 1993).
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Addenda
References
Page 41: Cell-cycle regulation of Myf5 expression in C2 cells was originally reported in Lindon C., 
Montarras D., & Pinset C. (1998) Cell cycle-regulated expression of the muscle determination factor 
Myf5 in proliferating myoblasts. J. Cell Biol. 140, 111-118.
Pages 48 and 150: Sajko et al. (2004) refers to the following omitted publication: Sajko S., Kubinova 
L., Cvetko E., Kreft M., Wernig A. & Erzen I. (2004) Frequency of M-cadherin-stained satellite cells 
declines in human muscles during aging. J. Histochem. Cytochem. 52, 179-185.
Definitions
“Stem celP: adult stem cells were originally defined as cells capable of maintaining a tissue by 
generating differentiation-competent progeny and undergoing repeated self-renewal throughout the 
normal lifespan of an organism (see page 30). So far only HSC have been demonstrated to fulfill these 
criteria robustly. However, both HSC and several other adult cell types are capable of generating 
several sorts of differentiated cell, and many authors now regard such multipotency as a defining 
characteristic of stem cells when combined with self-renewal. By these criteria not only HSC but 
certain primitive epidermal and neural cells can be regarded as adult stem cells, though in these cases it 
is not yet known whether self-renewal is maintained throughout an entire lifespan.
“Satellite cell niche”: here refers to the anatomical situation between the basal lamina and sarcolemma 
of myofibres by which satellite cells were originally defined (Mauro 1961).
“Phenotype”: is strictly defined as the observable characteristics of an organism resulting from the 
interaction between genotype and environment. In this thesis the term is used more loosely to define 
cell populations by observable characteristics such as the expression of specific marker proteins. 
“Lineage”: a lineage is defined as the descendents of one individual. Cells which differ with regards 
to Pax3 expression (4.5) appear to form separable adult populations, but each population could have 
derived from multiple progenitors. Therefore a description of Pax3+ and Pax3~ muscle cells as separate 
lineages is inaccurate.
Note on possible inter-muscle heterogeneity of satellite cells
In Chapter 3, grafts o f EDL and soleus single myofibres were occasionally found to give rise to very 
large clusters of muscle whereas grafts of TA single myofibres never gave rise to large clusters. 
However, the difference between the amounts of muscle formed by EDL and TA single myofibres was 
not found to statistically significant using the Kruskal-Wallis and Dunn’s tests. Consequently it is 
possible that the apparent inter-muscle heterogeneity resulted from chance alone. In Chapter 5, when 
analysed at a later timepoint TA myofibre grafts generated significantly larger amounts of newly­
regenerated muscle than EDL myofibre grafts, though the total amounts o f muscle formed did not 
differ. Therefore though the findings described in this thesis provide some evidence of satellite cell 
inter-muscle heterogeneity, further experiments, possibly combined with improved methods of data 
analysis, are required before such heterogeneity can be demonstrated unequivocally.
